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 Synthetic calcium phosphate (CaP) materials exhibit unique chemical, biological and physical 
properties. Subsequently, they are routinely used as bone graft substitute materials.  
 
 There is significant demand for a reliable synthesis technique that can rapidly produce bioactive 
CaP biomaterials[1-4][1-4]. The purpose of this research was to evaluate the potential of specific 
combustion synthesis (CS) techniques: Self-propagating high-temperature synthesis (SHS) and 
decomposition combustion synthesis (DCS) for the production of CaP constructs and powders and to 
clarify the relationships between CS reactant properties, reaction parameters and product properties.  
 
 CS reactions are highly versatile; reactant composition and stoichiometry can be modified to 
incorporate specific atoms or ions into the final products to enhance mechanical performance, specific 
material properties, bioactivity and functionality in vivo.  
 
 SHS reactant composition and reactant stoichiometry were modified to generate porous three-
dimensional CaP scaffolds substituted with silver (Ag), strontium (Sr), magnesium (Mg), β-tricalcium 
phosphate (TCP) or reacted hydroxyapatite (HA). Post-synthesis, 100 TCP constructs were heat treated 
and coated with collagen, alginate or chitosan to produce CaP-based composite devices. Product 
composition, morphology and mechanical properties were characterized to elucidate the effects of altering 
reactant composition and stoichiometry on product properties. Antimicrobial performance of the CaP-Ag 
constructs was assessed against Escherichia coli, while cytotoxicity, biocompatibility and biologic 
response to the CaP-Ag constructs were assessed with a human fetal osteoblast cell line (ATCC, CRL-
11372).  
 
DCS reactant ratio was modified to generate CaP biopowders with specific chemistries. Product 
composition and morphology were analyzed and in vitro testing methods were utilized to determine the 
effects of controlling product composition on cytotoxicity, proliferation, biocompatibility and 
biomineralization.  
 
 SHS and DCS represent manufacturing methods that can be utilized to synthesize CaP constructs 
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CHAPTER 1 PROJECT MOTIVATION AND INTRODUCTION 
 
 There is significant demand for a reliable synthesis technique that can quickly produce bulk 
quantities of bioactive synthetic bone tissue substitute materials. Additionally, this synthesis technique 
should be robust enough that product composition and chemistry can be customized for specific bone 
tissue engineering applications and improve product quality, capabilities, life expectancy and 
functionality in vivo. 
 
1.1 Bone Replacement Materials 
 
 Autologous bone (From self) is considered the gold-standard bone graft material. The advantage 
of an autograft is that it contains viable osteoblasts and osteogenic precursor cells that can contribute to 
the formation of new bone[5, 6]. Additionally, autologous bone retains the three essential functions that 
are required for bone regeneration: osteogenesis, osteoinduction and osteoconduction. There are, 
however, disadvantages associated with using autologous bone. There is a finite amount of bone tissue 
can be harvested and the harvesting procedure may lead to donor site discomfort, weakness resulting in 
fracture and morbidity at the harvest site[6, 7]. A viable alternative to autologous bone is synthetic bone.  
 
Synthetic Calcium Phosphate Materials are Utilized as Bone Replacement Materials and in Bone Tissue 
Engineering Due to Their Physiochemical and Biological Similarity to the Mineral Phase of Natural 
Bone. 
 
 Synthetic calcium phosphate (CaP) materials became commercially available as bone substitute 
materials for dental and medical applications in the 1980s[8, 9] and over the last three decades there has 
been increasing interest and progress in the application of synthetic CaPs as bone tissue replacement 
materials and bone tissue scaffolds[2, 4, 10-12]. Synthetic CaPs are used in a plethora of biomedical 
applications as coatings, cements, powders and three-dimensional (3D) tissue scaffolds. As coatings, they 
are applied to metallic or bioinert components to improve biologic activity and osteointegration i.e. the 
formation of an interfacial mineralized layer between the implant and bone tissue[4, 12]. As cements, 
powders and 3D tissue scaffolds they are utilized in crainomaxillofacial reconstruction, in dental surgery 
for repair of periodontal disease, in orthopedic surgery as bone fillers, bone replacements and as bone 
tissue scaffolds[1, 4, 5]. Continuing research on potential applications of CaP materials includes use as 
drug delivery devices[13, 14] and as carriers of growth factors, cells and proteins for bone tissue 
engineering[4]. CaP materials possess unique chemical, biological and physical properties. They stimulate 
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a biologic response similar to that exhibited during bone healing[1]. Synthetic CaP materials have been 
shown to be bioactive[2, 4, 15-17], promote bone growth on and/or within the construct 
(osteoconduction)[3, 18] and induce osteogenesis by stimulating undifferentiated cells to differentiate into 
preosteoblast cells in a non-osseous environment (osteoinduction)[1, 3, 4, 18, 19]. Additionally, CaP 
materials encourage the formation of a physico-chemical bond between the host tissue and implant 
material resulting in tissue integration[1, 4, 17, 20, 21]. Synthetic CaP materials represent an alternative 
source of bioactive materials for use in bone tissue engineering applications.   
 
1.2 Shortcomings of Current Calcium Phosphate Production Processes   
 
 Current synthesis techniques for CaPs can be divided into wet methods or solid-state 
reactions[22]. Wet methods include aqueous precipitation, gel casting, slurry dipping and spraying, sol-
gel or hydrolysis of calcium phosphates[4, 8, 9, 22]. Solid-state reactions include uniaxial (pressure 
applied along one axis) or isostatic compaction of loose powder with subsequent heat treatment; hot-
pressing; 3D laser printing and selective laser sintering[4, 8, 9, 22]. There are significant inadequacies 
with the synthesis methods currently utilized for the CaP production that increase production time, 
production costs and labor for bulk production. Synthesis times for wet methods can take weeks to 
produce small quantities of CaP and require precise measurements of liquid solutions[23, 24], while 
solid-state reactions can require multiple heat treatments to produce CaP[4, 8, 25].  
 
Combustion Synthesis Could Be a Viable Technique for Calcium Phosphate Production.  
 
 Combustion synthesis (CS) is an overarching term coined for self-sustaining exothermic reactions 
that utilize internally generated energy[26] to rapidly produce a desired product. Wet methods and other 
varieties of solid-state reactions require hours or even days for CaP production[4, 8, 9, 22], while CS 
reactions are less than 20 seconds from initiation to completion and require less than 10 minutes to 
cool[26-33]. Many forms of combustion synthesis such as Self-Propagating High-Temperature Synthesis, 
Decomposition Combustion Synthesis, Explosion Synthesis, Field Activated Synthesis and Microwave-
Assisted Synthesis have been utilized to manufacture ceramics[34, 35], intermetallics[36] and metals for a 
wide variety of applications. Recently, there has been increased interest in the use of combustion 
synthesis as a method to produce nickel titanium[30], cobalt chromium and calcium phosphate for 




 Combustion synthesis reactions are highly versatile; reaction parameters can be altered to modify 
product chemistry, composition, morphology and material properties. To provide a better understanding 
of the CaP CS systems, this research focused on analyzing the relationships between reactant, reaction 
and product properties (Figure 1.1). 
 
 The research in this dissertation focuses on two types of combustion synthesis for production of 
CaP biomaterials: Self-propagating high-temperature synthesis (SHS) and decomposition combustion 
synthesis (DCS) and presents their abundant potential for production of synthetic bone substitute 
materials and devices.  
 
 
Figure 1.1 Diagram of the suggested relationships between reactant, reaction and product properties. 
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CHAPTER 2 LITERATURE REVIEW 
 
 Understanding the fundament components of a project is essential for designing experiments and 
conducting research. The following chapter includes a literature review on combustion synthesis, the 
microstructure and properties of select calcium phosphate and the anatomy and properties of bone.  
 
2.1 Combustion Synthesis Fundamentals 
 
 Combustion synthesis (CS) is an attractive alternative to the conventional methods of producing 
calcium phosphate (CaP) materials (e.g. wet chemistry precipitation; calcination; sol gel)[4, 22, 23, 38-
40] with respect to process time, process versatility and process simplicity. CS reactions are self-
sustaining reactions that utilize the energy generated from exothermic reactions of preceding reactant 
layers to sustain the propagation of a combustion wave through the adjacent reactant layers[26, 27, 29, 
41-43] converting them into the desired CaP products[27, 29, 41]. Subsequently, the energy and time 
required for CaP fabrication are significantly low. CS reactions are highly versatile; reactant 
stoichiometry can be controlled to produce products with specific mono-, bi-, tri- or multiphasic 
compositions[27, 29, 41] while reactant chemistry can be modified to incorporate specific chemical 
elements, ions or chemical compounds (e.g. silver; magnesium; strontium; carbonate ions; silica) into the 
CaP product[44]. 
 
CS can be separated by reaction mode into two categories: propagation mode and simultaneous 
combustion mode[26, 33, 45]. Propagation mode occurs when the reaction is initiated by a localized heat 
source applied to the sample which “Proceeds through the reactants in the form of a propagating, 
unidirectional wave front converting reactants to products.”[41] The wave front is driven by the 
exothermic heat released during the reaction of adjacent layers[26-28, 33, 36, 43, 46]. Self-propagating 
high-temperature synthesis (SHS) is an example of propagation mode CS. The research discussed in 
Chapter 4 describes CaP produced via SHS. 
 
Simultaneous combustion mode occurs when the reactants are uniformly heated to ignition 
temperature and react simultaneously. This produces numerous wave fronts that convert the reactants to 
products and propagate in varying, complex paths[26, 31, 33]. Decomposition combustion synthesis 
(DCS) is an example of simultaneous CS and the work presented in Chapter 6 discusses CaP production 




 A thorough examination of the thermochemistry involved in graphically and theoretically 
determining the adiabatic temperature of a reaction was presented by Moore[33, 47] and Munir[26]. 
Briefly, during the CS reaction there are four significant temperature points that can affect the reaction 
and, subsequently, the final product: the theoretically calculated adiabatic temperature (Tad) and the 
measured initial temperature (To), ignition temperature (Tig) and combustion temperature (Tc)[26, 33, 47]. 
To indicates the temperature of the reactant sample prior to ignition, Tig is the temperature at which the 
reaction is initiated while Tc is the steady state accumulation of heat generated at a constant velocity[26, 
33, 47]. A schematic of the time-temperature profile for an SHS reaction is shown in Figure 2.1. 
 
 
Figure 2.1 Time versus temperature profile for a propagation mode CS reaction. Cooling rate, theoretical 
adiabatic temperature, combustion temperature, ignition temperature and initial temperature are shown.  
 
 
 Thermodynamic calculations for the enthalpy and free energy of the reaction systems can predict 
the capability and stability of the reaction as well as the most likely product formed. The complex and 
extensive nature of thermodynamic calculations pertaining to CS reactions are discussed by Moore[33, 
47] and Munir[26] and readers are guided to these references for additional information. Briefly, to 
understand the thermodynamics behind CS reactions a relationship between reactants and products is 
needed. A general CS reaction is expressed in Equation 2.1.  
 
i i j jn R n P                                                                  (2.1) 
  
where Ri and Pj refer to the reactants and products, respectively and ni and nj are the stoichiometric 
coefficients of the reactants and products, respectively[26, 27, 33, 34, 47]. The CS reaction must go to 




 In general, exothermic CS reactions become self-sustaining at adiabatic temperatures (Tad) above 
1800K[26, 33]. Tad is the combustion temperature (Tc) of a reaction at which no heat is lost from the 
reaction to the  surrounding environment. An enthalpy versus temperature diagram showing the 
relationship between the reactants and products of an adiabatic SHS reaction is shown in Figure 2.2.  
 
 In CS reactions, reactants must be heated from their initial temperature (To) to their ignition 
temperature (Tig). The amount of heat required, H(R), to heat the reactants from their initial temperature 
to their ignition temperature in an adiabatic system is described by Equation 2.2[26, 27, 33]: 
 
 ( )  ∫ ∑    
   
  
(  )   ∑    (  )                                                   (2.2) 
 
where Cp(Ri) and L(Ri) are the heat capacity and phase change transformation enthalpy (if a phase change 
occurs) of the reactants and ni denotes the mole fraction of each reactant[27, 33]. In propagation mode 
(Self-propagating high-temperature synthesis, SHS, Chapters 4-5), the heat source is turned off after the 
reaction is initiated because the reactants have reached a steady-state[27]. Only the heat of the reaction, 
[ΔH(Tig)], is used to heat reactants in adjacent layers from To to Tig once the combustion reaction has 
reached a steady-state and the propagating reaction is at a distance where the original heating source is no 
longer an influence[26, 33]. This means that the remaining heat must be absorbed by the products[26, 33]. 
In an adiabatic system, the heat that will be absorbed by the products reaction after the reaction is initiated 
is given in Equation 2.3[26, 27, 33]: 
 
 ( )  ∫ ∑    
   (  )
   
(  )   ∑    (  )                   (  )                          (2.3) 
 
where Cp(Pj) and L(Pj) are the heat capacity and phase change transformation enthalpy (if a phase change 
occurs) of the products and ni denotes the mole fraction of each reactant[26, 27, 33]. 
 
 In an adiabatic system, the total heat available for reaction once the system has reached steady-
state, [ΔH(Tig)], is the sum of the two enthalpies calculated in Equations 2.2 and 2.3[26, 27, 33]. 
 
[ΔH(Tig)]= -[H(P)+H(R)]                                                        (2.4) 
 
 If To is increased to Tig, as is the case for simultaneous combustion mode (Decomposition 
combustion synthesis, DCS, Chapter 6), H(R) will decrease to zero and all of the heat generated from the 
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reaction, [ΔH(Tig)], will be absorbed by the products[26, 33]. This will shift the adiabatic temperature to 
Tad(Tig) (Figure 2.2). Equations 2.2 and2.3 are still valid, however, Equation 2.2 must be corrected by 
substituting Tad(Tig) for Tad(To)[26, 33]. 
  
 
Figure 2.2 Enthalpy versus temperature diagram. The relationship between the reactants and products of 
an adiabatic SHS reaction is displayed. 
 
  
 In CS, wave velocity, wave stability and maximum combustion temperature are dependent on: 
The heat generated by the reaction, the amount of heat lost to the environment and the amount of heat 
transferred to the adjacent reactant layer that is still below ignition temperature (has yet to react)[26, 33]. 
Typically CS is conducted in non-adiabatic conditions, which means that the actual combustion 
temperature is lower than the theoretical (calculated) combustion temperature. This difference is 
accounted for by the term ΔQ at Tc(To) in Figure 2.2[26, 33].  
  
 Thermodynamic analyses are of paramount importance for CS reactions. Decreasing reaction 
exothermicity (heat generation) while increasing the heat transferred away from the reaction front can 
slow combustion wave propagation or even quench the reaction[26, 33], while increasing reaction 
exothermicity can alter reaction velocity and reaction time[26, 33], subsequently altering product 
composition and morphology. CS reaction thermodynamics are an essential tool that can be used to 






























2.2 Calcium Phosphate Fundamentals 
  
 The following information gives a basic introduction to the crystal structure and specific 
properties on the three polymorphs of calcium phosphate (CaP) produced with combustion synthesis. 
Comprehensive investigations on the structure and chemistry of CaPs have been prepared by Elliot[48] 
and Dorozhkin[22].  
 
 Calcium phosphates (CaP), also known as calcium orthophosphates, are salts of orthophosphoric 






. CaPs consist of 
three major chemical elements: calcium (oxidation state +2), phosphorus (oxidation state +5) and oxygen 
(oxidation state –2)[1, 22, 48]. Changes to the calcium to phosphate ratio produce CaPs with different 
structures and compositions. A phase equilibrium diagram for a calcium oxide (CaO) diphosphorous 
pentoxide (P2O5) system[48, 49] shows the melting points, inversion temperatures and phases present in 
the CaP system (Figure 2.3).  
 
2.2.1 Hydroxyapatite (HA) 
 
 Apatites are a group of phosphate based minerals with a hexagonal crystal structure and the 
general chemical formula Ca5(PO4)3X, where X is an electronegative element or group e.g. a hydroxyl 
group (OH
-
). Apatites crystalize in the P63/m space group, have lattice parameters of a=9.4 and c=6.9Ǻ 
and two formula units per unit cell[1, 22, 48, 50-53]. 
 
 Hydroxyapatite (HA), Ca10(PO4)6(OH)2 is the second most stable and second least soluble 
CaP (After fluorapatite)[1, 17, 22, 48, 51-53]. Pure HA crystallizes in the monoclinic space group P21/b 
and has lattice parameters a=9.42148 Ǻ, b=2a, c=6.8147Ǻ and γ=120°; however, at temperatures above 





c)/2] and a packing factor of 12[1, 22, 48, 50-53]. Figure 2.4a and Figure 2.4b 
show the hexagonal crystal structure of HA[53]. There are calcium channels illustrated by blue hexagons 
that run down the structure in a helical pattern with hydroxyl groups (white dots) running down the center 
of each channel[53]. 
 
 Biological apatites are best described as calcium deficient HA and the incorporation of 
substitutional atoms greatly affects the mechanisms of formation, stability, morphology and the 































[1, 22, 48, 67]. 
 
 
Figure 2.3 Phase diagram of a calcium oxide-diphosphorous pentoxide (CaO-P2O5) system. 
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Figures 2.4a-b Images of 3D ball-and-stick models of the HA crystal structure. Blue dots are calcium, red 
dots are oxygen and green dots are phosphate ions. The white dots are hydroxyl groups and the blue 
hexagons illustrate calcium channels surrounding hydroxyl groups in a helical pattern.  
  b 
  a 
  a 
  b 
  c 
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2.2.2 Tricalcium Phosphate (TCP)   
 
 There are two phases of anhydrous tricalcium phosphate (Ca3(PO4) 2): α-TCP and β-TCP 
predominately utilized in bone tissue engineering applications[1, 17, 22, 48, 53, 54, 68]. Both α- and β-
TCP are more soluble and less stable than HA[1, 17, 22, 48, 53, 68] allowing for more extensive 
resorption after implantation[8, 13, 17, 22]. The β-TCP polymorph is stable up to a temperature of 
1125°C[17, 22, 48, 49] and at temperatures greater than 1125°C a high temperature phase transition from 
β-TCP to α-TCP occurs  (Figure 2.3)[49]. The α-TCP phase is more stable than β-TCP at temperatures 
between 1125°C and 1430°C[49]. 
 
 
Figure 2.5a-b Images of 3D ball-and-stick models of the -TCP crystal structure. a. Blue dots are 
calcium, red dots are oxygen and green dots are phosphate ions. b. Displays two columns composed of 
alternating cation-cation groups (A, red arrow) and alternating cation-anion groups (B, grey arrow). Every 
A column is surrounded by B 6 columns (black hexagon). The dotted line outlines the monoclinic with a 
pseudo-hexagonal crystal structure. 
 
 
 The α-TCP phase is monoclinic with a pseudo-hexagonal crystal structure with P21/a space 
groups and lattice parameters a=12.8872 Ǻ, b=27.280Ǻ, c=15.2192Ǻ, β=126.201°[1, 17, 22, 48, 53, 68, 
  a 
A 
B 
  b 
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69]. It has a packing factor of 8 or 12 and a volume of about 4312.51Ǻ [volume=a*b*c*sin[22, 48, 53]]. 
There are 24 formula units per unit cell[1, 17, 22, 48, 53, 68]. -TCP has a lower theoretical density than 
β-TCP which correlates to increased resorption[1, 8, 52, 70]. Figure 2.5a and Figure 2.5b display the 
crystal structure of -TCP[53, 69]. In the -TCP structure there are two columns composed of alternating 
cation-cation groups (A, red arrow) and alternating cation-anion groups (B, grey arrow). Every A column 
is surrounded by 6 B columns (black hexagon)(46). Calcium vacancies are located in the B column(46). 
These vacant sites decrease order within the structure and are potential locations for mono- and divalent 
cation substitutions(46).  
 
 The β-TCP phase is rhombohedral with an R3c space group and lattice parameters a=10.4391Ǻ, 
c=37.3756Ǻ in a distorted, pseudo-hexagonal setting. There are 21 formula units per hexagonal unit 
cell[1, 17, 22, 48, 53, 68, 71]. It has a volume of about 3527.196A [volume=(3√3*a
2
c)/2] and a packing 
factor of 8 or 12[1, 17, 22, 48, 53, 68, 71]. The solubility of β-TCP is approximately twice as high as HA, 
but lower than -TCP[1, 17, 22, 48, 52, 70, 71]. 
 
 
Figures 2.6a-c Images of 3D ball-and-stick models of β-TCP rhombohedral (distorted, pseudo-hexagonal) 
crystal structure. a-b. Blue dots are calcium, red dots are oxygen and green dots are phosphate ions. c. 
  a 
  b 
  c 
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Displays And A and B column running along the c-axis. The black hexagon outlines the rhombohedra or 
distorted, pseudo-hexagonal crystal structure. 
 
 Figures 2.6a-c display the crystal structure of β-TCP[53, 71]. In the β-TCP structure there are two 
columns (A and B) that run along the c-axis Figures 2.6c. The A column has the form: P(1)O4 Ca(4)O3 
Ca(5)O6   P(1)O4 and is surrounded by six B columns[53, 71]. Every Ca(4), Ca(5) and P(1) x and y atomic 
coordinate is zero indicating that the A column forms a straight line. There are four calcium and two 
phosphate atoms in the A column and no shared oxygen atoms among the P(1)O4, Ca(4)O3 and Ca(5)O6 
groups[53, 71]. The Ca(4) site is under bonded and typically unoccupied indicating some structural 
disorder and decreased stability[53, 71]. The B column has the form: P(3)O4 Ca(1)O7  Ca(3)O8 Ca(2)O8  
P(2)O4  P(3)O4 and is surrounded by two A and four B columns Figure 2.6c[53, 71]. Every Ca(1), Ca(2), 
Ca(3), P(2) and P(3) x and y atomic coordinate has a different value indicating that the B column is 
slightly distorted(49). The B column is more dense than the A column[53, 71]. It has six calcium and four 
phosphate atoms and some sharing of the phosphate polyhedra[53, 71]. It is likely that the Ca(2)O8 and 
P(2)O4 groups and the Ca(1)O7 and P(3)O4 groups share a corner while the Ca(1)O7 and Ca(2)O8 groups 
share an edge with the Ca(3)O8 group[53, 71].  
 
2.2.3 Multiphasic Calcium Phosphates 
  
 The rate of CaP dissolution in solution (HA<β-TCP<-TCP<<Amorphous CaP) is dictated by 
microstructural order and density (packing factor)[2, 17, 48, 72]. For example, α-TCP and β-TCP are 
more soluble and less stable than HA largely due to their lower densities and the higher number of 
unoccupied sites in their microstructures. Biphasic and triphasic CaPs are routinely used in reconstruction 
of bone defects as a method to control bioresorption[12] and it has been demonstrated that the bioactivity 
of biphasic CaPs can be directly controlled via manipulation of the CaP composition[8, 12, 14, 17, 53]. 
Currently available synthetic CaP materials are comprised of hydroxyapatite (HA)[16, 73], tricalcium 
phosphate (TCP)[74] or mixtures with varying percentages of HA and TCP[8, 9, 12, 75, 76] because the 
preferential dissolution of TCP increases bioresorption[8, 12, 77].  
 
 Basic knowledge of the microstructure, chemistry and properties of calcium phosphates is a 
fundamental requirement for designing bone substitute materials. For example, altering product 
composition can increase or decrease sorption rates in vivo subsequently altering product functionality 
and biologic response to the implant, so understanding properties associated with each CaP phase is 




2.3 Bone Anatomy and Physiology Fundamentals  
 
 The complex and extensive nature of the anatomy and physiology of bone are thoroughly 
discussed by Glimcher[78], Buckwalter(64), Martini[79], Black[80] and Piez[81] and readers are guided 
to these references for additional information. In short, bones are heterogeneous materials that form part 
of the endoskeleton of vertebrates. They are a load bearing organ that plays a large role in locomotion, 
provides anchoring points for muscles and ligaments, protects internal organs, stores minerals and 
produces white and red blood cells[1, 78, 79, 82].  
 
2.3.1 Structure of Bone 
  
 Bone is a complex and specialized form of connective tissue. It is a composite material comprised 
of an organic matrix strengthened by calcium phosphate crystals[1, 78, 79, 82-84]. Bone consists of 20 
weight % (wt%) water, 40-65wt% mineral and 15-35wt% organic matrix[1, 78, 79, 81, 82]. The mineral 
portion of bone consists of a calcium deficient apatite that closely resembles AB-type carbonate 
substituted HA[1, 57, 78, 79, 82, 85]. Trace elements (e.g. fluorine; magnesium) and/or hydroxyl groups 
(OH
-
) are also found in the mineral component of bone[1, 54, 78, 79, 82, 84]. Bone mineral crystals range 
in size from 20 to 1100Ǻ[1, 78, 79, 82]. The organic matrix is 90-95% type I and type IX collagen, about 
1% glycosaminoglycans and about 5% non-collagenous proteins[1, 78, 79, 81, 82]. The combination of 
organic and inorganic components generates physicochemical and biological aspects important to the 
functionality of bone.   
 
2.3.2 Cortical and Cancellous Bone 
 
 Adult bone is composed of about 20% cancellous bone and 80% cortical bone by mass; however, 
bones at specific locations throughout the body have different ratios of trabecular to cortical bone[1, 78, 
79, 82]. Cancellous (spongy) bone is a porous (30-90% porosity), 3D honeycomb-like scaffold 
interspersed throughout the bone marrow cavity[54]. It is organized into semilunar osteons, also known as 
packets, that are about 35nm thick[1, 78, 79, 82]. The mineral component of cancellous bone is composed 
of plates and rods 50-400nm thick. Cancellous bone has a density of 1.0g/ cm
3
[1, 54, 80, 83, 84]. Cortical 
(compact) bone has a density of 2.0g/cm
3
. It is less porous than spongy bone (5-30% porous), highly 
organized and surrounds the marrow cavity[1, 54, 78, 79, 82]. Compact bone is organized into cylindrical 
osteons (Haversian systems)that are approximately 200nm wide and 400nm tall[1, 78, 79, 82]. Figure 2.7 
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displays the microstructure of bone and the complex organization of cortical bone and the honeycomb-
like morphology of trabecular bone[79].     
 
 
Figure 2.7 Bone microstructure and morphology. The complex organization of cortical bone and the 
honeycomb-like morphology of cancellous bone are displayed.     
 
 
2.3.3 Mechanical Properties of Bone 
   
 Bone is anisotropic, its elastic properties and strength depend on its microstructural 
orientation[54, 83, 84]. As such the mechanical properties of bone are highly dependent on loading 
direction. Table 2.1 presents mechanical data for both compact and spongy bone in multiple loading 
directions(23, 62, 65, 66, 68) and compares these values to values for synthesized hydroxyapatite (HA).  
 
 Unfortunately, the mechanical properties of synthesized materials do not match the values for 
bone; however, novel research has improved improve the mechanical integrity and performance of bone 
substitute materials. Specifically, the utilization of polymer coatings (e.g. type I collagen; alginate; 
chitosan) to produce a bioactive composite material has increased compressive strength and fracture 
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toughness[5, 10, 15, 76, 86-88]. Readers are guided to Wang[54] and Al-Munajjed[10] for more 
information on the synthesis, characterization and properties of CaP-polymer composites. 
 
Table 2.1 Mechanical testing data for synthesized HA and cortical and spongy bone. L=Longitudinal 
loading, T=Transverse loading, SI=Superior/inferior loading, I=Isotropic plane, OA=Osteoarthritic 
femoral head, S=Side plane, B=Basal plane.  
 
 
2.3.4 Bone Remodeling Cycle  
 
Bone is a dynamic tissue. It is continuously being resorbed and remodeled through a highly 
coordinated cycle of tissue resorption and formation[1, 79, 80, 82]. It is estimated that 10% of an adult 
skeleton is remodeled every year which is important for maintenance of healthy bone[1, 79, 80, 82]. Bone 
remodeling removes bone defects and fractures up to the critical defect size; a defect size that will not 
naturally heal during the lifetime of the animal(23). 
 
Bone remodeling is the process of resorption of old bone by osteoclasts and the production of 
new bone by osteoblasts[1, 19, 79, 80, 82]. Osteoclasts (OC) are multinucleated cells derived from 
hematopoietic stem cells that differentiate along the monocyte–macrophage lineage[1, 19, 79, 80, 82]. 
OCs resorb bone through acidification and enzymatic degradation[1, 19, 79, 80, 82]. Osteoblasts (OB) are 
derived from pluripotential mesenchymal stem cells[1, 19, 79, 80, 82]. Mature OBs are non-migratory, 
highly differentiated cells[1, 19, 79, 80, 82]. Active OBs are mononuclear, have high alkaline phosphatase 
activity and synthesize and secrete type I collagen, glycoproteins (e.g. osteopontin; osteocalcin), 
cytokines, growth factors and calcium phosphate crystals[1, 19, 79-82, 90-93].  
 
Bone remodeling has been described by the following sequence of events: 1) Osteoclast 


































































82, 94-96]. The bone remodeling cycle can be broken down further into 11 steps: 1) Activation phase- 
pre-osteoclasts are attracted to the remodeling sites; 2) Activation phase- the pre-osteoclasts form 
multinucleated osteoclasts; 3) Resorption phase- osteoclasts remove cavities called “resorption pits;” 4) 
Resorption phase- calcium and minerals are released into the blood stream; 5) Resorption phase- after the 
resorption pit is formed osteoclasts apoptose; 6) Reversal phase- mesenchymal stem cells appear along 
the resorption pit; 7) Reversal phase- the cells proliferate and differentiate into pre-osteoblasts; 8) 
Formation phase- pre-osteoblasts differentiate into osteoblasts; 9) Formation phase- osteoblasts release 
osteoid, a soft, non-mineralized matrix, along the surface of the resorption pit; 10) Quiescence phase- the 
osteoid becomes mineralized via hydroxyapatite; 11) Quiescence phase the remodeled site remains 
dormant[94, 95]. The bone remodeling cycle is shown in Figure 2.8[94].  
 
 
Figure 2.8 Summary of the bone remodeling cycle. 
 
 
2.4 Design Requirements for a Bone Substitute Material 
  
 Biocompatibility has been defined as “The manner in which a material alters local tissue 
physiology.”[21] The biocompatibility of a biomaterial is determined by the reactions between the 
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biomaterials surface and the host environment(61, 62, 64, 74-76). Materials are biologically compatible if 
they do not produce a toxic, injurious or immunological response in living tissue(61, 62, 64, 74-76). Some 
factors such as patient age, gender, health and immunobiology determine the host’s inflammatory 
response to a biomaterial; however, material properties such as toxicity, chemistry and morphology play a 
large role in the inflammatory response a biomaterial generates[3, 21, 79, 80, 82, 97]. To prevent 
rejection, encapsulation by fibrous tissue, infection, tissue necrosis or any other negative outcome 
synthetic implant materials must be biocompatible. Bone substitute materials should also exhibit unique 
chemical, biological and physical properties. They should generate a biologic response similar to that 
exhibited during bone healing[1] and be bioactive[2, 4, 15-17]. They should promote bone growth on 
and/or within the construct (osteoconduction)[3, 18] and induce osteogenesis by stimulating 
undifferentiated cells to differentiate into preosteoblast cells (osteoinduction)[1, 3, 4, 18, 19]. 
Additionally, they should encourage the formation of a physico-chemical bond between the host tissue 
and implant material resulting in tissue integration[1, 4, 17, 20, 21]. 
 
 The intention of this literature review was to present a helpful introduction to fundamental 
concepts exercised within the succeeding chapters. For additional information the reader is guided to 







CHAPTER 3 EXPERIMENTAL MATERIALS AND METHODS 
 
 This chapter includes information on the materials and experimental methods employed in the 
production and subsequent characterization of calcium phosphate (CaP) constructs produced via self-
propagating high-temperature synthesis (SHS). It also contains information pertaining to experiments 
performed on the CaP constructs post-synthesis. Detailed experimental protocols can be found in the 
appendices.  
  
 This chapter does not contain information about the experimental methods and procedures for 
decomposition combustion synthesis (DCS) as they are located in Chapter 5 per CSM graduate school 
guidelines for “Including manuscripts submitted and/or prepared for submission to scholarly journals and 
proceedings.” 
 
3.1 Self-Propagating High-Temperature Synthesis of Calcium Phosphate Experimental 
 Procedure (Appendices A and B) 
 
Detailed protocols for reactant powder preparation and self-propagating high-temperature (SHS) 
are presented in Appendices A and B. Briefly, to produce hydroxyapatite (HA) and tricalcium phosphate 
(TCP) control samples, reactant powders of calcium oxide (CaO) (Fisher, 325 mesh, 99.99% pure) and 
diphosphorous pentoxide (P2O5) (Fisher, 100 mesh, 99.99% pure)[27, 29, 41] were combined in 
polyethylene containers with the stoichiometries displayed in Table 3.1 and mixed (LabRAM, Resodyn 
Acoustic Mixers, Inc.) for 60s to ensure homogeneity. Due to the hygroscopic and reactive nature of 
P2O5, powders were prepared in a desiccated argon atmosphere[27, 29, 41]. Experiments assessing the 
effects of altering reactant composition were conducted by adding the weight percentages (wt%) of silver 
(Ag, CERAC, 325 mesh, 99.99%), strontium oxide (SrO, Alfa Aesar, 325 mesh 99.9% pure), magnesium 
oxide (MgO, Alfa Aesar, ground to 325mesh, 99.7% pure), reacted β-TCP and reacted HA displayed in 
Table 3.1 to the CaO and P2O5 reactants. The designations for all compositions are displayed in Table 
3.1. 
 
 Pellets with dimensions d=0.5in, h=1.5in, w=5g were isostatically cold-pressed at 2000psi with a 
stainless steel uniaxial die. Subsequently, the pellets were placed in a small combustion chamber on a 
tungsten coil (heating element) and reacted in an argon atmosphere[27, 29, 41]. Reaction temperature was 
measured with sheathed tungsten-rhenium thermocouples inserted 3mm deep into holes 5mm apart and 
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3mm from the top of the pellet (Figures 3.1a-b). Post-synthesis the constructs were air-cooled to room 
temperature (>200°C/min)[27].  
 





Figure 3.1a-b a. Schematic of a small combustion chamber. The pellet was placed on a tungsten coil 
(heating element, red arrow) and sheathed tungsten-rhenium thermocouples were inserted 3mm deep into 
holes 5mm apart and 3mm from the top of the pellet (blue arrow). 
HA HA - 56.84 43.16
TCP TCP - 54.24 45.76
Ag0.5% 0.5 53.97 45.53
Ag1% 1 53.7 45.3
Ag2% 2 53.15 44.85
Sr1% 1 53.7 45.3
Sr5% 5 51.53 43.47
Sr7% 7 50.44 42.56
Mg1% 1 53.7 45.3
Mg5% 5 51.53 43.47
Mg7% 7 50.44 42.56
βinTCP1% 1 53.7 45.3
βinTCP5% 5 51.53 43.47
βinTCP7% 7 50.44 42.56
HAinTCP1% 1 53.7 45.3
HAinTCP5% 5 51.53 43.47








CaO (g) P2O5 (g)
CaP-Ag
  a  b   
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 The basic reaction for the TCP system considered in this research includes a TCP phase where the 
Ca the crystal structure has been substituted by an Ag, Mg, or Sr ion: 
 
               
 
→    (   )                         (    ) 
              
 
→         (   )                         (    ) 
              
 
→         (   )                     (    ) 
             
 
→         (   )                          (    ) 
 
where 0≤x≤1. It is theorized that the reduction of CaO by P2O5 in the Lewis acid-base reaction drives the 
formation of TCP. The intermediate steps for the proposed reaction of CaO and P2O5 are given in 
equations 3.2a-e. It is important to note that the empirical and molecular formulae for diphosphorous 
pentoxide are different; P2O5 and P4O10 respectively. The reaction occurring is actually between CaO and 
P4O10 (3.2b). As P4O10 volatizes during SHS it forms two phosphite ions (PO3) and two phosphonite ions 
(PO2) (3.2c). The phosphite and phosphonite ions are strong Lewis acids and reduce (accept) oxygen from 
the Lewis base, CaO. During the reduction-oxidation (Redox) reaction four phosphate ions (PO4
3-
) and six 
calcium atoms are generated (3.2d) which combine and form two TCP molecules (3.2e). 
 
               
 
→    (   )                         (    ) 
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 The basic reaction for the HA system considered in this research includes a HA phase where the 
Ca the crystal structure has been substituted by either an Ag, Mg, or Sr ion: 
 
                    
 
→          (   ) (  )                       (    ) 
                    
 
→          (   ) (  )                    (    ) 
                   
 
→          (   ) (  )                        (    ) 
 
where 0≤x≤1.   
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3.1.1 HSC Chemistry Analysis  
  
 The CaP SHS reaction thermodynamics were examined using HSC Chemistry7.1 (Outokumpu 
Technology). Gibbs free energy (ΔG) of HA, β-TCP and -TCP were calculated and are presented in 
(Figure 3.2). HA has the lowest Gibbs free energy (highest driving force for formation) and 
thermodynamically is the most likely to form. 
 
 
Figure 3.2 Gibbs free energy (ΔG) of HA, β-TCP and -TCP calculated with HSC Chemistry. 
 
 
3.2 Post-Synthesis Characterization  
  
Porous 5g CaP constructs substituted with specific weight percentages of Ag, Sr, Mg, βinTCP or 
HA were successfully prepared with SHS (Figures 3.3a-c). For characterization and in vivo testing, 
reacted constructs were cold-mounted (LECO) and sectioned in the transverse direction to a thickness of 
approximately 1mm or mechanically ground into finer particles or remained intact. 
 
Post-synthesis, 100 TCP samples were heat treated in a box-type muffle furnace (Blue M) at 1200 






Figures 3.3a-c Synthesized CaP materials. a. As synthesized CaP construct. b. Embedded and sectioned 
(1mm thick) sample. c. Crushed CaP powder. 
 
 
3.2.1 Scanning Electron Microscopy and Electron Dispersive Spectroscopy 
  
SEM was performed on powders and sections with a FEI Quanta 600 SEM with a Princeton 
Gamma Tech energy dispersive x-ray spectroscopy (EDS) facility under high vacuum, 20kv and a spot 
size of 4.0. Samples were sputter-coated with gold (Hummer V) and analyzed for composition, 
morphology, grain growth and specific structural formations. ImageJ (W. Rasband, National Institutes of 
Health, 1997) processing software was used to analyze product microporosity (Appendix D).  
 
3.2.2 Brunauer–Emmett–Teller Surface Area Analysis and Barrett–Joyner–Halenda Pore Size 
 and Pore Volume Analysis 
 
 Brunauer–Emmett–Teller (BET) surface area analysis and Barrett–Joyner–Halenda 
(BJH) pore size and pore volume analyses were performed with an ASAP2020 Accelerated Surface Area 
and Porosimetry Analyzer (Micrometrics). The powders were weighed (<0.5g), vacuum cooled to –197°C 
and dosed with adsorptive gas (N2). Pressure equilibration time was 10s. 
 
3.2.3 X-ray Diffraction (Appendix E) 
 
X-ray diffraction (XRD) patterns were obtained with a Phillips Analytical PW3240 X’PERT data 
collector using 2θ scans ranging from 10 to 60°. Peak matching was performed by comparing respective 
2θ values to standard peak values in the International Centre for Diffraction Data (ICDD) cards (00-550-
898, 09-0348, 01-073-1731, 00-033-1173, 78-0649). An error tolerance of (+/-) 0.1 2θ was used to 
determine peak values. Crystal size and lattice strain were estimated from XRD patterns using the 
Scherrer equation[61, 98-100]. 
 a  b  c 
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3.3 Post-Synthesis Collagen, Alginate and Chitosan Coatings 
 
CaP constructs and fracture sections were coated with type I collagen (C), alginate (A) or 
chitosan (T). Flat 1mm thick sections of CaP embedded in epoxy were also coated for 
immunofluorescence microscopy and contact angle measurements. Table 4.4 presents the compositions 
studied. The HA constructs were dissolved due to the acidic nature of solutions need to prepare the 
collagen and chitosan coatings.  
 
Table 3.2 Matrix of CaP and coatings studied. 
 
 
3.3.1 Type I Collagen Coating  
 
Constructs and flat sections were sterilized in a dry oven for 24h at 105°C. Under a sterilized and 
ventilated biosafety cabinet (BSC), sterile glass beakers were filled with 100ml of type I collagen solution 
(0.1%w/v collagen to acetic acid, Sigma, C8919). Constructs were placed in the solution and covered 
with Parafilm prior to removal from the BSC. In the BSC, flat sections were placed in a sterile Petri dish, 
coated with 2ml of collagen solution and covered with Parafilm prior to removal. The collagen was 
allowed to bind for 24h at room temperature, on a shaker table. After 24h, excess collagen solution was 
aspirated from the beakers and the samples were rinsed three times with 1.0M phosphate buffered saline 
(PBS). Samples were set in sterile Petri dishes and allowed to dry overnight in a sterile BSC. 
  
3.3.2 Immunofluorescence Labeling (Appendix F) 
  
 Following collagen attachment, cold-mounted samples were set in empty pipette tip boxes and the 
bases of the boxes were filled with PBS to maintain a moist environment. Samples were covered with 
1mg/ml labeling buffer (bovine serum albumin, BSA) in 1.0M PBS, sat for 1h in a sterile BSC and rinsed 
with PBS. The samples were coated with a primary antibody which binds to a specific antigen of type I 
collagen and allowed to sit for 1h before rinsing with PBS. A secondary antibody known to conjugate to 
the primary antibody and containing a fluorophore, fluorescein isothiocyanate (FITC), was applied to the 
surface of the samples and the specimens were left in the pipette tip boxes overnight at 4°C. After 12h, 
the samples were rinsed with PBS to remove excess secondary antibody. 






 Following immunofluorescence labeling, mounted and labeled samples were coated with a thin 
layer of Fluoromount. A coverslip was placed on top of the Fluoromount and gently pressed down to 
remove bubbles. The samples were placed in a refrigerator (4°C ) overnight to allow the Fluoromount to 
dry. The next day samples were imaged using an Olympus IX81 Motorized Inverted Microscope under 
the FITC filter. Standard magnification was 10x, bin size was 2 by 2 and the exposure was 100 lux 
seconds. Multiple images of all samples (~15) were taken across the sample surface. The threshold was 
adjusted using ImageJ to estimate the percent area of collagen attachment. Areas of super saturation 
(bright white spots) corresponding to collagen attachment were targeted by the threshold adjustment.  
 
3.3.3 Alginate Coating  
  
 Under a sterilized and ventilated BSC, sterile glass beakers were filled with 100ml of alginate 
solution (1%w/v calcium chloride to alginate solution, Fluka Analytical, FMC BioPolymer, 20G:40M) 
Sterilized constructs were placed in the solution and covered with Parafilm prior to removal from the 
BSC. The alginate was allowed to bind for 24h at room temperature on a shaker table. After 24h, samples 
were removed from the beaker and placed in a sterile Petri dish. In the BSC, flat sections were placed in a 
sterile Petri dish, coated with 2ml of alginate solution and the Petri dish was covered with Parafilm prior 
to removal. Coated constructs and sections were allowed to dry overnight in a refrigerator (4°C). 
 
3.3.4 Chitosan Coating 
 
 Under a sterilized and ventilated BSC, sterile glass beakers were filled with 100ml of chitosan 
solution (1wt% chitosan:2wt% acetic acid: 2.5wt% gluteraldehyde, FMC BioPolymer). Sterilized 
constructs were placed in the solution and covered with Parafilm prior to removal from the BSC. After 
24h, samples were removed from the beaker and placed in a sterile Petri dish. In the BSC, flat sections 
were placed in a sterile Petri dish, coated with 2ml of chitosan solution and the Petri dish was covered 
with Parafilm prior to removal. The chitosan was allowed to bind for 24h at room temperature on a shaker 
table. Coated constructs and sections were allowed to dry overnight in a refrigerator (4°C). 
 
3.3.5 Fourier Transform Infrared Spectroscopy  
 
A Nicolet 4700 Fourier transform infrared spectrometer (FTIR) (Thermo Electron Corporation) 
and OMNIC™ 7.2 software (Thermo Electron Corporation) was used to analyze the molecular structure 
of the reactants, CaP products and coatings. The FTIR passes IR light through the sample and the 
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transmitted IR light is correlated to energy absorption of atomic bonds at each wavelength. Fourier 
transforms convert transmittance data into a transmittance spectrum, indicating which IR wavelengths the 
sample absorbed. Vibrational frequencies in the spectra correlate to bond strength and the quantity of 
bonds present. For this work, peak values in the transmittance spectra were characterized using peak 
values from literature[13, 19, 23, 37, 39, 56, 57, 60, 62, 101-112] and the Spectral Database for Organic 
Compounds (SDBS) provided by the National Institute of Advanced Industrial Science and Technology 
(AIST).  
 
3.4 Post-Synthesis Characterization-Mechanical Testing 
 
 Compression testing was performed with a static mechanical testing frame (Instru-met) tension 
and compression tester and a 50lb load cell on constructs d=0.5in, h=1in. The samples were loaded 
parallel to their long axis and tested at a constant cross-head displacement rate of 0.1in/min. 
  
3.5 Antimicrobial Activity Experimental Procedure 
  
 Powders were sterilized in a drying oven (Binder) at 105°C for 24h. After sterilization, 1mg of 
powder, 1ml of phosphate buffered saline (PBS, OmniPur) and 1ml of Luria-Bertani (LB) broth (Difco) 
containing ~1x10
5
 colony forming units (CFU)/ml E.coli (BAA-1025 ATCC) were added to autoclaved 
(121°C 30m) 30ml glass bottles[60, 112]. The bottles were incubated at 30°C and agitated at 150rpm for 
24h[60, 112]. Subsequently, 0.1ml of each solution was spread with a sterile glass rod on the center of a 
20ml LB agar plate. The plates were incubated for 24h at 37°C[60, 112]. At t=0, 4, 8 and 24h the number 
of colonies were counted and photographed. Additionally, a colony of interest from each plate was wet-
mounted on a glass slide. CFUs were counted and cell morphology was analyzed with an optical 
microscope (Infinity 2 Olympus CX41, Olympus U-CMAD3) at 40x. Control plates were E.coli only[60] 
and TCP and HA without Ag. 
 
3.5.1 Inductively Coupled Plasma-Atomic Emission Spectroscopy 
 
 Inductively coupled plasma atomic emission spectroscopy (ICP-AES, Perkin-Elmer Optima 
5300DV) was performed on 1ml of media diluted (1:10) with nitric acid. Media was sampled on days 1, 




3.5.2 Contact Angle Measurements (Appendix G) 
 
 A detailed protocol for operating the goniometer is presented in Appendix G. A 10µl drop of de-
ionized water was placed onto a sectioned surface and the contact angle was measured with the static 
sessile drop method using a standard goniometer(Model 200-00, Ramé-Hart Instrument Co.) and imaged 
with DROPimage Standard (Ramé-Hart Instrument Co.) software[59, 113]. 
 
3.6 Human Fetal Osteoblast 1.19 Cell Line Cell Culture Procedure (Appendix H) 
 
A detailed protocol for culturing human fetal osteoblast cells is presented in Appendix H. Briefly, 
sterile technique was used throughout the entire cell culture procedure. Cell culture was performed in a 
BSC sterilized with 90% ethyl alcohol.  
 
Two aliquots of cells, 1-2 million cells/aliquot, were thawed using a double boiler method in a 
water bath at 37°C for five minutes. Each thawed aliquot was transferred into a T-25 TCPS flask (Nunc). 
Ten milliliters of 37°C cell culture medium; 1:1 Dulbecco’s Modified Eagle’s Medium/F-12 (HyClone), 
10% Fetal Bovine Serum (HyClone) and 0.3mg/mL of G-418 (MP Biomedicals) were added to each 
flask[114-116]. The flasks were incubated at 34°C with 98% humidity and 5% CO2. Medium was 
changed every two to three days, the cells were check daily and counted weekly.  
 
When the flasks reached 80% confluence they were expanded. Medium was aspirated off the 
cells, two milliliters of 0.25% trypsin-EDTA (MP Biomedicals) were added and the flasks were incubated 
for 15 minutes at 37°C with 98% humidity and 5% CO2[114-116]. The mixture of trypsin and cells was 
dispersed into a T-75 TCPS flask (Nunc), supplemented with 25ml of warm medium and incubated at 
34°C with 98% humidity and 5% CO2. The cells were expanded into T-175 flasks (Nunc) after 80% 
confluence was reached in the T-75 flasks. 
 
3.6.1 Cell Culture Experimental Procedure 
  
 Powders were sterilized in a drying oven (Binder) at 105°C for 24h. After sterilization, 100µg of 
CaP-Ag powder was placed in 5 separate test wells on each tissue culture polystyrene (TCPS) 6-well plate 
(Fisher). The sixth well was a control and contained only cells. The experiment was run in triplicate. 
Wells were seeded at a density of ~5x10
3
cells/well[114] and 8ml of cell culture media (37°C) was added 
to each well. Medium was changed every 2 days. During medium aspiration the Pasteur pipette did not 
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contact the bottom of the well, minimizing the amount of powder removed from the well plate during 
medium changes. The well plates were incubated at 37°C with 98% humidity and 5% CO2[114], 
examined daily for signs of contamination and tracked microscopically. The human fetal osteoblast cell 
line (ATCC, CRL-11372) used has been genetically modified to proliferate at temperatures ≤34°C 
(doubling time of 96h) and differentiate at temperatures ≥37°C[114]. At the conclusion of the experiment, 
medium was aspirated from the wells and the cells were fixed with a 1:0.25 gluteraldehyde (MP 
Biomedicals) to sodium cacodylate buffer (Electron Microscopy Sciences) solution[97] to stabilize the 
cell membrane and prevent degradation.  
 
The bottoms of the TCPS well plates were cut off and the surface with the fixed cells and CaP 
was sputter-coated with gold (Hummer V). Field emission-SEM (FE-SEM) and energy dispersive 
spectroscopy (EDS) were performed with a JEOL JSM-7000F SEM to analyze osteoblast morphology. At 
the conclusion of the experiment the cells were fixed with a 1:0.25 gluteraldehyde to sodium cacodylate 
solution. Fixation stabilized the cell membrane and prevented cell degradation. The cells were 
immobilized and analyzed for nodular growths on the CaP-Ag powder and cells.  
 
3.6.2 Cell Culture Scanning Electron Microscopy 
  
 SEM was performed with an FEI Quanta 600 SEM. High-resolution, 15kv and a spot size of 3.5 
minimized charging and refined the biologic images. The bottoms of TCPS well plates were carefully cut 
off (Dremel) and the surface with the fixed cells and CaP-Ag was analyzed.  
 
3.6.3 Cell Culture Field Emission-Scanning Electron Microscopy and Electron Dispersive 
 Spectroscopy 
 
 FE-SEM and EDS were performed with a Joel JSM-7000F scanning electron microscope to 
analyze cytotoxicity and mineralized matrix deposition. The bottoms of TCPS well plates were carefully 
cut off (Dremel) and the surface with the fixed cells and CaP was sputter-coated with gold (Hummer V). 
 
3.7 Statistical Analysis 
 
 Results are stated as means ± standard deviation. Statistical analyses were performed with a 
Kruskal-Wallis non-parametric test followed by the Mann-Whitney post hoc test (Minitab 16) to assess 
significance (p<0.05, p<0.10)[59]. 
29 
 
CHAPTER 4 EXPERIMENTAL RESULTS AND DISCUSSION OF RESULTS 
 
 This chapter presents the results from experiments that utilized self-propagating high-temperature 
synthesis (SHS) for production of 3D calcium phosphate (CaP) constructs and the results of 
characterization techniques preformed on the synthesized constructs. Data discussed in this chapter 
includes information from provisional patent #61822073[44], data submitted for consideration of a 
provisional patent and a manuscript submitted to Acta Biomaterialia.  
 
 This chapter does not contain information about the experimental results from decomposition 
combustion synthesis (DCS) as they are located in Chapter 5 per CSM graduate school guidelines for 
“Including manuscripts submitted and/or prepared for submission to scholarly journals and proceedings.” 
 
4.1 Self-Propagating High-Temperature Synthesis Reaction Characterization 
 
 Combustion synthesis (CS) reactions are unique in that their reaction parameters are highly 
versatile. They can be modified to alter the CS reaction and subsequently the specific properties of the 
CaP product. A detailed experimental analysis was conducted to elucidate the effects of altering reactant 
stoichiometry and reactant composition by adding specific reactants (e.g. Ag; SrO; MgO; β-tricalcium 
phosphate; hydroxyapatite) to the CaP self-propagating high-temperature (SHS) reaction system. Figure 
1.1 illustrates the relationships that were discovered between reactant, reaction and product properties in 
the CaP self-propagating high-temperature synthesis system. 
  
 The substituent reactants were selected for their atomic similarity to calcium (e.g. atomic radius; 
valence) and because studies have demonstrated that they can enhance the bioactivity and functionality of 
CaP materials. Silver (Ag) has demonstrated exceptional antimicrobial activity[13, 14, 58, 59, 112] and 
low mammalian cytotoxicity [13, 58, 59, 117]. Consequently, CaP materials substituted with Ag have 
shown promise as bone tissue scaffolds that can locally inhibit bacterial growth[13, 14, 58, 59, 62, 112]. 
CaP materials substituted with <20 weight percent (wt%) Sr have exhibited higher compressive strengths 
than tricalcium phosphate (TCP) and hydroxyapatite (HA) scaffolds, while the addition of Mg and Sr in 









4.1.1 Reactant Data 
 
 Pellets with dimensions d=0.5in, h=1.5in, w=5g were isostatically cold-pressed at 2000psi. They 
were weighed and their green body densities (density of the unreacted pellet, gbd) were calculated (Table 
4.1). A minimum of 10 pellets (n=10) were pressed for each experiment.  
 
Reactant Stoichiometry Can Alter Green Body Density. 
 
 The difference in gbd between samples arises from a difference in reactant atomic density: CaO 
has a higher density than P2O5 (Table 4.2)[119-121]. TCP had the lowest gbd because it has the highest 
P2O5 content, while HA has a higher CaO to P2O5 ratio than TCP and subsequently a higher gbd. 
Increasing the ratio of CaO to P2O5 by changing reaction stoichiometry increased gbd. 
 
Reactant Composition Can Alter Green Body Density. 
 
 The addition of Ag, SrO, MgO, reacted β-TCP and reacted HA increased gbd, because Ag, SrO, 
MgO, reacted β-tricalcium phosphate (β-TCP) and reacted HA have higher atomic densities than P2O5 
(Table 4.2).The Ag1%, Ag2%, Sr1%, Sr5% and βinTCP1, 5 and 7% samples had significantly higher 
gbds than the TCP sample (p<0.05) (Figure 4.1).  
 
 HA had a higher gbd than the HAinTCP1, 5 and 7% samples (p<0.05) possibly because the 
reacted HA added to the CaP reaction was synthesized via SHS and has a density lower than CaO and just 
slight greater than P2O5 (Figure 4.1).  
 
 Pellet gbd is an important process variable because it can be used to control product properties by 
altering the SHS reaction. Section 4.1.2 shows how reactant properties can alter the SHS combustion 
reaction.  
 
4.1.2 Self-Propagating High-Temperature Synthesis Reaction Data  
 
 During the reaction, a combustion wave propagated through the pellet, indicative of a propagation 
reaction[26, 27, 34, 42]. Figures 4.2a-c illustrate the propagation of the combustion wave through a pellet 
during self-propagating high-temperature synthesis (SHS) after the temperature of the bottom of the pellet 
is increased to ignition temperature (Figure 4.2a) and the SHS reaction is initiated (Figure 4.2b). After the 
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reaction, the construct cools to room temperature (Figure 4.2c). Figure 4.2d displays a reacted and cooled 
CaP construct.  
 
Table 4.1 Unreacted pellet data and reaction data. Light green headings display unreacted pellet data and 




Table 4.2 Reactant and select element data.  
 
Avg. Std. Dev. Avg. Std. Dev. Avg. Std. Dev.
HA HA - 56.84 43.16 0.00176 0.00008 1117 189 2.65 1.98
TCP TCP - 54.24 45.76 0.00136 0.00008 1013 52 1.66 1.26
Ag0.5% 0.5 53.97 45.53 0.00168 0.00004 675 274 - -
Ag1% 1 53.7 45.3 0.00177 0.00005 629 217 - -
Ag2% 2 53.15 44.85 0.0017 0.00004 508 190 - -
Sr1% 1 53.7 45.3 0.00172 0.00009 895 50 - -
Sr5% 5 51.53 43.47 0.00169 0.00011 870 274 - -
Sr7% 7 50.44 42.56 0.00179 0.00017 624 409 - -
Mg1% 1 53.7 45.3 0.00157 0.00007 608 92 - -
Mg5% 5 51.53 43.47 0.00177 0.00003 654 162 - -
Mg7% 7 50.44 42.56 0.00158 0.00014 593 208 - -
βinTCP1% 1 53.7 45.3 0.00161 0.00013 298 145 - -
βinTCP5% 5 51.53 43.47 0.0016 0.00013 449 71 - -
βinTCP7% 7 50.44 42.56 0.00175 0.00038 - - - -
HAinTCP1% 1 53.7 45.3 0.0015 0.00007 - - - -
HAinTCP5% 5 51.53 43.47 0.00155 0.00008 - - - -





























CaO 3.34 42.00 30.00 2613
P2O5 2.39 0.36-0.84 0.24 340
MgO 3.58 37.01 45-60 2852
SrO 4.70 44.30 10.00 2531
HA 3.16 180-184 - 1614
β-TCP 3.14 120-180 - 1670
Air (80°C) 1.00 1.01 0.03 -
Ca 1.55 25.93 201.00 1115
Ag 10.49 25.35 429.00 1234
Mg 1.74 24.87 156.00 923




Figure 4.1 Average green body densities of unreacted pellets. Green body density increased as the ratio of 
CaO:P2O5 increased. 
O
p<0.05 versus TCP, 
+
p<0.05 versus HA. 
 
 
 Reaction data for average combustion temperature (Tc) and reaction velocity is presented in Table 
4.1. Due to the corrosive nature of the P2O5 byproducts (orthophosphoric acid, H3PO4), the thermocouple 
ports were damaged so no data was collected for the βinTCP7% and HAinTCP1, 5 and 7% samples. 
 
 Figures 4.3a-h show reaction temperature versus reaction time data for all systems measured at 
thermocouple 1 (C1) and thermocouple 2 (C2). Similar to previous research SHS ignition time (Tig) was 
less than 10s and reaction duration was less than 15s from initiation to completion[27, 29, 41]. Reaction 
ignition temperatures appear to be below the eutectic temperature of 475°C[27, 48, 49] for all samples. 
 
Reactant Stoichiometry and Reactant Composition Effect Combustion Temperature. 
 
 Average combustion temperature for TCP and HA was similar, 1013 and 1117°C, respectively 
(p>0.05), while average combustion temperature for the CaP-Ag, CaP-Mg, CaP-Sr and CaP-βinTCP 
samples decreased and was significantly lower than the HA and TCP samples (p<0.05).  
 
 Average combustion temperatures for all samples are significantly lower than the calculated 
temperature accepted as minimum for a self-sustaining combustion reaction, 1800K[26]. The systems 
used to calculate the accepted minimum temperature are assumed to be adiabatic (Tad); however, the CaP 
SHS system is non-adiabatic, exothermic energy in the form of heat is given off during the combustion 
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reaction through conduction, convection and radiative heat loss. Additional sources of error that could 
contribute to lower temperature measurements occur during data collection e.g. ceramic sheaths can act as 
heat sinks; reaction velocity is faster than thermocouple time resolution resulting in system latency; 
reaction front thickness is smaller than thermocouple diameter; thermocouples can move and/or come out 
of the pellet during the reaction[53]. Even though reaction temperatures are significantly lower than the 
calculated adiabatic temperature, a combustion reaction did occur. This alludes to the extremely reactive 




Figures 4.2a-d Images taken of a SHS reaction and a reacted pellet. a. The heating coil heats the bottom of 
the pellet from initial temperature (T0) to ignition temperature (Tig). b. The coil was turned off and the 
 a  b 







reaction propagated through the pellet. The direction of combustion wave propagation is depicted with the 
red arrow. c. Post-SHS, the pellet is air cooled. d. A reacted pellet in a small combustion chamber. 
 
   
Figures 4.3a-b Reaction temperature versus reaction time data for HA, TCP and CaP-Ag samples. Initial 







Figures 4.3c-h Reaction temperature versus reaction time data for HA, TCP and CaP-Sr, CaP-Mg and 
CaP-βinTCP samples. 
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Figure 4.4 Average combustion temperature for each sample. Combustion temperatures decreased with 
the addition of Ag, MgO, SrO or β-TCP. 
O
p<0.05 versus TCP, 
+
p<0.05 versus HA.  
  
Reactant Stoichiometry Effects Reaction Velocity. 
 
 Average reaction velocity was calculated by dividing 5mm (distance between thermocouples, C1, 
C2) by the difference between combustion temperature times at C1 and C2 (Table 4.1). Samples left 
blank did not have a sample size greater than or equal to 7 (n≥7). Average reaction velocity for the HA 
sample was greater than the TCP sample; however, statistical analysis shows no significant difference 
between the samples (p>0.05).  
  
 The thermal conductivity of air is less the thermal conductivity of all reactants (Table 4.2). As the 
reaction front propagates through pellets that have less void space (air) between reactant particles, the 
amount of heat transferred between particles is higher and transferred at a higher rate. Subsequently, more 
heat is available for the reaction i.e. less heat is lost as the reaction propagates through the pellet. Green 
body density (gbd) is proportional to reaction temperature and indirectly related to reaction velocity. 
 
Reactant Stoichiometry and Reactant Composition Could Effect Product Cooling Time. 
 
Reliable product cooling data was not collected for this research, which is regrettable because 
product cooling plays a significant role in product morphology. It is speculated that product cooling time 
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would increase as reaction temperature increases i.e. the total time required to cool a reacted construct 
with a high combustion temperature would increase. This suggests that the HA and TCP samples would 
have longer cooling times than the CaP-Ag, -Sr, -Mg, -βinTCP and -HAinTCP samples, resulting in 
different product morphologies. 
 
 Changes in combustion temperature and reaction velocity elucidate the relationship between 
reactant stoichiometry, reactant composition and reaction properties. Section 4.2 expands on how reactant 
and reaction properties can alter product morphology and subsequently, biologic response to the CaP 
product.  
 
4.2 Post-Synthesis Characterization-Product Morphology and Composition  
 
 Porous 5g TCP, HA and CaP constructs substituted with specific weight percentages of Ag, Sr, 
Mg, reacted β-TCP or reacted HA were successfully synthesized using SHS. Post-synthesis, 100 TCP 
pellets were heat treated for 2h at 1200 or 1300°C. Constructs remained intact (Figure 4.5a) or were cold 
mounted in epoxy and sectioned horizontally into 1mm thick sections (Figure 4.5b) or were crushed into 
fine powder particles for characterization and in vitro testing (Figure 4.5c)  
 
 
Figures 4.5a-c Synthesized CaP materials. a. As synthesized CaP construct. b. Embedded and sectioned 
(1mm thick) sample. c. Crushed CaP powder. 
 
 
4.2.1 Scanning Electron Microscopy of Calcium Phosphate Particles and Sections 
  
 High magnification (1000x) scanning electron microscopy micrographs (SEMs) of synthesized 
TCP display a matrix with no distinguishable crystal structure impregnated with spherical grains (Figures 
4.6a-b). The HA sample has an angular, plate-like microstructure similar to the mineral fraction of 
bone[1, 123, 124]. The HA surface is more jagged and rougher than the TCP sample. This is significant 
because it was demonstrated that as surface roughness increases, collagen synthesis by osteoblast cells 
 a  b  c 
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increases, which could improve osteointegration; however, as surface roughness increases, cell 
proliferation decreases, which would decrease the number of cells available for bone remodeling and 
regeneration[125-129]. To better illustrate crystal size and shape, traditional metallographic methods such 
as a formic acid etch and light polishing can be performed[27, 29]; however, etching and polishing 
processes were not performed on the samples in Figures 4.6a-b. 
 
  
Figures 4.6a-b High magnification micrographs (1000x) of HA and TCP particles. a. TCP particles 
displayed a matrix with no distinguishable crystal structure impregnated with spherical grains. b. HA 
particles exhibited an angular, plate-like microstructure. 
 
 High magnification (1000x) backscatter micrographs of CaP-Ag and CaP-Sr particles (Figure 
4.7a,c) exhibit an angular, plate-like microstructure with no distinguishable amorphous matrix, similar to 
the HA sample.  
 
 EDS detects x-rays emitted by a sample after a high-energy electron beam is focused on the 
sample surface, subsequently exciting and ejecting electrons from the inner electron shell. To stabilize the 
atom and compensate for the missing inner electrons (electron holes), electrons from the outer, high-
energy shells fill the holes and the difference in energy between the inner and outer shells is emitted in the 
form of an x-ray. The energy of the emitted x-rays can be correlated to specific elements to analyze 
composition. The energies can also determine which shells lost electrons and which shells’ electrons 
filled the holes e.g. a hole in the K shell filled with an L shell electron (K); a K shell hole filled with an 
M shell electron (Kβ); or an L shell hole filled by an M shell electron (L). EDS spot scans (Figures 4.7 
b,d) confirm the presence of carbon, oxygen, calcium and phosphorous in the samples. The carbon in the 
samples was produced by the carbon tape used to attach the powders to the SEM sample stage. To prevent 
 a   b 
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loose powder on the surface from damaging the vacuum system in the SEM a small amount (<0.10g) of 
powder was applied to the carbon tape resulting in a thin, non-uniform layer of CaP. Consequently, 
carbon peak intensity increases (Ag2%) or decreases (Ag1%) depending on where the sample is analyzed 
(i.e. a dense cluster of particles or a sparsely covered area). As expected, the CaP-Ag samples contained 




Figures 4.7a-d Backscatter micrograph and EDS scans of CaP-Ag and CaP-Sr samples. An angular, 
acicular microstructure similar to the HA sample is exhibited. No distinguishable amorphous matrix, 
similar to the TCP sample, was detected. a. CaP-Ag particles. c. CaP-Sr particles. EDS full scans of b. 
CaP-Ag particles and d. CaP-Sr particles. No Ag or Sr was detected in the TCP and HA controls. 
 
 
 High magnification (1000x) backscatter micrographs of CaP-Mg and CaP-βinTCP particles 
(Figure 4.8a,c) display a matrix with no distinguishable crystal structure impregnated with angular grains, 
similar to the TCP sample; however, the grains in the matrix are more defined and larger than the TCP 
 a   b 
 c   d 
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sample, similar to the HA sample. An EDS full scan (Figure 4.8b) confirms the presence of carbon, 
calcium, oxygen and phosphorous in the TCP, HA and CaP-Mg samples. As expected, the CaP-Mg 
samples also contained Mg and no Mg was detected in the TCP and HA controls. As wt% Sr and Mg 
increased, oxygen peak intensity decreased, indicating less oxygen in the CaP products. This decrease 
could arise from the change in reactant stoichiometry (i.e. less P2O5 is used as SrO wt% increases) and 
could generate oxygen deficient products such as dehydroxylated apatite [Ca10(PO4)6], as opposed to TCP 
or HA, to compensate for the lack of oxygen available in the reaction. The absence of OH groups in the 
products generates vacancies (potential locations for Ag, Sr and Mg ion incorporation into the crystal 
structure), signifying the importance of reactant stoichiometry on product composition and crystal 
structure. 
   
 
  
Figures 4.8a-d Backscatter micrographs and EDS scans of the CaP-Mg, CaP-βinTCP and CaP-HAinTCP 
samples. A matrix with no distinguishable crystal structure interspersed with angular grains, similar to the 
TCP sample is exhibited in all samples; however, the grains in the matrix are acicular, larger and more 
defined than the grains in the TCP sample. a. CaP-Mg particles. c. CaP-βinTCP particles. b. An EDS full 
 a   b 
  c   d 
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scan of CaP-Mg particles. Carbon, calcium and phosphorous were detected in the TCP, HA and CaP-Mg 
samples. The CaP-Mg samples also contained Mg, but no Mg was detected in the TCP and HA controls. 
d. CaP-HAinTCP particles displaying a matrix with no distinguishable crystal structure impregnated with 
grains, similar to the TCP, CaP-Mg and βinTCP samples; however, the grains in the matrix are more 
defined and larger than the grains in the other samples. Large cracks span the particle surface indicative of 
high amounts of residual strain in the microstructure. 
 
  A high magnification backscatter micrograph of CaP-HAinTCP particles (Figure 4.8d) 
displays a matrix with no distinguishable crystal structure interspersed with angular grains, similar to the 
TCP, CaP-Mg and CaP-βinTCP samples; however, the grains in the matrix are more defined and larger 
than the other samples. Increased contractive strain on the crystal structure resulting from the different 
coefficients of thermal expansion between CaP matrix and the HA particles generates the large cracks that 
span the CaP-HAinTCP surface[130]. The elongated, acicular particles could be HA particles that were 
not heated to melting temperature.  It is theorized that the particles provided nucleation sites for grain 
growth during product cooling resulting in larger crystals[27, 43]. Future work could elucidate the 
mechanisms that dictate grain growth of the HA crystals in this system and provide a reproducible method 
for production of CaP constructs with a controlled (i.e. increased) grain size. The ability to control 
product grain size by altering SHS reaction parameters is significant because grain (crystal) size is 
inversely proportional to mechanical strength and bioresorption[17, 130, 131]. SHS reactions possess the 
ability to customize product functionality by simply modifying reaction parameters. 
 
Reactant Stoichiometry and Reactant Composition Affect Crystal Morphology. 
 
 The rapid velocity of the combustion wave through the pellet does not provide significant time 
for extensive crystal growth within the samples, consequentially crystal growth occurs post-synthesis 
during cooling[27] and increases as product cooling time increases.  
 
 Thermodynamically, crystal growth along the c-axis of a hexagonal crystal has the lowest free 
energy (highest driving force)[48, 78, 124]. The HA, CaP-Ag and CaP-Sr samples exhibited an angular, 
acicular morphology similar to that of an apatite crystal, while the CaP-Mg and CaP-βinTCP samples 
exhibited a CaP matrix with no identifiable crystal structure interspersed with angular, plate-like crystals. 
This indicates that altering reactant stoichiometry and reactant composition affects product morphology 






Post-Synthesis Heat Treatment of the TCP Samples Increases Grain Growth.  
 
 Figures 4.9a-b display TCP samples heat treated for 2h at 1200 or 1300°C. The grains displayed 
in the images of heat treated samples (light blue or brown outlines are shown for clarification) appear 
larger than the grains in the non-heat treated TCP sample (Figure 4.6a). Grain growth could have occurred 
through coarsening during heat treatment (solid-state sintering)[132, 133], which demonstrates the 
potential for post-synthesis heat treatment alter product morphology (increase grain size). 
 
  
Figures 4.9a-b High magnification SEMs (1000x) of heat treated TCP samples. TCP samples heat treated 
for 2h at a. 1200°C or b. 1300°C are displayed. The grains in the images (light blue or brown outlines are 
shown for clarification) appear larger than the grains in the non-heat treated TCP sample. 
  
  
4.2.2 Product Microporosity Analysis From Scanning Electron Microscopy Micrographs 
 
 During SHS reactions, a molten zone (mz) is generated at the reaction front if the reactants have a 
melting point lower than the combustion temperature[27, 29, 33, 42]. As the mz cools, pockets of O2 gas 
formed during P2O5 volatilization are trapped in the synthesized construct, generating product 
microporosity[27, 29, 42]. The size of the gas pockets generated during SHS can be quantified by 
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Reactant Stoichiometry and Reactant Composition Effect Product Microporosity. 
 
 Backscatter micrographs (25x) of TCP and HA sections display CaP (white areas) embedded in 
an epoxy cold-mount (grey area). Figures 4.10a-b illustrate the multimodal porosity characteristic of 
traditional CaO-P2O5 CaP SHS reactions i.e. CaO and P2O5 are the only reactants. Large pores (>1mm 
diameter) in addition to pores smaller than 1mm in diameter are present in both samples; however, 
microporosity in the HA sample is noticeably less than the TCP sample.  
  
 ImageJ analyses of low magnification (25x) micrographs (Figure 4.10a) were used to quantify the 
microporosity generated by O2 off-gas formation. Micrographs were binarized (Figure 4.10b), white 
corresponding to pores and black corresponding to CaP, and the percentage of white surface area to total 
surface area was calculated (Table 4.3). Outlines of the pores defined by the software are displayed in a 
representative image Figure 4.10c. Microporosity is highest for the TCP sample (83.50%), lowest for the 
HA sample (31.60%) and decreases as substituent concentration increases from 0.5wt% to 7wt% for all 
samples except CaP-HAinTCP. As substituent and CaO concentration increase, P2O5 content decreases 
resulting in less O2 gas formation during the combustion reaction. This could decrease the size of the O2 
gas pockets generated during the reaction, subsequently decreasing product microporosity. Product 
morphology (microporosity) can be controlled by reactant stoichiometry and reactant composition.   
 
Potential for Silver and Strontium Substitution into the Calcium Phosphate Crystal Structure. 
 
 To analyze the percent of Ag particles on the CaP-Ag surface, the low magnification micrographs 
were binarized again, Ag particles corresponding to black and white corresponding to all other surface 
area. The percentage of black area to CaP surface area (100%-microporosity%) was determined. Ag 
particle to total CaP surface area was less than the surface area for the original Ag wt% added, even 
though Ag particles (bright white circles) are distributed throughout the CaP surface (light grey areas) 
Figure 4.10f. The difference in the measured and theoretical amount of Ag present on the CaP-Ag surface 
indicates that the Ag could have substituted into the CaP crystal structure.  
 
 The same analysis was performed on the CaP-Sr sample. Similar to the Ag sample, there was a 
significant difference in the measured and theoretical amount of Sr present on the CaP-Sr surface, 
indicating that after the SrO reactant was reduced, the remaining Sr could have substituted into the CaP  
crystal structure. The substitution of atoms into the CaP crystal structure indicates the potential of SHS 




 CaP traditionally has an imperfect, Ca-deficient crystal structure[57, 84, 134]. The Ca vacancies 
provide locations for divalent cations substitutions into the crystal structure. Substitutions routinely occur 
in the Ca vacancies in the mineral component of bone. CaP scaffolds substituted with <20 weight percent 
Sr have exhibited higher compressive strengths than tricalcium phosphate (TCP) and hydroxyapatite (HA) 
scaffolds and the addition of Mg and Sr in CaP scaffolds has shown increased bone formation, 
bioresorption and cellular activity[63, 64, 118]. SHS could provide an alternative method for production 
of CaP constructs substituted with Ag, Sr or Mg that exhibit increased mechanical properties and 
bioactivity. 
 
Table 4.3 Product porosity, crystal size and lattice strain.
 
 
Reaction Velocity Effects Molten Zone Size, Which Dictates Product Nanoporosity.  
 
Product nanoporosity is effected by the size and cooling rate of the mz generated at the reaction 
front during SHS. Solidification shrinkage occurs during cooling, generating product nanoporosity. 
Concurrent shrinking of the mz surface forms nanoporosity inside the construct to compensate for the 
volumetric contraction (shrinkage) of the mz as it solidifies (cools)[135, 136]. Due to changes in reaction 
parameters (increased reaction velocity) the HA samples could have had a smaller mz than the TCP 
sample. As mz size decreases, more nanoporosity is formed to compensate for the higher amount of 
Avg. Std. Dev. Avg. Std. Dev.
HA 31.60 15.41 47.01 108.03 22.04 0.0012 0.0004
TCP 83.50 2.67 86.17 43.54 14.49 0.0027 0.0008
Ag0.5% 68.90 5.36 74.26 54.61 20.86 0.0023 0.0008
Ag1% 67.70 7.08 74.78 61.62 24.67 0.0021 0.0006
Ag2% 64.40 15.26 79.66 47.97 21.64 0.0027 0.0012
Sr1% 74.09 5.63 79.72 61.89 24.74 0.0021 0.0005
Sr5% 61.29 10.21 71.49 56.94 15.42 0.0023 0.0008
Sr7% 60.18 4.55 64.73 73.69 35.79 0.0021 0.0010
Mg1% 73.08 11.68 84.76 59.13 37.09 0.0030 0.0021
Mg5% 70.60 16.85 87.45 54.15 28.53 0.0028 0.0019
Mg7% 64.68 14.26 78.94 45.89 18.99 0.0028 0.0010
binTCP1% 48.90 1.38 50.28 36.37 13.66 0.0030 0.0005
binTCP5% 62.61 1.25 63.85 61.36 36.40 0.0026 0.0019
binTCP7% 62.90 1.33 38.43 44.56 26.07 0.0035 0.0023
HAinTCP1% 29.55 0.91 30.46 46.09 14.37 0.0025 0.0006
HAinTCP5% 23.81 0.76 24.57 52.57 20.33 0.0022 0.0004
HAinTCP7% 41.57 0.43 42.00 51.40 14.14 0.0023 0.0007
HT1200 56.22 1.64 57.86 60.86 19.17 0.0020 0.0005
HT1300 34.04 0.66 34.70 91.91 30.28 0.0014 0.0007









shrinkage that occurs during product cooling. Product morphology (nanoporosity) can be controlled with 





Figures 4.10a-f Backscatter micrographs used to analyze product microporosity. Backscatter micrographs 
of CaP (white areas) embedded in epoxy (grey areas) illustrating the multimodal porosity in the a. TCP 
 c 
  d 
  e    f 
 a   b 
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sample and  b. HA sample. c. ImageJ analysis of low magnification (25x) Ag2% micrograph. d. Binarized 
micrograph, white corresponds to pores and black corresponds to CaP, and the percentage of white 
surface area to total surface area was calculated. e. Outlines generated by ImageJ thresholding. f. Ag2% 
micrograph binarized to Ag grains (grey arrows) to determine percent of Ag on the fracture surface. 
 
 
Product densification could have occurred during heat treatment (solid-state sintering) of the 
HT1200 and HT1300 samples[132, 133], suggesting why nanoporosity decreased in the heat treated 
samples. This demonstrates the potential for post-synthesis heat treatment as a method to alter product 
morphology (nanoporosity). 
 
Crystal Growth During Cooling Generates Product Nanoporosity. 
 
Originally, it was speculated that only mz size and cooling rate affected product nanoporosity; 
however, nanoporosity data for samples with large mzs, as opposed to small mzs similar to the HA 
sample, contradicts this assumption. While mz size could affect product nanoporosity, it is likely that 
another mechanism, anisotropic crystal growth also dictates product nanoporosity.  
 
Combustion temperature decreased as additional reactants were added to the system, resulting in 
larger mzs[26, 33, 34, 47]. If mz size was the only factor that altered product nanoporosity, the CaP-Ag, 
Sr, -Mg samples should have had less nanoporosity than the HA sample; however, the Ag, Sr and Mg 
samples had quantities of nanoporosity similar to HA. During product cooling, crystal growth along the c-
axis occurred, generating elongated apatitic crystals in the HA, CaP-Ag, -Sr and -Mg samples. The 
crystals formed volumetric borders around the molten material essentially generating localized nano-sized 
areas of solidification shrinkage during product cooling. Consequently, product nanoporosity, generated 
from these areas, increased. Even though the CaP-βinTCP and CaP-HAinTCP samples had low 
combustion temperatures and large mzs, they had significantly less crystal growth than the HA, CaP-Ag, -
Sr and -Mg samples. This resulted in less localized solidification shrinkage and subsequently less 
nanoporosity. As such, it is suggested that nanoporosity is affected by mz size, mz cooling and crystal 
growth during mz cooling.  
 
 Porosity values from the ImageJ and BET/BJH analyses can be added together to approximate 
total porosity in the micron and submicron range (Table 4.3). HA had a total porosity less than TCP. The 
Ag, Sr and Mg substituted samples had total porosities similar to TCP while the βinTCP, HAinTCP and 





Figure 4.11 Diagram of nanoporosity formation. Formation of nanoporosity by shrinkage during 




 The TCP, CaP-Ag, CaP-Sr and CaP-Mg synthesized constructs have total porosities between 
64.73-87.45% and meet the suggested minimum macroporosity required (40%) for bone ingrowth in 
addition to meeting pore diameter requirements for bodily fluid circulation (<10m) and bone-cell 
colonization (>100m)(18, 55). Subsequently, they could be considered as scaffolds for bone tissue 
engineering applications. The HA, CaP-βinTCP and CaP-HAinTCP samples had very low total porosities 
which could decrease bone cell migration into the constructs(18, 55). The multimodal pore sizes 
determined during analysis for all samples show pores that could support osteoblast migration (20, 61-
63). Additionally, the measured porosity increases surface area, subsequently increasing adsorption sites 
for selected proteins involved in bone formation and remodeling e.g. bone morphogenetic proteins 
(BMPs); glycoproteins; osteonectin; growth factors(64-66).    
 
 The changes in product micro- and nanoporosity elucidate the relationship between reactant 
stoichiometry, reactant composition, reaction properties and product properties and show how SHS 
reactions can be controlled to alter product morphology and subsequently, biologic response to the 
synthesized CaP product.  
  
4.2.4 X-ray Diffraction of Calcium Phosphate Particles 
 
 XRD patterns of the compositions studied are shown in Figures 4.12a-i. All synthesized CaP 
samples contained CaO, indicating incomplete conversion of reactants to CaP products. This could result 
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from decreased reaction exothermicity and insufficient heat to completely melt the CaO[27]. The addition 
of substituent reactants caused reaction temperature (exothermicity) to decrease and CaO peak intensity to 
increase. To control CaO content in the final products, reaction stoichiometry could be altered such that 
reactions contain less CaO, facilitating complete reactant to product conversion during SHS. Product 
diffraction patterns were compared to P2O5, calcium carbonate (CaCO3), pyrophosphate (Ca2H2P2O7), 
monocalcium phosphate [Ca(H2PO4)2] and dicalcium phosphate [Ca(HPO4)] diffraction patterns; 
however, no peak matches were found. Reaction temperatures are significantly greater than the 
volatilization temperature of P2O5 (<375°C), suggesting that P2O5 fully decomposes into oxygen gas and 
phosphate ions during SHS.  
 
Post-Synthesis Heat Treatment Affects Product Composition. 
 
 The HA sample is monophasic, it contains only HA peaks, while the TCP control contains both 
- and β-TCP peaks (biphasic)(Figure 4.12a). HA and β-TCP have the lowest Gibbs free energy of 
formation (HA≈-12700KJ/mol; β-TCP≈-3,800KJ/mol)[137] and are the most thermodynamically 
favorable product phases[27, 39, 48, 78, 99, 137, 138] so their presence in all diffraction patterns was 
anticipated.  
 
 Similar to other reported work, post-synthesis heat treatment was applied to the TCP constructs to 
further control product phase composition[68, 109]. TCP samples were heat treated at 1200°C (HT1200) 
to produce a biphasic material of  >95% β-TCP and <5% -TCP, while TCP samples heat treated at 
1300°C (HT1300) produced a 50-50% β- to -TCP biphasic material, which demonstrates the ability of 
post-synthesis heat treatment to alter product composition. 
 
 The Ag substituted samples contained peaks that matched the CaP-Ag ICDD card 00-033-1173. 
No Ag metal or silver oxide peaks were observed suggesting that all of the Ag reactant powder was 
substituted into the CaP microstructure or that the quantity used was too small to be identified with XRD. 
Figures 4.12b-c demonstrate the changes in product composition with increasing Ag concentration. 
Ag0.5% and 1% are comprised of CaP-Ag, -TCP, β-TCP and HA peaks (multiphasic), while only one 
-TCP peak was identified in Ag2.0% (dashed circle) in addition to CaP-Ag, β-TCP and HA peaks 
(multiphasic).  
 
 The Sr substituted samples contained peaks that matched the CaP-Sr ICDD card 00-034-0484.  
No SrO or Sr peaks were detected, suggesting that the SrO reactant powder was reduced during the 
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reaction and Sr was substituted into the CaP microstructure or that the amounts of Sr and SrO were too 
small to be identified with XRD. Figures 4.12d-e demonstrate changes in product composition with 
increasing Sr concentration. Sr1% and 5% are comprised of CaP-Sr, -TCP, β-TCP and HA peaks 
(multiphasic); however, only one -TCP peak was identified in Sr7% (dashed circle) in addition to CaP-
Sr, β-TCP and HA peaks (multiphasic). As Sr content increased, CaP-Sr peaks shifted (dashed line) 
indicating changes to lattice parameters possibly resulting from Sr substitution.  
 
  




Figures 4.12b-c XRD patterns of Ag substituted samples. c. Full scan from 10-60° 2. d. Magnification of 
scan range 25-40° 2 illustrating the dissapearance of the -TCP peaks (dashed circle) at 30.3, 30.6 and 
30.7 2 and the shifting of the -TCP peaks (dashed line) at 34.1 and 34.6 2 as Ag concentration. 
  a 




 The Mg substituted matched the CaP-Mg ICDD card 00-033-1173. No MgO or Mg peaks were 
detected suggesting that the MgO reactant powder was reduced and Mg was substituted into the CaP 
microstructure or that the amounts of Mg and MgO were too small to be identified with XRD. Increasing 
Mg concentration did not affect product composition as significantly as increasing Ag or SrO 
concentration. All Mg substituted samples are comprised of CaP-Mg, β-TCP and HA peaks (triphasic) 
and no significant peak shifting was observed Figures 4.12f-g. 
 
 Samples prepared with reacted β-TCP or reacted HA are comprised of β-TCP and HA peaks 
(biphasic) Figures 4.12h-i. Increasing β-TCP and HA concentration did not affect product composition as 
significantly as increasing Ag or SrO concentration. No significant peak shifting was observed and no -
TCP peaks were detected. As expected, as β-TCP and HA reactant concentration increased, β-TCP and 




Figures 4.12d-g XRD patterns of the Sr and Mg substituted samples. d. Full scans from 10-60° 2  of the 
Sr substituted samples. e. Magnification of scan range 25-40° 2 illustrating the dissapearance of the -
  e  d
  




TCP peaks (dashed circle) at 30.3, 30.6 and 30.7 2 and the shifting of peaks (dashed lines) as Sr 
concentration increases. f. Full scans from 10-60° 2 of the Mg substituted samples. g. Magnification of 




Product Composition is Influenced by Reactant Stoichiometry, Reactant Composition and Combustion 
Temperature. 
  
 The CaO-P2O5 phase diagram indicates that -TCP is the high temperature CaP polymorph[27, 
48, 49]. The decrease of this phase from the Ag2% and Sr7% XRD patterns suggests that SHS 
combustion temperature did not reach the required temperatures for -TCP formation (>1430°C)[27, 48, 
49]. The effects of decreasing combustion temperature by increasing Ag and SrO concentration on 
product composition are revealed by the behavior of the -TCP triplet peaks at 30.3, 30.6 and 30.7 2. As 
Ag and SrO reactant content increases, -TCP peak intensity decreases and the -TCP peaks eventually 
disappear. Additionally, the -TCP doublet peaks at 34.1 and 34.6 2 shift as a result of the d-spacings 
changing as Ag substitutes into the CaP crystal structure.   
 
  
Figures 4.12h-i XRD patterns of the CaP samples prepared with reacted β-TCP or reacted HA. h. Full 
scans from 10-60° 2  of the β-TCP substituted samples displaying the increase in β-TCP as reactant 
concentration of β-TCP increased. i. Full scans from 10-60° 2 of the HA substituted samples exhibiting 
an increase in HA content as HA reactant content increased.  
 
 
Average combustion temperature for the CaP-Mg and CaP-βinTCP samples was significantly lower than 
the required temperature for -TCP formation. No -TCP peaks were detected in the CaP-Mg, CaP-




βinTCP and CaP-HAinTCP samples. Unlike the CaP-Ag and CaP-Sr samples, no significant peak shifting 
was detected in the CaP-Mg, CaP-βinTCP and CaP-HAinTCP samples.  
 
 The number of -TCP peaks detected decreased and eventually disappeared as combustion 
temperature decreased. Additionally, peak shifting decreased as combustion temperature decreased. The 
decrease in combustion reaction temperature elucidates the important role of reactant stoichiometry and 
reactant composition on product composition.  
  
 
4.2.5 Crystal Size and Lattice Strain Analysis from X-ray Diffraction Data 
 
 Crystal size and lattice strain were analyzed from XRD data using Scherrer’s equation and are 
presented in Table 4.3 and Figures 4.13a-b[61, 98-100]. 
Reactant Stoichiometry and Reactant Composition Affect Crystal Growth. 
 
 Crystal growth in the apatite system, growth along the c-axis of hexagonal crystals, is 
thermodynamically the most favorable (lowest free energy) of all the calcium orthophosphate systems[48, 
78]. Samples with a reactant stoichiometry similar to apatite had more grain growth (larger average 
crystal size) because crystal growth is driven by thermodynamic fundamentals (reactions occur when 
ΔG<0)[138]. Calcium to phosphate ratios (c:p) similar to and different than HA (c:p=1.67) were 
generated as reactant composition and reactant stoichiometry changed. Samples with a reactant 
stoichiometry similar to HA had a larger crystal size. The HA sample had the largest average crystal size, 
108nm, which was significantly larger than the TCP, Ag2%,Mg7%, binTCP1%, binTCP7% and HT1200 
samples  (p<0.05). The Ag and Sr samples had an angular, acicular morphology similar to the HA sample 
in addition to having crystal sizes similar to the HA sample (Figures 4.7a-b). This indicates how reactant 
composition and reactant stoichiometry can be used to control crystal growth and subsequently product 
morphology. 
 
 While SHS reaction properties could also influence grain growth, their effects are overshadowed 
by changes to reactant stoichiometry. With future work, it would be interesting to hold reactant 
stoichiometry constant and alter reaction parameters to elucidate the effects of SHS reaction properties on 
crystal growth. 
 
Two Mechanisms Affect Lattice Strain: Grain Growth and Difference in Atomic Radii.  
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 Grain boundaries are areas of high lattice deformation and lattice strain. Total grain boundary 
surface area decreases as crystal growth occurs, reducing the amount of residual lattice strain in the 
sample. HA has a large crystal size (i.e. more crystal growth) and as a result the HA sample had less 
lattice strain than the TCP, Ag2%, Mg7%, binTCP1% and binTCP7% samples (p<0.05). Lattice strain in 
the TCP sample is the highest likely resulting from the significantly low crystal growth that occurred.  
 
 The Ag, Sr and Mg substituted samples had crystal sizes similar to the TCP sample, therefore a 
similar lattice strain compared to the TCP sample is to be expected; however, the Ag, Sr and Mg 
substituted samples had higher amounts of lattice strain than the TCP sample. This indicates that lattice 
strain is generated by two components: Crystal growth and the difference in atomic radii between atoms 
in the crystal structure and atoms substituting into the crystal structure.  
 





 As atoms are substituted into the CaP microstructure they replace sites occupied by Ca atoms. If 
there is a difference in atomic radii between Ca and the atoms substituting into the vacant Ca sites (i.e. Sr, 
Ag, Mg) the crystal lattice will become distorted and lattice strain will increase. Analyzing this 
component of lattice strain suggests that Ag, Sr and Mg substituted into the CaP microstructure. 
 
Heat Treating TCP Samples Decreased Lattice Strain by Increasing Crystal Size. 
 
 In addition to altering reaction parameters to control product properties, post-synthesis heat 
treatments can be applied to synthesized constructs to alter product properties. During heat treatment, 
grain growth occurs through sintering (grain boundary motion and Ostwald ripening)[8, 24, 25, 52, 68, 
139-141]. Subsequently, crystal size increases (decreasing grain boundary surface area) and lattice strain 
decreases. Both heat treated samples, HT1200 and HT1300, had larger crystal sizes and less lattice strain 
than the TCP sample. The HT1200 sample had smaller crystals and more lattice strain than the HT1300 
sample.  
 
 The rate of CaP dissolution in solution (HA<β-TCP<-TCP<<Amorphous CaP) is dictated by 
CaP microstructure and composition[2, 17, 48, 72]. The change in reactant stoichiometry and reactant 
composition decreased combustion temperature, inhibiting formation of the second most soluble phase, 
-TCP. Biphasic CaPs consisting of specific compositions of HA/β-TCP are routinely used as bone 
replacements because the preferential dissolution of β-TCP increases bioresorption[8, 12, 77]. The 
addition of reacted β-TCP and/or HA to the CaP system provides a mechanism for controlling product 
composition, subsequently generating a method to customize product dissolution. For example, the 
HAinTCP system could be selected for applications that require slower bioresorption rates (i.e. the CaP 
scaffold needs to remain intact for a longer period of time) because the HA will remain intact while to β-
TCP preferentially dissolves. This could be particularly advantageous for repairing large defects 
(diameter is greater than >10mm) or for patients with compromised would healing capability.  
 
 Product dissolution (bioresorption) is also related to product crystallinity. Producing a more 
crystalline CaP, in contrast to the mixture of amorphous and crystalline CaP synthesized in the TCP 
sample, could generate CaP materials with more regulated dissolution rates, potentially providing the 




 Research experiments are being conducted on the samples studied for this dissertation to assess 
the solubility of CaP biomaterials synthesized via SHS. The solubility experiments could illustrate how 
reactant stoichiometry, reactant composition and reaction properties can be used to predict and control 
product bioresorption. 
 
4.3 Post-Synthesis Collagen, Alginate and Chitosan Coatings  
 
 The following sections present results from experiments assessing the potential of CaP constructs 
produced with SHS as scaffolds for polymer and protein coatings. This data was submitted for 
consideration of a provisional patent.  
 
 CaP materials have considerable deficiencies as bone substitute materials with respect to 
mechanical properties. As a way to enhance their mechanical properties, polymers have been incorporated 
into CaP scaffolds. CaP-polymer composites have demonstrated significant increases in mechanical 
strength (over-lapping the lower end of mechanical properties of bone) while being readily incorporated 
into bone metabolism[10, 11, 16].  
 
 CaP constructs produced though SHS were coated with type I collagen, alginate or chitosan. Flat 
1mm thick sections of CaP embedded in epoxy were also coated for immunofluorescence microscopy and 
contact angle analysis. Table 4.4 presents the compositions studied. The HA constructs were dissolved 
due to the acidic nature of solutions need to prepare the collagen and chitosan coatings.  
 




4.3.1 Type I Collagen Attachment 
  
 A CaP construct coated with type I collagen is displayed in Figure 4.14a.The collagen coatings 
applied to the TCP, HT1200 and HT1300 sections were imaged using immunofluorescence microscopy. 
The secondary antibody applied during immunofluorescence labeling re-emits light after excitation so 
supersaturated (bright) areas represent regions of collagen attachment. Figure 4.14a-c display collagen 






attachment to a HT1200 sample at 400x magnification. Collagen fibrils (red arrows) are visible in regions 
of super saturation[142]. Figures 4.14b-c exhibit collagen attachment, super saturated white areas denoted 
with blue arrows, to a HT1200 section and a HT1300 section (100x).  
   
C                
   
Figures 4.14a-d.Immunofluorescent images if CaP coated with type I collagen. a. A CaP construct coated 
with type I collagen. b. Collagen attachment, super saturated white areas denoted by blue arrows, to a 
HT1200 sample at 400x magnification. Collagen fibrils (red arrows) are visible in regions of super 
saturation. c. Collagen attachment to a HT1200 section (100x). d. Collagen attachment to a HT1300 
section (100x).   
 
 
4.3.2 Chitosan and Alginate Coatings 
 
 The collagen, alginate or chitosan coating applied to the TCP, HT1200, HT1300 and HA 
(chitosan only) constructs were imaged digitally. A representative image of a collagen coated HT1300 
sample is displayed in Figure 4.15. 
 







4.3.3 Fourier Transform Infrared Spectroscopy of Coated Constructs  
 
 An analysis of product composition and molecular structure (bonds) was performed with Fourier 
transform infrared spectroscopy (FTIR) on the HA, TCP, heat treated and coated samples (Figure 4.16). 
As expected, a very strong phosphate (PO4
3-
) peak corresponding to the anti-symmetric P-O stretching 
mode[48, 106, 110] is present in all of the systems between 1061 and 1024cm
-1
. The second PO4
3-
 peak 
between 550 and 600cm
-1
 corresponds to the O-P-O bending mode[48, 106]. A very weak P-OH peak 
(~2160 cm
-1
) is present in all spectra. The small peak at 2300cm
-1
 comes from CO2 in air around the 
sample and indicates that peaks collected in the background spectrum did not completely subtract from 
the collected spectrum. The broad peak present between 2800-3400cm cm
-1
 in all coated HT1200 spectra 
and the HT1300C and HT1300A spectra and the weak peak found in the TCP, HA A and HT1300T 
samples between 3437-3571cm
-1
 corresponding to OH stretching vibrations of water in the samples[48, 
106, 110]. The small peak at 1640cm
-1
 (O-H-O bending) is also due to the presence of water in the 
sample.  The water peaks dominate the spectrum and make it difficult to distinguish smaller peaks that 
could arise from organic-inorganic interactions. To avoid this problem in the future, samples could be 
dehydrated (i.e. frozen or lyophilized). The peak at 1430 cm
-1
 in the HT1300T and HA A spectra 
corresponds to a carbon-carbon bond (C-C stretch) in the inorganic coatings. The peak between 1700-
1650cm
-1
 corresponds to a carbonyl bond (C=O double bond stretch) occurring in the inorganic coatings.  
 
 
Figure 4.15 Collagen coated HT1300 sample. 
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 While a detailed analysis of the interactions between the organic and inorganic phases was not 
performed it is likely that there were some interactions between the substrates and the coatings. Ca can 
bind to the anionic carboxylic acid (COOH) sites of amino acids in collagen fibrils[2, 108, 143-146]. 
Alginate is a linear polysaccharide consisting of COOH and OH bonds in linked guluronate (G) blocks 
and mannuronate (M) blocks. The G-blocks can be cross-linked with divalent cations, i.e. Ca in a CaP 
construct, to form an alginate-CaP composite material[5, 88, 147, 148]. Chitosan is also a linear 
polysaccharide. It is comprised of linked D-glucosamine and N-acetyl-D-glucosamine blocks containing 
anionic sites (e.g. OH) that could provide locations for Ca binding.  
 
 
Figure 4.16 Fourier transform infrared spectroscopy patterns of HA, TCP, heat treated and coated 
samples.   
 
 
There is Potential for Coating Calcium Phosphate Constructs Produced via Self-Propagating High-
Temperature Synthesis with Polymers and/or Proteins to Create a Bone Substitute Composite Device. 
  
 These initial results can validate the potential of CaP constructs as scaffolds for polymer and/or 
protein attachment. While there were issues with coating the HA, future experiments on coating HA 
constructs in a less acidic environment could improve the coating process. Overall, there is significant 
potential for creating CaP-polymer/protein composites and I am excited to see the progression of this 




4.4 Post-Synthesis Characterization-Mechanical Properties  
 
 Post-synthesis, the mechanical strength of the synthesized CaP constructs and coated CaP 
constructs was performed. Unfortunately, the compression testing yielded compressive strengths that had 
large standard deviations and the compressive strengths were not statistically significant (Figure4.17a). 
 
 Table 4.5 Construct mechanical properties.  
 
 
Avg. Std. Dev. Avg. Std. Dev. Avg. Std. Dev.
HA 30.35 3.59 4.62 2.54 47.01 0.65
TCP 31.97 2.77 3.58 1.97 86.17 0.37
Ag0.5% 43.80 14.64 1.31 0.64 74.26 0.59
Ag1% 16.55 3.64 1.10 0.69 74.78 0.22
Ag2% 8.43 0.25 0.57 0.51 79.66 0.11
Sr1% 54.72 23.36 3.43 2.55 79.72 0.69
Sr5% 36.03 35.00 1.48 1.16 71.49 0.50
Sr7% 12.79 1.32 2.27 1.14 64.73 0.20
Mg1% 20.50 13.45 0.76 0.48 84.76 0.24
Mg5% 26.52 2.47 1.39 0.94 87.45 0.30
Mg7% 10.68 0.01 0.42 0.01 78.94 0.14
binTCP1% 23.23 5.24 4.26 2.10 50.28 0.46
binTCP5% 34.58 5.49 3.12 1.72 63.85 0.54
binTCP7% 45.66 5.66 5.41 2.31 38.43 1.19
HAinTCP1% 32.74 15.37 1.47 0.62 30.46 1.07
HAinTCP5% 34.02 4.32 0.60 0.73 24.57 1.38
HAinTCP7% 35.70 0.83 5.61 3.92 42.00 0.85
HT1200 5.46 0.30 1.23 0.45 57.86 0.09
HT1300 3.94 0.11 0.67 0.39 96.31 0.04
1200C 2.54 0.05 2.14 0.42 - -
1200A 11.22 8.67 10.09 7.25 - -
1200T 15.15 0.62 13.09 10.49 - -
HAA 7.47 1.12 13.98 9.24 - -
1300C 3.98 0.68 0.82 0.26 - -
1300A 5.01 3.48 0.80 0.31 - -








 An alternative method, an analysis of toughness (i.e. Amount of total damage accumulation over 
time constructs can withstand) was performed. Traditionally, the compressive strengths of synthetic bone 
substitute materials are presented; however, an analysis of toughness is also a valid measure for 
comparison. Bone is a dynamic material, when fractures are formed a cascade of events heals and repairs 
the damage. Subsequently, bone can withstand a large accumulation of damage over time (high 
toughness). Bone substitute materials will eventually be incorporated into bone through fracture healing 
and remodeling. As such, an analysis of their toughness will provide an estimation of their mechanical 
response to loading. 
  
 The area under the stress-strain curves (toughness) was calculated, analyzed and is presented in 
Table 4.5 and Figure 4.17b. The calculated standard deviations were large for the toughness data; 
however, there was a significant difference between all samples (p<0.05). HA had a higher toughness 
than Ag2% (p<0.05). The HAinTCP5% sample had a significantly lower toughness than the βinTCP1%, 
βinTCP5%, HAinTCP7%, 1200A(lginate) and 1200T (chitosan) samples, while the HT1300 and 1300T 
samples had lower toughness values than the 1200A and 1200T samples (p<0.05).   
 
Reactant Composition, Reactant Stoichiometry and Reaction Properties Affected Porosity and 
Subsequently Mechanical Strength and Toughness. 
 
 In ceramic materials, pores act as stress concentrators and decrease the cross-sectional area over 
which load is applied subsequently decreasing compressive strength[133, 149]. An increase in porosity 
typically decreases compressive strength and mechanical stability due to the decrease in the solid material 
present in the specimen[133, 150]. Cracks under compression propagate stably and twist out of their 
origin parallel to the compression axis[130, 133]. Therefore, compressive fracture under slow strain rates, 
is caused by the extension and lining up of many cracks to form a crushed or damaged zone opposed to a 
single large crack[133, 149]. By considering pores as cracks, their homogeneous distribution facilitates 
crack propagation and decreases compressive strength. Consequently, the effects of pore size and 
distribution not just total porosity, must be considered when assessing mechanical strength[150].  
 
 
 Porosity also contributes to the fracture toughness of bone[54]. In the longitudinal direction 
porosity and fracture toughness are inversely related, potentially due to the net decrease in crack surface 
area[54]. In the transverse direction porosity has less influence on toughness due to toughening 
mechanisms e.g. osteon pullout and cement line de-bonding[54]. Figure 4.17c displays toughness data 
normalized by total porosity. HA, βinTCP1%, βinTCP7% and HAinTCP7% had the highest normalized 
61 
 
toughness. Toughening of ceramic and composite materials is a function of multiple mechanisms[130, 
133, 149, 150]. It is likely that the CaP-βinTCP and CaP-HAinTCP samples had a high toughness because 
the β-TCP and HA particles in the CaP matrix deflected cracks along the particle/CaP matrix interface, 
while the HA sample had a higher toughness due to its lower porosity. 
 
 
Table 4.5 Construct mechanical properties. 
 
 
Avg. Std. Dev. Avg. Std. Dev. Avg. Std. Dev.
HA 30.35 3.59 4.62 2.54 47.01 0.65
TCP 31.97 2.77 3.58 1.97 86.17 0.37
Ag0.5% 43.80 14.64 1.31 0.64 74.26 0.59
Ag1% 16.55 3.64 1.10 0.69 74.78 0.22
Ag2% 8.43 0.25 0.57 0.51 79.66 0.11
Sr1% 54.72 23.36 3.43 2.55 79.72 0.69
Sr5% 36.03 35.00 1.48 1.16 71.49 0.50
Sr7% 12.79 1.32 2.27 1.14 64.73 0.20
Mg1% 20.50 13.45 0.76 0.48 84.76 0.24
Mg5% 26.52 2.47 1.39 0.94 87.45 0.30
Mg7% 10.68 0.01 0.42 0.01 78.94 0.14
binTCP1% 23.23 5.24 4.26 2.10 50.28 0.46
binTCP5% 34.58 5.49 3.12 1.72 63.85 0.54
binTCP7% 45.66 5.66 5.41 2.31 38.43 1.19
HAinTCP1% 32.74 15.37 1.47 0.62 30.46 1.07
HAinTCP5% 34.02 4.32 0.60 0.73 24.57 1.38
HAinTCP7% 35.70 0.83 5.61 3.92 42.00 0.85
HT1200 5.46 0.30 1.23 0.45 57.86 0.09
HT1300 3.94 0.11 0.67 0.39 96.31 0.04
1200C 2.54 0.05 2.14 0.42 - -
1200A 11.22 8.67 10.09 7.25 - -
1200T 15.15 0.62 13.09 10.49 - -
HAA 7.47 1.12 13.98 9.24 - -
1300C 3.98 0.68 0.82 0.26 - -
1300A 5.01 3.48 0.80 0.31 - -









Figure 4.17a-c CaP construct mechanical testing data. a. Measured compressive strength of the calcium 






 Porosity plays a large role in the mechanical properties of a ceramic construct. In theory, a 
uniform distribution of nanopores could affect the mechanical properties as much or more than a uniform 
distribution of micropores. This research illustrates how reactant and reaction properties can be used to 
control product morphology and subsequently, the biomechanical properties of the CaP constructs. 
 
4.5 Post-Synthesis Characterization- Antimicrobial Activity and Biocompatibility of Calcium 
Phosphate Constructs Substituted with Silver 
 
 The following information was taken from a manuscript submitted to Acta Biomaterialia and 
includes information from provisional patent #61822073[44]. This experiment was used to determine the 
antimicrobial activity and biocompatibility of CaP constructs substituted with Ag.  
 
4.5.1 Antimicrobial Activity of Calcium Phosphate Construct Substituted with Silver 
 
 In the growing field of medical device production there has been an increasing demand for bone 
implants with bactericidal properties[13, 14, 58] to decrease the incidence of bacterial infections resulting 
from orthopedic surgeries[59]. CaP constructs are routinely used as bone replacement materials as they 
mimic the mineral component of bone, are bioactive[2, 4, 15-17]and bioresorbable[2, 8, 17, 77]. Heavy 
metals have been investigated as an alternative to antibiotic therapy [13, 14, 58, 59, 62, 112] to decrease 
the incidence of post-operative implant associated infections and deep periprosthetic infections caused by 
antibiotic resistant bacteria[58]. Of the heavy metals studied Ag has demonstrated exceptional 
antimicrobial activity[13, 14, 58, 59, 112] and low mammalian cytotoxicity[13, 58, 59, 117]. 
Consequently, CaPs substituted with Ag have shown promise as bone tissue scaffolds that can locally 
inhibit bacterial growth[13, 14, 58, 59, 62, 112]. 
 
 The application of Ag particles as an antimicrobial component of CaP constructs was investigated 
by exposing E.coli to a solution of CaP-Ag particles and LB broth and culturing this solution on LB agar 
plates.  
 
Calcium Phosphate Constructs Substituted with Silver Were Bactericidal and Released Significantly Low 
Quantities of Silver. 
 
 The reaction of E.coli to Ag substituted CaP compared to the HA and TCP controls is exhibited in 
Figure 4.18a. As expected, the control samples displayed significant colony formation (black arrows). 
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The HA control had the lowest number of colonies formed of all the controls while the TCP and E.coli 
only controls contained dense bacterial lawns. All of the Ag substituted samples exhibited a significant 
reduction in colony formation (Table 4.6). Additionally, as Ag concentration increased, the number of 
colonies present after 24h decreased confirming the bactericidal capabilities of CaP materials substituted 
with Ag[13, 58, 59, 62, 112]. Optical microscopy showed significant differences in bacterial morphology 
between the Ag substituted samples and the controls (Figure 4.18b-c). E.coli in the controls displayed 
rod-shaped, cylindrical, segmented morphology[62] and were observed undergoing healthy binary fission 
(Figure 4.18b)[61]. Cells in the Ag substituted samples were difficult to count because the long, jagged 




Figure 4.18a-c Images from antimicrobial activity experiments. a. Colony formation (black arrows) at 






like morphology (green arrow) and c. the Ag substituted samples showing chains of rough cells forming 
into clusters (red arrow).  
 
 
4.5.2 Inductively Coupled Plasma-Atomic Emission Spectroscopy of Silver Substituted Calcium 
 Phosphate Constructs  
 
ICP-AES analysis (Figure 4.19) was used to examine the concentration of Ag released as a 
function of time[13]. The Ag substituted samples released low amounts (0.014-0.028ppm) of Ag between 
days 1-21. As expected, Ag2% released the highest concentration of Ag, however the concentration 
decreased over time from 0.028 to 0.018ppm. Conversely the amount of Ag released for Ag0.5 and 1% 
increased with time. In vivo, 0.2ppm is the lowest-observed-adverse-effect level (LOAEL) for Ag and 
concentrations below this are considered normal[13, 117]. Eukaryotic cells have higher functional and 
structural redundancy than bacterial and archaeal cells, necessitating higher concentrations of metal ions 
to generate a cytotoxic response[58]. Minute concentrations of metal ions produce a toxic effect on living 
bacteria[13, 58, 61] while these low concentrations have minimal cytotoxic effects on human cells[13, 58, 
61]. 
 
4.5.3 Biocompatibility of Silver Substituted Calcium Phosphate Powders 
 
 Cytocompatability tests were performed using a human osteoblast(OB) cell line (hFOB1.19 
ATCC, CRL-11372). Cytotoxicity and cell morphology were analyzed with SEM.  
 
Calcium Phosphate Constructs Substituted with Silver Did Not Appear to be Cytotoxic. 
 
 The OBs adhered to the tissue-culture polystyrene (TCPS) well plates and colonized the surface 
in a uniform monolayer over a 7 day period. Figures 4.20a-b show OBs attached to the well plate 
substrate uniformly spreading around the Ag2% powder (white circular particles). Cell adhesion to and 
proliferation across the CaP could indicate an attempt to colonize the CaP covered substrate. Figures 
4.20a-b show cells displaying a typical, healthy morphology[151] in the presence of Ag0.5% particulates 
(white arrows). Cells were elongated with pseudopodia extending from advancing and trailing edges. Cell 





Figure 4.19 CaP-Ag ICP-AES data. ICP-AES analysis was used to examine the concentration of Ag 
released as a function of time. In vivo, 0.2ppm is the lowest-observed-adverse-effect level (LOAEL) for 




Figures 4.20a-b CaP-Ag cell culture micrographs. Micrographs of osteoblasts (black arrows) cultured 
with a. Ag2% powder at 50x and b. Ag0.5% particles (white arrows) at 750x. 
 
4.5.4 Contact Angle Measurements   
 The contact angles measured for the TCP and HA sectioned samples were 47.25±0.49 and 
63.65±4.31°, respectively. Contact angles for the CaP-Ag 0.5, 1 and 2% sectioned surfaces were 
 a  b 
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62.60±2.26, 69.25±4.73 and 34.35±6.85°, respectively. Contact angles for the HA, Ag0.5 and 1% 
surfaces were similar (p>0.05) while contact angles for the TCP and Ag2% surfaces were similar 
(p>0.05). Ag2% had the lowest contact angle. Contact angles for the HA, Ag0.5 and 1% surfaces were 
significantly higher than the TCP and Ag2% samples (p<0.05). Figure 4.21a displays an image of the 
measured contact angle for Ag0.5% sample and Figure 4.21b displays an image of Ag2%. The green lines 
determine the horizontal edge of the surface, the center of the water drop and the outline of the drop, 
while the white line is the contact angle calculated by DROPimage. 
 
  
Figure 4.21a-b Image of CaP-Ag contact angles. a. Displays an image of the measured contact angle for 
Ag0.5% and b. Ag2%. The green lines determine the horizontal edge of the surface, the center of the 




Ag Substituted Samples Could Inhibit Bacterial Adhesion While Augmenting Bone Cell Attachment. 
 
 In vivo, initial bacterial adhesion to a material’s surface and subsequent biofilm formation are 
significant steps in the pathogenesis of infection[59]. Bacterial adhesion is suggested to involve lectin-like 
interactions between surfaces and physicochemical surface properties[59, 152]. Bacterial attachment and 
subsequent biofilm formation increase with increasing surface hydrophobicity[59, 152]. Bacteria that are 
unable to initially adhere to the implant surfaces are promptly killed by the immune system[59]. 
Hydrophilic surfaces tend to inhibit bacterial adhesion[59, 152], while contact angles between 30-60° 
increase L292 fibroblast cell attachment[153] and contact angles around 70° stimulate fibroblast adhesion 
and collagen secretions[128]. Contact angle measurements show that all Ag substituted samples could 
inhibit bacterial adhesion, while bone cell attachment and functionality would be best augmented by the 
HA, Ag0.5% and 1% samples.   
 
 As the medical device field has grown so has the need for preventing post-operative infections. 
Transition metals have been studied for their bactericidal capacities[13, 58, 61, 62, 112] and Ag has 
performed well as an antimicrobial agent[13, 58, 61, 62, 112]. CaPs substituted with Ag are innovative 
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materials that could play a pivotal role in the transition to the next generation of bone replacement 
materials. SHS provides a highly adaptable manufacturing method that can produce CaP materials 
substituted with Ag that not only promote tissue regeneration but also inhibit bacterial adhesion to the 
implant surface[59]. 
 
4.6 Summary of Experimental Results 
 
 Calcium phosphate (CaP) constructs substituted with specific weight percentages of Ag, Sr, Mg, 
reacted β-TCP and reacted HA were successfully produced using self-propagating high-temperature 
synthesis (SHS). SHS provides a unique method for production of CaP as product properties can be 




CHAPTER 5 BIOLOGIC POTENTIAL OF CALCIUM PHOSPHATE BIOPOWDERS 
PRODUCED VIA DECOMPOSITION COMBUSTION SYNTHESIS FOR BONE TISSUE 
ENGINEERING 
 
 As mentioned in Chapter 1, there are multiple methods of combustion synthesis. The first portion 
of this dissertation focused on self-propagating high-temperature synthesis (SHS) for the production of 
three-dimensional calcium phosphate (CaP) constructs, while Chapter 5 focuses on an alternative method 
of combustion synthesis, decomposition combustion Synthesis (DCS) for production of CaP powders. 
The following is taken from a manuscript submitted to and published in the International Journal of High-












The aim of this research was to evaluate the biologic potential of a novel synthesis technique used 
to produce calcium phosphate (CaP) biopowders. Decomposition combustion synthesis (DCS) is a 
modified combustion synthesis method capable of producing CaP powders for use in bone tissue 
engineering applications. During DCS, the stoichiometric ratio of reactant salt to fuel was adjusted to alter 
product chemistry and morphology. In vitro testing methods were utilized to determine the effects of 
controlling product composition on cytotoxicity, proliferation, biocompatibility and biomineralization. In 
vitro, human fetal osteoblasts (ATCC, CRL-11372) cultured with CaP powder displayed a flattened 
morphology, and uniformly encompassed the CaP particulates. Matrix vesicles containing calcium and 
inorganic phosphate budded from the osteoblast cells. CaP powders produced via DCS represent a source 
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Combustion synthesis is an overarching term coined for self-sustaining exothermic reactions that 
utilize internally generated energy[26] to rapidly produce a desired product. Traditional combustion 
synthesis methods utilize solid-state reactions of reactant powders[27] whereas decomposition 
combustion synthesis (DCS) requires the aqueous decomposition and subsequent reconstitution of the 
reactants into a gelatinous foam prior to ignition[104, 154]. Calcium phosphate DCS is a self-propagating 
high-temperature synthesis (SHS) process that utilizes the heat generated by the exothermic reaction of 
urea, calcium nitrate and ammonium phosphate to generate and sustain the propagation of a combustion 
wave[29, 32, 41] through the reactants. 
 
DCS is a novel combustion synthesis technique that has been used to produce many advanced 
materials, including calcium phosphate (CaP)[31, 154]. DCS reactions are unique in that modified 
reactant salt and fuel stoichiometries can be used to produce CaP powders with diverse chemistries and 
morphologies[155] allowing the final product to be customized to specific manufacturing requirements. 
Additionally, DCS product synthesis time (~20min) is significantly lower than that of traditional synthesis 
techniques such as wet chemistry precipitation[23, 38, 39, 68, 109] or solid-state reactions[57, 103, 156].  
 
Synthetic CaP materials have been shown to be bioactive[2, 15, 16], they promote bone growth 
on and/or within the construct (osteoconduction)[3, 18] and induce osteogenesis by stimulating 
undifferentiated cells to differentiate into preosteoblast cells (osteoinduction)[3, 18, 19]. Additionally, 
CaP materials are surface reactive. They encourage the formation of a physico-chemical bond between 
the host tissue and implant material[20, 21] resulting in tissue integration. 
 
Currently available synthetic CaP materials are comprised of hydroxyapatite (HA) [16, 73], 
tricalcium phosphate (TCP)[74] or mixtures with varying percentages of HA and TCP[8, 9, 12, 75, 76]. 
Biphasic, triphasic and multiphasic CaPs are commonly utilized in reconstruction of bone defects[12] and 
it has been demonstrated that the bioactivity of biphasic CaPs can be directly controlled via manipulation 
of the CaP composition[8, 75, 157]. In addition to calcium and phosphate, bone mineral can contain 
carbonate ions[1, 38, 48, 85] and trace elements[1, 48]. DCS reactions are unique in that modifications to 
the combustion reaction e.g. increasing reaction ignition temperature, decreasing reaction cooling rates, 
changing reaction atmosphere could provide the ability to control the combustion reaction and 
subsequently product composition. Specifically, reactant stoichiometry can be controlled to produce 
products with specific bi-, tri- or multiphasic compositions. The CaP DCS reaction system could be 
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modified to include dopants that enhance the mechanical, chemical and biological properties of the 




 [158] for 
increased microhardness and cellular response. Whereas post synthesis heat treatment[68, 109] could be 
applied to the final products to produce pure (single) phase CaP powders. Subsequent to interaction with 
the human body, a CaP implant with biomimetic properties and compositional similarity to natural bone 
may reduce healing time, improve tissue integration and improve long term in vivo function[129, 159]. 
 
DCS represents a potential processing mechanism for the production of biologically active CaP 
biopowders that can be used as components in medical devices, bone cements, coatings and bone tissue 
engineering applications. The intent of this research is to examine the biologic potential of CaP 
biopowders synthesized via DCS and to quantify the effects of controlling reaction parameters (e.g. 
reactant stoichiometry) on biologic activity.  
 
5.2 Materials and Methods 
 
A detailed description of the DCS procedure has been given elsewhere[31]. Briefly, salts of calcium 
nitrate tetrahydrate [ OHNOCa 223 4)(  ], ammonium phosphate [ 424 )( HPONH ] and urea [ 22)(NHCO ] 
were dissolved in 10ml of de-ionized water in a beaker and heated on a hot plate for 20min. During 
heating, the hydrolyzed reactants were vaporized until a white foam formed. Then the beaker with foam 
was placed into a Blue M™ box-type muffle furnace at 1000°C (+/-)10°C until the foam ignited (~2-
8s)[31]. The decomposition of calcium nitrate tetrahydrate into NO3
-





drives the combustion reaction while the oxidation and complete decomposition of 
urea energetically sustains the reaction. Reaction 5.1 
 
[Ca(NO3)2∙4H2O] + Y[(NH4)2HPO4] + Z[CO(NH2)2] →      (5.1) 
Cax(PO4)Y+ Cax(PO4)Y (OH)2 + fXYZ(NO3+ NH4+NH3(g)+CO2(g))       
 
 5.2.1 Powder Stoichiometry 
 
The ratio of calcium nitrate tetrahydrate (CaN) to ammonium phosphate (AmP) directly 
determines the amount of calcium and phosphate in the system[154]. This ratio will be referred to as the 
calcium to phosphate (c:p) ratio. For example, to obtain a stoichiometric ratio (3:2) of calcium to 
phosphate in the products, a c:p ratio of 1.5 is needed. Therefore the CaN term (X) in reaction 1 needs to 
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be multiplied by 3 and the AmP term (Y) needs to be multiplied by 2. C:p ratios and the coefficients used 
to obtain these ratios are shown in Table 5.1.  
 
Table 5.1. C:p ratio reactant data.  
c:p Ratio 
CaN (X)  
Coefficients 
AmP (Y)  
Coefficients 
1.3 3 2.3 
1.5 3 2 
1.7 3 1.765 
 
 
A stoichiometric fuel ratio (amount of urea to the amount of CaN and AmP) was determined by 
calculating an elemental equivalence ratio (ϕe= Sum of oxidizing and reducing elements in the mixture) 
for the reaction[155, 160]. Calculations for ϕe for this system are given by Equation 5.2. 
 
3[Ca(NO3)2∙4H2O] + 2[(NH4)2HPO4] + Z[CO(NH2)2]        (5.2) 
3[1]0 + 2[16] + Z[6] = 3 
Therefore Z=3=ϕe.           
            
Table 5.2 lists the valences for the reactants in this system. These valences were used to calculate 
ϕe.  
 
Fuel ratios were obtained by multiplying (ϕe) by the elemental stoichiometric coefficient 
multipliers shown in Table 5.2. For example to obtain a stoichiometric fuel ratio, the urea term (Z) in 
reaction 1 is multiplied by 5.2. 
 

























Tables 5.3a-b present matrices of sample stoichiometries studied. Samples in Table 5.3a have 
varying c:p ratios, and a constant fuel ratio (urea:CaN+AmP). Samples in Table 5.3b have a constant c:p 
ratio, but varying fuel ratios. 
 













5.2.2 Product Characterization 
 
Scanning electron microscopy (SEM) was performed with a FEI Quanta 600 SEM. High vacuum 
with a 20kv beam and spot size of 4.0 created optimal measurement conditions and minimized 
charging[161]. The CaP powders were sputter-coated with gold (Hummer V) and analyzed for 
composition, morphology, grain growth and specific structural formations (i.e. Necking).  
 
X-ray diffraction (XRD) patterns were obtained with a Phillips Analytical PW3240 X’PERT data 
collector using 2θ scans ranging from 10 to 80 degrees. An internal silicon powder (99.9% pure, Alfa 
Aesar) with a 1:4 ratio of silicon to CaP was used to correct for machine error[162, 163].
 
The XRD 
patterns were corrected with the P’Analytical High Score data program. Peak matching was performed by 
comparing respective 2θ values to standard peak values in the International Centre for Diffraction Data 
(ICDD) cards. An error tolerance of (+/-) 0.1 2θ was used to calculate peak values.  
 
A Nicolet 4700 Fourier transform infrared spectrometer (FTIR) (Thermo Electron Corporation) 
and OMNIC 7.2 software (Thermo Electron Corporation) were used to analyze the molecular structure of 
the reactants and CaP products. For this work, peak values in the transmittance spectra[1, 23, 38, 48, 56, 
110, 164] were characterized using peak values from literature[37, 103, 165, 166] and the Spectral 
Database for Organic Compounds (SDBS) provided by the National Institute of Advanced Industrial 
Science and Technology (AIST).  
 
















5.2.3 Human Fetal Osteoblast 1.19 (hFOB 1.19) Cell Culture 
 
Two aliquots of hFOB 1.19 cells (ATCC, CRL-11372), 1-2 million cells/aliquot, were thawed 
using a double boiler method in a water bath at 37°C for 5min. Each aliquot was transferred to a T-25 
TCPS flask (Nunc) and 10ml of cell culture media (37°C); 1:1 Dulbecco’s Modified Eagle’s Medium/F-
12 (HyClone), 10% Fetal Bovine Serum (HyClone) and 0.3mg/ml of G-418 (MP Biomedicals) were 
added to each flask[114, 115]. The flasks were incubated at 34°C with 98% humidity and 5% CO2[114, 
115]. This line has been genetically modified for proliferation at 34°C and differentiation at ≥37°C. 
Media was changed every 2-3 days[114, 115]. The cells were checked daily and counted weekly. When 
the flasks reached 80% confluent they were expanded. The medium was aspirated off the cells and 2ml of 
0.25% trypsin-EDTA (MP Biomedicals) was added. The flasks were incubated for 15min at 37°C with 
98% humidity and 5% CO2. The mixture of trypsin and cells was dispensed into a T-75 TCPS flask 
(Nunc), supplemented with 25ml of medium (37°C) and incubated at 34°C with 98% humidity and 5% 
CO2. After reaching 80% confluent the cells were expanded into a T-175 flask (Nunc) and 45ml of cell 
culture medium (37°C) was added[114, 115]. The flasks were incubated at 34°C with 98% humidity and 
5% CO2.  
 
5.2.4 Cell Culture Experimental Procedure 
 
 CaP powders were sterilized in a drying oven (Binder) at 105°C for 24h. After sterilization 100µg 
of powder was placed in 5 test wells on each tissue culture polystyrene (TCPS) 6-well plate (Fisher). The 
sixth well was a control and contained only cells. The experiment was run in triplicate. Wells were seeded 
at a density of ~5x10
3
[114] and 8ml of cell culture medium (37°C) was added to each well. The medium 
was changed every 2-3 days. During medium aspiration the glass pipette did not contact the bottom of the 
well, minimizing the amount of powder removed from the well plate during medium changes. The well 
plates were incubated at 39.5°C with 98% humidity and 5% CO2, examined daily for signs of 
contamination and tracked microscopically. On days 1, 3, 7, 14 and 21[97] 2ml of medium from each 
well was transferred into a sterile vial and stored at -4°C. Day 1 started 24h after seeding. At the 
conclusion of the experiment media was aspirated from the wells and the cells were fixed with a 1:0.25 
gluteraldehyde (MP Biomedicals) to sodium cacodylate buffer (Electron Microscopy Sciences) 
solution[97] to stabilize the cell membrane and prevent degradation.  
  
 The bottoms of the well plates were cut off (Dremel) and the surface with the fixed cells and CaP 
was sputter-coated with gold (Hummer V). SEM was performed with a FEI Quanta 600 using high-
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resolution, 15kv and a spot size of 3.5. Additionally, field emission-SEM (FE-SEM) and energy 
dispersive spectroscopy (EDS) were performed with a JEOL JSM-7000F SEM to analyze composition, 
mineralized matrix formation and osteoblast morphology. 
 
 The amount of bone alkaline phosphatase (ALP-b) in the medium samples was measured with an 
ALP-b microassay (Alkaline Phosphatase Detection Kit Fluorescence, Sigma). These measurements were 
used to track changes in the amount of ALP-b throughout the experiment and to quantify the effects of c:p 
ratio and fuel ratio on ALP-b secretion. Readings were taken at 2min intervals for 10min on a Synergy 4 
Hybrid Multi-Mode Microplate Reader (BioTek Instruments, Inc.) and analyzed with the Gen5 data 
analysis software. Data from the readings taken at 10min are reported. Differences in ALP-b activity were 
statistically analyzed with Kruskal-Wallis one-way ANOVA (p<0.05) followed by a Mann-Whitney post 
hoc test (Minitab 16, Minitab Inc.) to assess significance (p<0.10).  
 
5.3 Results and Discussion 
 
In previous work it was noted that DCS ignition times were consistently between 2-8s and 
reaction times were less than 15s from initiation to completion[31, 154]. During reactions, multiple points 
in the foam ignited at once followed by propagating combustion waves, indicative of simultaneous or 
explosive combustion[34]. The reactions produced a friable, white, porous powder that upon gentle 
handling crumbled into finer powder particles. No fluid remained post reaction. 
 
During DCS reactions, a molten zone (mz) is generated at the reaction front if the reactants have a 
melting point lower than the combustion temperature[27, 29, 33, 42]. As the mz cools, pockets of 
ammonia (NH3) and carbon dioxide (CO2) gas, formed during AmP and urea volatilization, are trapped in 
the synthesized construct generating product microporosity[27, 29, 42]. The size of the gas pockets 
generated during DCS can be quantified by analyzing product microporosity (<10µm) and controlled by 
increasing or decreasing the NH3 and CO2 off-gassing during DCS (i.e. altering AmP and urea content by 
changing c:p and/or fuel ratio).  
 
 SEM images of powders post-synthesis display multimodal porosity (Figures 5.1a-b)[27, 72] and 
there appears to be no obvious uniform particle geometry that would indicate sintering of the reactants. 
Product morphology is indicative of a SHS reaction[27, 29, 33]. Porosity data analysis for this research is 
presented elsewhere[31]. Briefly, total porosity (PTotal) values for sample c:p1.3 x=4.5 and sample c:p1.7 
x-4.5 are 57.8 and 52.5%, respectively. The product powder has an average porosity between 52-58% and 
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as a result it does not meet the suggested minimum porosity and pore diameter required for bone 
ingrowth[2, 167]. Subsequently, it could not be considered applicable as a bone scaffold but rather as a 
mineralized, bioactive component in a larger construct e.g. composite bone graft substitutes[168, 169], 
implant coatings[10, 169], bone cement[13, 86]. The pore sizes determined from image analysis[31] show 
pores that could support osteoblast migration [16, 17, 77, 82] and the measured porosity increases surface 
area subsequently increasing adsorption sites for selected proteins[140, 170, 171]. This illustrates how 
DCS reaction parameters (c:p ratio and fuel ratio) can be used to control product porosity and potentially 
biologic functionality.  
 
   
Figures 5.1a-b. SEM micrographs of synthesized powder. a. c:p1.3 x=4.5 powder at 1000x (arrows 
indicate crystalline structures and arrow heads indicate amorphous structure). b. SEM micrograph of c:p 
1.7 x=4.5 powder at 1000x. 
 
 
5.3.1 DCS Produced Multiphasic CaP Powders  
 
Figure 5.2a and Table 5.4 show XRD patterns where the fuel ratio was held constant at 4.5 and 
the calcium to phosphate (c:p) ratios were 1.3, 1.5 and 1.7. The CaP powder contains multiple phases. 
Characteristic α-TCP peaks are present at 14.0, 18.5, 19.1 and 47.3 2θ (ICDD Card 03-0681); β-TCP 
peaks are present at 20.4, 23.4, 26.2, 32.9, 35.2 and 39.3 2θ (03-691, 06-0425); and HA peaks are present 
at 17.8, 28.9, 50.7 and 52.1 2θ (72-1243, 73-0293). Figure 5.2b and Table 5.4 show three systems where 
the fuel ratios were 3, 4.5 and 7.5 while the c:p ratio was held constant at 1.5. Characteristic α-TCP peaks 
are present at 14.0, 19.1, 24.0, 30.8, 35.1 and 47.3 2θ; β-TCP peaks are present at 16.3, 20.4, 26.4, 32.9, 
35.2 and 39.3 2θ; and HA peaks are present at 17.9, 28.4, 50.4, 51.9 and 53.4 2θ. Additionally, carbonate 
apatite (CA) peaks are present at 33.9, 39.4, 40.0, 41.1, 41.3 and 48.0 2θ (011-3826). The carbonate ion 





) could substitute into the CaP structure resulting in carbonate apatite formation[38, 39, 56, 57]. 
Traditional CaP synthesis techniques rely on a CO2 atmosphere[23, 57] or the addition of a reactant 
containing carbonate[39] to incorporate CO3
2- 
in the final product. Due to the highly adaptable nature of 
DCS reactions, reactions could be performed in a CO2 atmosphere or with carbonate containing reactants 
to increase carbonate concentration in the final products, however these additional processing variables 
are unnecessary as carbonate ions are formed from the decomposition of urea[31] during DCS reactions. 
 
Reaction ignition temperature was 1000°C and maximum reaction temperatures reached up to 
1550°C but due to different wave front velocities, reaction rates and cooling rates the reaction 
temperature at specific areas in the sample could vary between 800 and 1550°C. This range encompasses 
the formation temperatures on the CaO-P2O5 phase diagram[48, 49] for -TCP, β-TCP and HA peaks. 
These phases were present in the CaP product XRD patterns, indicating that reaction temperatures 
throughout the sample fluctuated between 800 and 1550°C.  
 
 




Figure 5.2b. XRD patterns of product powders with varying fuel ratios and a constant c:p ratio. 
 
 
Table 5.4 Peaks detected in XRD patterns. 
  α-TCP β-TCP HA CA 
c:p1.3 x=4.5 
c:p1.5x=4.5        
c:p1.7 x=4.5 
14.0  18.5  
19.1  47.3  
20.4  23.4  
26.2  32.9  
35.2  39.3   
17.8  28.9  
50.7  52.1 
33.9  39.4  
40.0  41.1  
41.3  48.0  
x=3 c:p1.5  x=4.5 
c:p1.5  x=7.5 c:p1.5 
14.0  19.1  
24.0  30.8  
35.1  47.3  
16.3  20.4  
26.4  32.9  
35.2  39.3  
17.9  28.4  
50.4  51.9  
53.4   
33.9  39.4  
40.0  41.1  





FTIR was used to characterize product composition and molecular structure. IR peak values 
correlate to specific bonds. IR spectra of CaP products with varying c:p ratios and constant fuel ratio are 
shown in Figure 5.3a and Table 5.5. A weak OH
-
 peak corresponding to OH stretching vibrations[48, 106, 
110] is found in all spectra at peak values between 3437 and 3571cm
-1
. A very strong PO4
3-
 peak 
corresponding to the anti-symmetric P-O stretching mode[48, 106, 110] is present in all of the systems 
between 1061 and 1024cm
-1
. The second PO4
3-
 peak between 550 and 600cm
-1
 corresponds to the O-P-O 
bending mode[48, 106]. A very weak P-OH peak (~2160 cm
-1
) is present in all of spectra. Two small 
CO3
2-
 peaks corresponding to the v3 stretching vibrations between 1455 and 1411cm
-1
 are present in all 
spectra. These CO3
2- 
peaks could be correlated to a B-type carbonate ion substitution in the CaP 
structure[19, 23, 38, 56, 164]. Two very weak CO3
2- 
peaks are present between 880-800 and 720-680 cm
-
1
[19, 23, 55, 110, 164]. These CO3
2- 
peaks could be correlated to either an A- or B-type carbonate ion 
substitution in the CaP structure[19, 23, 38, 56, 164]. An additional CO3
2- 
could be present between 1090-
1020, but it is masked by the strong PO4
3-




) is present in all CaP 
spectra. The NO3
-
 peaks indicate that there was not a complete conversion of reactants to products during 
the DCS reaction. A weak ammonia (NH4
-
) peak at 1440cm
-1










increases resulting in increased peak intensity 
 



























c:p1.5x=4.5        
c:p1.7 x=4.5 






1455    
1411 







   
  
  
x=3 c:p1.5 3437   
3571 
1061-1024 550-600 2160 1455    
1411 




x=4.5 c:p1.5 3437   
3571 
1061-1024 550-600 2160 1455    
1411 










IR spectra of CaP products with varying fuel ratios and constant c:p ratios are shown in Figure 
5.3b and Table 5.5. All spectra, except c:p1.5 x=7.5, contain a very weak OH
-
 peak between 3437 and 
3571cm
-1
. A very strong PO4
3-
 peak corresponding to the anti-symmetric P-O stretching mode[48, 106, 
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110] is present in all of the systems between 1061 and 1024cm
-1
. The second PO4
3-
 peak between 550 and 
600cm
-1
 corresponds to the O-P-O bending mode[48, 106]. A very weak P-OH peak (~2160 cm
-1
) is 
present in all spectra. Two small CO3
2-
 peaks corresponding to the v3 stretching vibrations between 1455 
and 1411cm
-1
 are present in all spectra except c:p1.5 x=7.5. Two very weak CO3
2- 
peaks are present 
between 880-800 and 720-680 cm
-1
 in all spectra. An additional CO3
2- 
could be present between 1090-
1020 but it is masked by the strong PO4
3-




) is present in all CaP 
spectra.  A weak NH4
-
 peak at 1440cm
-1




 are present in all spectra. 




 increases resulting in 
increased peak intensity.  
 
 
Figure 5.3a. Combined IR spectra of product powders with varying calcium to phosphate ratio.  
 
 




 and are present in the product powder as a result of an 
incomplete conversion of reactants to products during the combustion reaction. The amount of NH4
-
 
present in the spectra is directly controlled by the fuel ratio (Figure 5.3b) and indirectly controlled by the 
c:p ratio. Sample c:p 1.3 x=4.5 exhibits an NH4
-
 peak even though it has a fuel ratio of x=4.5. It is 
speculated that because the c:p ratio is so low the reaction is CaN deficient and it is likely that excess 







). Carbonate is present in bone (<8 mass %) and the incorporation of 
carbonate into synthetic CaPs has increased mechanical and biological properties[23, 38, 39, 55-57, 106, 
134, 164]. Controlling the amount of CO3
2-
 generated during DCS demonstrates the ability to customize 
product properties, and subsequently biologic performance by modifying reaction parameters (e.g. c:p 
ratio; fuel ratio). 
 
 
Figure 5.3b. Combined IR spectra of product powders with varying fuel ratio. 
  
 
Reaction 5.3 could be modified further to incorporate a mixed A/B type carbonate apatite 
formation.  
 
[Ca(NO3)2∙4H2O] + Y[(NH4)2HPO4] + Z[CO(NH2)2] →      (5.4) 







Where 0 < C < 1[38].  
 
5.3.2 The Synthesized CaP Powders were Not Cytotoxic 
 
Cytotoxicity and cell morphology were analyzed with SEM. Figure 5.4a shows osteoblasts in the control 
well at the conclusion of the experiment. The cells appeared to adhere to the well plates and colonized the 
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surface in a uniform monolayer. Figure 5.4b shows osteoblasts with a flattened morphology attached to 
the well plate surface and uniformly spreading around the CaP powder (white arrows). Cell adhesion to 
and proliferation across the CaP could indicate an attempt to colonize the CaP covered surface. Cell 
morphology in the presence of CaP powder is comparable to areas without CaP particulates[20].  
 
  
Figure 5.4a. Cell culture SEM micrographs. a. Osteoblasts in control well at 150x. b. Osteoblasts and CaP 
(white arrows) at 250x. 
 
Cell morphology, cellular response and matrix mineralization were observed with FE-SEM. 
Figure 5.5a shows cells displaying typical, healthy morphology[151] in the presence of CaP particulates 
(white arrows). The cells appeared flattened with pseudopodia extending out from obvious advancing and 
trailing edges. The cells maintained contact with neighboring cells through multiple projections 
(Fig.5b)[20, 172]. The projections (arrow heads) varied in length from 20-100μm. 
 
5.3.3 CaP Powders Did Not Inhibit Cellular Activity 
 
Spherical nodules (black arrows) developed on the osteoblasts (Figures 5.6a-b). EDS (Figure 5.7) 
was used to characterize the elemental composition of the spherical growths. They contained calcium, 
phosphorous, carbon and oxygen, indicative of matrix vesicle (MV) formation[91, 173]. Sodium and 
chlorine peaks result from the fixative and trace amounts of carbon result from the osteoblasts and TCPS 
well plates. MVs are cell-derived structures that contain high concentrations of calcium and inorganic 
phosphate, which creates an environment favorable for the nucleation of apatite crystals[91, 173]. MVs 
are commonly found in vivo at the mineralization front of developing and healing bone and they play a 
 a  b 
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large role in matrix mineralization[91, 173]. The presence of MVs on the osteoblasts indicates that the 
CaP particulates did not inhibit cellular activity. 
 
  
Figure 5.5a-b FE-SEM micrographs of CaP particulates. a. Sample c:p1.5 x=4.5 and cells at 300x. CaP 
particulates are indicated by a white arrow. b. Sample c:p1.5 x=4.5 and cells with projections (black 




Figure 5.6. Spot scan EDS of spherical growths on an osteoblast. 
 a  b 
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3.4 C:p and Fuel Ratio Determine Product Chemistry and Composition and Subsequently Effect 
Cellular Response and Biologic Activity 
 
The amount of bone specific alkaline phosphatase (ALP-b) present in the osteoblast culture media 
on days 1, 3, 7, 14 and 21 was measured with an ALP-b microassay. ALP-b is considered the single most 
accurate marker of bone formation[19, 90] and the secretion of ALP-b is often used to describe osteoblast 
differentiation[19, 90]. ALP catalyzes the hydrolysis of phosphomonoesters at an alkaline pH, providing 
inorganic phosphate for crystal formations[91]. Additionally, ALP hydrolyzes pyrophosphate, a strong 
inhibitor of CaP deposition at the extracellular level[91].  
 
Figures 5.8a-b show ALP-b content for samples with varying c:p ratios and a constant fuel ratio. 
A significant difference in ALP-b content for all samples (p<0.05) was noted between days 7 and 21 and 
days 14 and 21. On Day 7, ALP-b content was higher for cells grown on c:p1.3 x=4.5 and c:p1.7 x=4.5 
than for c:p1.5 x=4.5 and the control (p<0.10). On day 21 ALP-b content for cells grown on c:p1.5 x=4.5 
and 1.7 x=4.5 was higher than the control (p<0.10). Additionally, substrate c:p1.5 x=4.5 resulted in a 
higher ALP-b content than c:p1.3 x=4.5 (p<0.10). On day 21 the cultures associated with larger c:p ratios 
(e.g. c:p 1.5, c:p1.7) exhibited increased ALP-b content indicating that CaP powders with these c:p ratios 
can extend elevated ALP-b secretion levels compared to cell cultures with low c:p ratios.  
 
 
Figure 5.7a. Graph of ALP-b microassay results for varying c:p ratios with a constant fuel ratio. A 
significant difference in ALP-b content for all osteoblast cultures was noted between days 7 and 21 (▪ 




Figure 5.7b. Graph of ALP-b microassay results for varying c:p ratios with a constant fuel ratio. On Day 7 
ALP-b content was higher for c:p1.3 x=4.5 and c:p1.7 x=4.5 than for c:p1.5 x=4.5 and the control. On day 
21 ALP-b content for c:p1.5 x=4.5 and 1.7 x=4.5 was higher than the control and c:p1.5 x=4.5 had a 
higher ALP-b content than c:p1.3 x=4.5 (
+
p<0.10 vs. control, 
#
p<0.10 vs. c:p1.3 x=4.5, 
Δ
p<0.10 vs. c:p1.5 
x=4.5, *p<0.10 vs. c:p1.7 x=4.5).  
 
 
Figures 5.8c-d show ALP-b microassay data for osteoblast cultures grown on substrates prepared 
with varying fuel ratios and a constant c:p ratio. Similar to Figure 5.8a a significant difference in ALP-b 
content for all cultures (p<0.05) was measured between days 7 and 21 and days 14 and 21 (Figure 5.8c). 
On Day 7 (Figure 5.8d) ALP-b content for c:p1.5 x=3 and the control was similar (p>0.10) and less than 
c:p1.5 x=7.5 but greater than c:p1.5 x=4.5(p<0.10). ALP-b content for c:p1.5 x=7.5 was significantly 
greater than c:p1.5 x=4.5 (p<0.05). On day 21 ALP-b content for c:p1.5 x=3 was significantly higher than 
the control (p<0.10). On day 21 the culture grown on the substrate prepared with the lowest fuel ratio 
(e.g. x=3) exhibited increased ALP-b content indicating that CaP powders with low fuel ratios can 
prolong the period of increased ALP-b secretion levels compared to those from substrates prepared with 
high fuel ratios. 
 
Previous data show that biologically active CaP materials can induce a cellular response i.e. MV 
mediated ALP-b secretion[19, 90] during bone matrix mineralization. Subsequent to the first apatite 
crystals forming within the MV, ALP-b secretion is down-regulated[19, 90, 92, 174]. CaP powders 
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synthesized via DCS are unique in that their effects on cellular response and bioactivity in vitro can be 
manipulated by reaction parameters (fuel, c:p ratio). The biologic response they induce can mimic that of 
the control (cells only) or induce and sustain an extended period of elevated ALP-b secretion (Figs.8a-d) 
[19, 90], which could enhance early phase biomineralization.  
  
 
Figure 5.7c. Graph of ALP-b microassay results for varying fuel ratios with a constant c:p ratio. A 
significant difference in ALP-b content for all osteoblast cultures was noted between days 7 and 21 
(▪p<0.05 vs. day 21) and days 14 and 21 (◊p<0.05 vs. day 21).  
 
 
C:p and fuel ratio affect DCS reactions and subsequently product chemistry and composition[31]. 
The relationship between c:p ratio and ALP-b secretion was not clearly defined in this study, however 
preliminary data show that DCS combustion temperature is directly related to product composition i.e. the 
phases (-, β-TCP, HA, CA) present and the percentage of each phase present. Additional research on the 
effects of c:p ratio on combustion temperature and subsequently product composition could elucidate the 
effects of c:p ratio and product composition on cellular function and bioactivity. Additionally, the use of 
diffraction techniques beyond the scope of this research i.e. Rietveld refinement could provide a more 
detailed examination of the specific effects of c:p ratio on product phase composition. Conversely, the 





 content in the product powder increased (Figure 5.3b). On day 21 the substrate prepared with the 
lowest fuel ratio (c:p1.5 x=3) exhibited the highest cellular ALP-b production (Figure 5.8d) indicating 
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content) prolong elevated osteoblast ALP-b 
secretion whereas ALP-b secretion in cultures grown on substrates with high fuel ratios was similar to the 
control. These results suggest that CaP DCS reaction parameters can be used to directly control in vitro 
biologic activity.  
 
 
Figure 5.7d. Graph of ALP-b microassay results for cultures on substrates prepared with varying fuel 
ratios with a constant c:p ratio. On Day 7 ALP-b content for c:p1.5 x=3 and the control was similar 
(p>0.10) and less than c:p1.5 x=7.5 but greater than c:p1.5 x=4.5. ALP-b content for c:p1.5 x=7.5 was 
significantly greater than c:p1.5 x=4.5. On day 21 ALP-b content for c:p1.5 x=3 was significantly higher 
than the control (
+
p<0.10 vs. control, p<0.10 vs. c:p1.5 x=3, 
Δ




5.4 Conclusions  
 
DCS was used to synthesize novel multiphasic CaP powders with specific c:p and fuel ratios 
(Figure 5.1). The synthesized powder was amorphous and crystalline and had a bimodal pore size 
distribution with an interconnected pore network (Figure 5.1). Stoichiometric and non-stoichiometric 
powders were obtained by varying reaction reactant ratios (Table 5.3). Controlling reactant ratios 













In vitro, hFOB cells cultured with CaP powder displayed a flattened morphology and adhered to 
and uniformly encompassed the CaP particulates indicating an attempt to colonize the CaP. MV 
containing calcium and phosphorous were present on the osteoblasts (Figures 5.6a-b)[91, 173] and their 
presence indicates that the CaP did not down-regulate cellular activity. CaP samples with high c:p ratios 
and fixed fuel ratios (e.g. c:p1.5 x=4.5, c:p1.7 x=4.5) and samples with low fuel ratios and fixed c:p ratios 
(e.g. c:p1.5 x=3) induced elevated levels of ALP-b in osteoblasts on day 21(Figures 5.8a-d). Conversely 
ALP-b levels from osteoblasts induced by samples with low c:p ratios and fixed fuel ratios (e.g. c:p1.3 
x=4.5) and samples with high fuel ratios and fixed c:p ratios (e.g. c:p1.5 x=7.5) were similar to the control 
on day 21. Controlling DCS reaction parameters (fuel, c:p ratio) produces CaP powders that can induce 
and sustain an extended period of elevated ALP-b secretion by osteoblasts or mimic the ALP-b activity of 
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CHAPTER 6 FUTURE WORK 
  
 The following are suggestions for further investigations that may advance the results of this 
research or improve future research experiments: 
 
Improve SHS reaction characterization. While thermocouples are a traditional source for SHS reaction 
temperature measurements, they do possess error that could contribute to the inaccurate temperature 
measurements e.g. ceramic sheaths can act as heat sinks;  reaction velocity is faster than thermocouple 
time resolution resulting in system latency; reaction front thickness is smaller than thermocouple 
diameter; the reaction front can propagate through the pellet in a non-uniform motion; thermocouples can 
move and/or come out of the pellet during the reaction. Thermocouples are very difficult to work with; 
the thermocouple ports are highly susceptible to damage by reaction byproducts and the labVIEW data 
collection program is very unreliable. Collecting better reaction temperature data could be used to 
correlate changes to reaction velocity and combustion temperature with changes to reactant and product 
properties. Additionally, an analysis of the size, velocity and formation of the molten zone in an SHS 
reaction would improve understanding of the relationships between reactant, reaction and product 
properties. 
 
Expand SHS experimental matrix. Fluorapatite (FA) is found in teeth and is the least bioresorbable form 
of CaP. It would be beneficial to expand the experimental matrix to include fluorine as a reactant to assess 
the potential of SHS for production of FA. It would be extremely beneficial to analyze the effects of 
significantly increasing and decreasing gbd on reaction and product properties. Applying heat to increase 
and decrease product cooling rate could alter grain size and elucidate the relationship between grain 
growth and product cooling. 
 
Improve product porosity analysis. A larger sample size (n>5) is necessary to increase statistical 
significance of the micro- and nanoporosity analyses conducted and could validate or disprove the 
relationships between reactant and reaction properties on porosity. Micro CT scans could provide 3D 
images of product porosity and would provide a more reliable source for product porosity measurements. 
 
Refinement of materials characterization. Traditional metallographic methods such as a formic acid etch 
and light polishing can be performed on CaP samples to define grains and validate speculations about 
crystal size and morphology. Rietveld refinement analysis with Fullprof Suite software could provide 
additional analysis on lattice strain, peak shifting, crystal orientation, a- and c- axis shifting and more 
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accurate peak matching. To further confirm the crystallographic orientation, morphology, compositions of 
specimens and to analyze changes in molecular bonding, Raman spectroscopy, TEM and XPS could be 
performed.  
 
Improving mechanical property analysis. While it is possible that porosity did play a large role on the 
mechanical properties of the synthesized CaP constructs, the highly variable compression data prevents 
any specific conclusions from being determined. Additional research on the mechanical properties of CaP 
constructs produced with SHS through nanoindentation, Vickers microhardness analysis or compression 
testing using a frame specifically designed for porous ceramics, could reveal any relationships between 
product composition/morphology and product mechanical properties and verify the mechanisms of 
transformation toughening occurring in the CaP system. 
 
Refinement of coating application and characterization. Determining ideal methods for collagen, alginate 
and chitosan attachment could be done by expanding the experimental matrix by increasing exposure 
times, coating concentrations, number of coatings applied and drying conditions, while a more detailed 
analysis of the bonds formed between the CaP and the coating materials could be performed with Raman, 
XPS, AFM and optical and immunofluorescent microscopy. Additionally, the incorporation of proteins 
(e.g. BMP; VEG-F) would significantly benefit in vivo capabilities and functionality. Cell culture, tissue 
culture and in vivo experimentation should be performed to further examine the biocompatibility, 





CHAPTER 7 CONCLUSIONS AND CLOSING REMARKS 
 
 
 This research demonstrates that self-propagating high-temperature synthesis (SHS) and 
decomposition combustion synthesis (DCS) are viable manufacturing methods for the production of 
calcium phosphate (CaP) biomaterials.  
 
Self-Propagating High-Temperature Synthesis for Production of Calcium Phosphate Constructs. 
 
 Porous 5g CaP constructs substituted with specific weight percentages of silver (Ag), strontium 
oxide (SrO), magnesium oxide (MgO), reacted β-tricalcium phosphate (TCP) and reacted hydroxyapatite 
Ag, Sr, Mg, reacted β-TCP and reacted HA were successfully produced using SHS.  
 
Reactant Properties (Stoichiometry, Composition and Pellet Green Body Density) Affected The 
Combustion Reaction (Combustion Temperature and Reaction Velocity). 
  
 The addition of Ag, SrO, MgO, reacted β-TCP and reacted HA effected the combustion reaction 
and consequently, product morphology and composition. Unreacted pellet green body density (gbd) 
increased with the addition of Ag, SrO, MgO, reacted β-tricalcium phosphate (β-TCP) and reacted HA, 
while average combustion temperature decreased as substituent content increased. The Ag, SrO, MgO, 
reacted β-TCP and reacted HA acted as thermal diluents by adsorbing heat generated by the combustion 
reaction subsequently decreasing reaction exothermicity (temperature). It is theorized that reaction 
velocity would increase as substituent content increased. Samples with higher gbds have less void space 
(air) between reactant particles and the thermal conductivity of air is less the thermal conductivity of all 
reactant materials. Subsequently, the amount of heat transferred between particles would be higher and 
transferred at a higher rate (reaction velocity) as the reaction front propagates through pellets. Changes in 
combustion temperature and reaction velocity elucidate the relationship between reactant stoichiometry, 
reactant composition and reaction properties. 
 
Reactant and Reaction Properties Affect Product Morphology and Composition.  
 
 The TCP sample displayed a matrix with no distinguishable crystal structure interspersed with 
spherical grains, while the HA sample had an angular, plate-like microstructure similar to the mineral 
fraction of bone. The addition of Ag and SrO generated morphologies similar to the HA sample, while the 
MgO, βinTCP and HAinTCP samples displayed a hybrid of both the TCP and HA microstructures. The 
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difference in product morphology results from changes to reactant composition. Grain growth along the c-
axis of a hexagonal crystal, i.e. in an apatite crystal, has the lowest Gibbs free energy (highest driving 
force). The stoichiometric ratio of calcium to phosphate (c:p) shifted from TCP (c:p=1.5) to HA 
(c:p=1.67) as reactant composition changed,  resulting in an apatitic crystal growth. 
 
 Product microporosity was highest for the TCP sample (83.50%), lowest for the HA sample 
(31.60%) and decreased as substituent concentration increased from 0.5wt% to 7wt%. As substituent and 
CaO concentration increased, P2O5 content decreased, resulting in less O2 gas formation during the 
combustion reaction. This could have decreased the size and number of O2 gas pockets generated during 
the reaction, consequently decreasing product microporosity.  
 
 The HA sample and Ag, Sr and Mg substituted samples had  greater nanoporosities (4.55-
15.41%) than the TCP sample (2.67%), while the CaP-βinTCP, CaP-HAinTCP had less nanoporosity than 
the TCP sample. Product nanoporosity is affected by the size and cooling rate of the molten zone (mz) 
generated at the reaction front during SHS in addition to crystal growth. Concurrent shrinking of the mz 
surface forms nanoporosity inside the construct to compensate for the volumetric contraction (shrinkage) 
of the mz as it solidifies (cools). As acicular (apatite) crystals grew during product cooling, they formed 
volumetric borders around the molten material, essentially generating localized nano-sized areas of 
solidification shrinkage that resulted in nanoporosity formation. Samples with apatitic morphologies had 
higher nanoporosities than the samples with non-apatitic morphologies.  
 
 The HA sample was monophasic, it contained only HA peaks, while the TCP control was 
biphasic, it contained both - and β-TCP peaks. The amount of -TCP peaks (the high-temperature 
polymorph) decreased as combustion temperature decreased, suggesting the relationship between reactant 
composition, combustion temperature and  product composition.  
 
 The HA sample had a morphology similar to apatite. Subsequently, it had the largest average 
crystal size (108nm), while samples with an amorphous matrix (TCP) interspersed with spherical grains 
had the smallest crystal size. Lattice strain is generated by two components: Crystal growth and the 
difference in atomic radii between atoms in the crystal structure and atoms substituting into the crystal 
structure. Lattice strain is inversely proportional to crystal size. Lattice strain decreases as crystal size 
increases because grain boundary surface area (areas of high lattice strain) decreases during crystal 
growth. HA had a large crystal size (i.e. more crystal growth) and minimal lattice strain, while the TCP 




 The rate of CaP dissolution in solution (Crystalline HA<β-TCP<-TCP<<Amorphous CaP) is 
dictated by CaP microstructure and composition. The change in reactant stoichiometry and reactant 
composition decreased combustion temperature, inhibiting formation of the second most soluble phase, 
-TCP, while producing a more crystalline CaP, in contrast to the mixture of amorphous and crystalline 
CaP synthesized in the TCP sample, could generate CaP materials with more regulated dissolution rates.  
 
 The changes in product morphology and composition clarify the effects of altering reaction 
parameters on product composition and morphology and demonstrates how SHS reactions can be 
modified to control product performance and functionality. 
 
Potential for Substitution in the Crystal Lattice. 
  
 It is theorized that the Ag, Sr and Mg substituted into the CaP crystal lattice at Ca sites. The 
difference in the measured and theoretical amount of Ag and Sr present on the CaP-Ag and CaP-Sr 
micrographs indicates that Ag and Sr could have substituted into the CaP crystal lattice. No Ag, Sr, Mg, 
SrO or MgO peaks were detected in the XRD patterns, implying that the SrO and MgO reactant powders 
were reduced during the reaction and Ag, Sr and Mg were substituted into the CaP microstructure. The 
difference in atomic radii between Ca and the atoms substituting into the vacant Ca sites the crystal lattice 
generated lattice distortion and increased lattice strain, inferring that Ag, Sr and Mg substituted into the 
crystal lattice. Analyzing product morphology and composition suggests that Ag, Sr and Mg could have 
substituted into the CaP crystal lattice. 
 
Antimicrobial Activity and Biocompatibility of Silver Substituted Constructs. 
 
 Constructs substituted with specific concentrations of Ag significantly reduced E.coli colony 
formation and released Ag concentrations well below the lowest-observed-adverse-effect level for 
humans. Contact angle measurements show that all Ag substituted samples could inhibit bacterial 
adhesion, while bone cell attachment and functionality would increase with the Ag0.5% and 1% samples. 
In vitro, osteoblasts cultured with CaP powder displayed a flattened morphology and uniformly 
encompassed the CaP-Ag particulates suggesting that the CaP-Ag materials are biocompatible. SHS 
provides a highly adaptable manufacturing method that can produce CaP materials substituted with Ag 




Post-Synthesis Heat Treatment Affects Product Composition and Morphology. 
 
 Similar to other reported work, post-synthesis heat treatment was applied to the TCP constructs to 
further control product composition. TCP heat treated at 1200°C (HT1200) produced a biphasic material 
of  >95% β-TCP and <5% -TCP, while TCP heat treated at 1300°C (HT1300) produced a 50-50% β- to 
-TCP biphasic material. During heat treatment, grain growth occurred through solid-state sintering 
(grain boundary motion and Ostwald ripening) and nanoporosity decreased through particle coarsening.  
These changes in product morphology and composition demonstrate the effects of post-synthesis heat 
treatment on the synthesized CaP constructs and demonstrate the potential for post-synthesis processing 
of the CaP materials. 
 
Potential for Generating a Calcium Phosphate Scaffold Coated with Coating with Type I Collagen, 
Alginate or Chitosan. 
 
 Any bonds between the CaP and the coating materials in addition to the bonds within the coating 
material s were detected and analyzed. The COOH and OH peaks indicate an increase in the number of 
COOH and OH bonds, because peak intensity (area under the peak) is correlated to bond quantity. The 
presence of these two bonds is significant because they generate binding sites for cationic sites within the 
CaPs, indicating the potential for creating a CaP material coated with collagen, alginate or chitosan. 
 
Decomposition Combustion Synthesis for Production of Calcium Phosphate Biopowders. 
 
DCS was used to synthesize multiphasic CaP powders with specific c:p and fuel ratios. 
Stoichiometric and non-stoichiometric powders were obtained by varying reaction reactant ratios. The 
synthesized powder was amorphous and crystalline and had a bimodal pore size distribution with an 
interconnected pore network. Fuel ratio directly determined NH2 and CO3
2- 
content in the final product 
while c:p ratio indirectly determined NH2 and CO3
2- 
content in the final product. In vitro, cells cultured 
with CaP powder displayed a flattened morphology and adhered to and uniformly encompassed the CaP 
particulates indicating an attempt to colonize the CaP. Matrix vesicles containing calcium and 
phosphorous were present on the osteoblasts and their presence indicates that the CaP did not down-
regulate cellular activity. CaP samples with high c:p ratios and fixed fuel ratios (e.g. c:p1.5 x=4.5, c:p1.7 
x=4.5) and samples with low fuel ratios and fixed c:p ratios (e.g. c:p1.5 x=3) induced elevated levels of 
bone alkaline phosphatase (ALP-b) in osteoblasts on day 21. Conversely, ALP-b levels from osteoblasts 
induced by samples with low c:p ratios and fixed fuel ratios (e.g. c:p1.3 x=4.5) and samples with high 
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fuel ratios and fixed c:p ratios (e.g. c:p1.5 x=7.5) were similar to the control on day 21. Controlling DCS 
reaction parameters (fuel, c:p ratio) produces CaP powders that can induce and sustain an extended period 
of elevated ALP-b secretion by osteoblasts or mimic the ALP-b activity of the control sample. 
 
 This research demonstrates that SHS and DCS are viable methods for production of CaP 
biomaterials. The synthesized materials were porous, biocompatible and bioactive. Reaction parameters 
were modified to incorporate an antimicrobial component, control product porosity, regulate product 
composition and generate adsorption and attachment sites for biopolymers, illustrating how the 
relationships between reaction parameters and product composition and morphology can be used to 
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APPENDIX A POWDER PREPARATION AND PELLET PRESSING PROTOCOL 
 
Glove Box Operation Instructions 
1. Sign in to the lab book and read previous user’s comments. 
2. 4 values on bottom panel need to be open (facing up) when Argon is connected. 
3. Check for leaks: Are the gloves deflated? Are readings bouncing up and down out of control? If 
so we have a leak, don’t use the glove box. 
4. Check the Argon tank pressure: If it’s empty change out tank and notify Nina Vollmer to 
purchase another one/have the empty picked up. 
5. Verify that minimal or no waste is in the waste container. 
6. Check desiccant bottle under the GB. The color needs to be blue. If it’s not, we have a leak and 
this set up needs to be replaced. 
 
 





# of cycles- we use 3 for opening/closing the door 
 
Vacuum 
This read out needs to be maintained between 2 and 3 marks above 30inHg 
 
Backfill (Gas Source) 
The DEFAULT is- Take from box 
When you have bad ATM pressure in the box-Take backfill from Box/Tank 
Be careful not to use the transfer case too often or without adequate equilibrium adjustment time, 
because the vacuum will get sucked into the transfer chamber 
 
Transfer Chamber Vacuum 
Needs to be at a strong + pressure ~1 or 2 
 
Glove Box Pressure 
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Needs to be between 0 and 1.5. A negative pressure (red circle) in the glove box can ruin powder 
viability. 
 
Using the Glove Box  
 
1. SAFETY FIRST!! Due to the extreme reactivity of CaO and P2O5, they must be continuously 
stored in an argon atmosphere. They will ignite and subsequently ignite any weigh papers or 
organic material around them.  
2. There are 2 waste containers- A clearly labeled Nalgene™ for unreacted/unpressed powder, and a 
weight boat kept in the bottom right side of the GB, near the transfer chamber, for used Parafilm 
and wrappers. 
3. Label EVERYTHING using the following format-  
  Contents- Reacted/unreacted powder and powder type 
  Date, Initials 
4. Be sure to re-wrap the lids with parafilm. It’s easy if you hold and stretch the parafilm.(it takes 
practice!) 
5. What you bring in the glove box you are responsible for. 
6. Clean the Carver™ cold isostatic press and the ACCULAB™ scale by sweeping loose particles 
away from them. 
7. Label a plastic container(s) for your pellet(s). 
Contents (Pellet #, CaP Type) 
Sample # 
Date, Initials 
8. Before you enter the glove box, make a plan of what you would like to bring in. We need to 
minimize the number of cycles we open the transfer chamber. Plan out items like: Parafilm strips, 
clean spatulas and spoons, Nalgenes etc. 
a. When bringing in a new Nalgene, leave the lid off so when the bottle is in the transfer 
chamber its inner volume will fill with Argon. Once the cycles have run, open the 
internal door, bring the bottle into the box, and close the door securely. Then hit Start to 
run the 3 transfer case cycles. 
 
Powder Preparation 
1. Once in the hood carefully open the sealed bottle of powder you will be using. Dispose of the 
wrapper in the weight boat trash pile on the bottom right corner of the GB.  
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2. Place the weigh boat on the scale, push tare, and let it settle.  
3. Use the following Powder Calculations to determine exact amounts. VERIFY THAT THE 
BOTTLE YOU’RE USING IS THE CORRECT ONE!! 






Phosphate: 30.9738 g/mol 
 
CaO= 40.078+15.999= 56.077 g/mol 
P2O5= (30.9738*2) + (15.999*5) =141.942 g/mol 
  
Tricalcium Phosphate (TCP)  
Ca3(PO4)2 We need 3 Ca and 2 P 











Ca10(PO4)6OH2 We need 10 Ca and 6 P 
 Remember our P2O5 powder has 2 units of P so when we calculate amounts we must remember to 
account for this. 
 
Total TCP Powder CaO P2O5 
50g 27.12 22.88 
100g 54.24 45.76 
200g 108.48 91.52 
400g 216.96 183.04 
500g 271.20 228.80 
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1. You must wear long pants, close toe shoes and safety glasses at all times while in the Foundry. 
2. The LABRAM™ mixer is in the sand prep/mixing room of the foundry. 
3. Carefully remove the cylindrical glass chamber and glass lid, and remove the rubber discs. Place 
them on the counter. 
4. Add one Nalgene to the sample holder plate on the top of the mixer. Make sure the parafilm and 
lid are on securely before it goes into the holder.  
5. Close the top holder on the bottle by spinning the inner circular knob tightly onto the bottle lid, 
and then secure the tri-prong holder over the bottle. Double check that the holders are screwed 
down tightly on the bottle. 
6. Plug in both the mixer and the CPU, and switch both on. The ON/OFF switch for the CPU is on 
the back, and the ON/OFF switch for the mixer is on the front under the lip with the label.  
7. Replace the glass chamber and glass plate. 
Programming the Mixer 
8. Press MODE (Menu) 
9. 100% MAX Adjust it to 75%; during mixing verify that we are between 60-80 G's. If not hit 
stop and return to this setting and decrease it to 70%, 65% etc. 
10. Vibrational Frequency=Auto 
11. TimerON Scroll over for time ~2 minutes 
12. Alert everyone in the room that you will be mixing something, each time you’re mixing powder! 
13. Press run and step back. 
Total HA Powder CaO P2O5 
50g 28.42 21.58 
100g 56.84 43.16 
200g 113.68 86.32 
400g 227.36 172.64 
500g 284.2 215.8 
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14. After mixing carefully remove the glass cylinders, and unscrew the tri-prong holder first, 
followed by the circular knob. 
15. Replace the rubber discs, glass chamber and glass lid. 




1. Prep the “Clam shell’ die and Carver™ cold isostatic press by sweeping loose particles from 
them.  
2. Plug one end of the die with the black rubber plug, and carefully add desired amount of CaP to 
open end of the die. Add the other plug(silver rod) to the top opening of the die. Place on the 
center of the Press with the silver rod on top. 
3. Slowly apply a load to the top plug of the die. DO NOT EXCEED 5,000 metric tons of pressure 
(the red second hand marks limit of pressure)! Let the press settle for 15 seconds and then release 
the pressure and remove the die. Handle with care as parts are very sensitive. 
4. Then remove the die from the press and slightly loosen the screws before proceeding to remove 
the pellet. Un-torqueing is VERY important! 
5. Flip the die, put both plugs, the shorter one first, into the opening and apply a very low pressure 
to it to “push” the pellet out of the die. Use the smaller silver ring on top of the die (Figure A-1a). 
This will allow the black plug to come out. Handle with care as parts are very sensitive. 
6. Now use the larger silver cap to remove the rest of the pellet (Figure A-1b).  
7. Use the Allen wrench to unscrew the screws holding the clam shell die together and remove both 
plugs.  
.   
8. Figure A-1a-b Pellet pressing images. Pressing a pellet with the clam shell die using a. a small 
ring and b and large ring. 
 a  b 
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9. Use calipers to measure height, diameter and the scale to measure weight. Record data, and 
calculate green body density calculations. 
10. Place the pellet in the correctly labeled plastic snap-top sample container. 
11. Seal the container with parafilm. 
12. Thoroughly clean the die and plugs with a brush. 
 
Pellet Green Body Density Calculations 
 
Bulk density is defined as the total mass of a body divided by the bulk volume. We will define it as all 
space that is interior to the surface of the body, including the volume of solid particles, the volume of any 
temporary additives and liquid present, and the volume of empty pore space. The bulk density of a green 
ceramic body provides valuable information needed to control the quality of a ceramic piece (after firing) 
with respect to its final size and the porosity and cracks in the body. Therefore, it is important that 
optimum measurement procedures to be followed in determining density. 
 
Density=Mass/volume 
Volume of a cylinder=pi*h*r^2 
 
Product Ordering Information 
Argon Cylinder Grade5 UHP Size # 2 249CF 1214070 General Air  
W/5%Re Wire 0.005 Dia  347.005.2 Rhenium Alloys Inc 
W/26%Re Wire 0.005 Dia  349.005.2 Rhenium Alloys Inc 
Tungsten Filament-Custom order H3-.030W R.D. Mathis Company 
CaO Powder 500g C117-500 Fischer Scientific 
P2O5 Powder 500g A245-500 Fischer Scientific 
Drierite Desiccant 5lb mesh #23005 W.A.Hammond-Drierite.com 
Kim Wipers (Large 15x16 3/4) 21905-049 VWR 
Kim Wipers (Small 4 1/2x8 3/8) 21905-026 VWR 
Ethanol 200 proof (reagent grade)  chem Req. Form Chemical Storage Coolbaugh 030 
Parafilm  PM999 Pechiney Plastic Packaging 
AmP Reagent grade A5764-500g Sigma Aldrich 
CNT Reagent grade 237124-500g Sigma Aldrich 
Urea U15-500g Fischer Scientific 
Snap Cap Vials 30dram PS 89097-530 VWR 
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Snap Cap Vials 5dram PS 89097-518 VWR 
Snap Cap Vials 5ml PE W/close 66018-109 VWR 










1. Scissors (2) or Wire Cutters  
2. Digital Caliper 
3. Drill Bit (small) 
4. Needle-Nose Pliers (2)  
5. Tweezers (2) 
6. Leads (4 total, 2 pairs for small chamber, 2 total, 1 group for large chamber) – One positive and 
One Negative [the negative has a notch at the end] 
7. 2 Spools of Tungsten Rhenium Alloy (positive/negative) → 5% Re = +; 26% Re = –  
8. Argon tank (at least 500 psi remaining, otherwise notify Nina or Jake)  
9. Tungsten Coil 
10. 7/16th Wrench 
11. DeWalt Cordless Power Wrench 
12. Adjustable Head Crescent Wrench 
Small/Large Reaction Chamber Set-Up: 
CHECK ALL EQUIPMENT BEFORE BEGINNING THE EXPERIMENT!!! 
1. Wire spools (found in the grey cabinet by the sink) have +/- designations based off of % 
Re [5% Re is (-), 26% Re = (+)]; negative wire goes to negative lead and positive wire 
goes to positive lead. 
2. Separate the positive and negative leads into pairs consisting of opposite charges (2 per 
reaction small chamber, 1 per reaction large chamber 
3. For small chamber reactions, there are two sets of wires. One set should be cut 
approximately 2 in long while the second set should be approximately 4in long. For large 
chamber reactions, wire should be cut approximately 4 in long 
 Wire is expensive, so take care when handling, cutting and using! 
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 All excess W can be recycled in the Folgers can in the grey cabinet. 
 
  
Figure B-1a-b Thermocouples and thermocouple housing. a. Thermocouples and b.  thermocouple 
housing in a small combustion chamber. 
 
4. Slightly unscrew the screws at the head of the leads (enough to allow for wire insertion 
on the washer side) then, with your finger holding the washer flush against the lead to 
keep the wire in place, use the needle-nose pliers to screw the juncture shut, making sure 
the wire is in line with the rest of the lead.   
5. Take one negative lead and one positive lead using either tweezers or the adjustable 
wrench, begin twisting the wires together – make sure that the twisted wire is tightly 
intertwined at the top but separated past the pinched off section (be careful not to bend 
the wire excessively at this stage)  where the wires first meet/twist is where the 
thermocouple reading will occur.  
6. Place positive and negative thermocouples into the appropriate slots (+/+ and -/-) by the 
tungsten coil 
7. Lightly pre-bend the thermocouple wires to cut down on placement time and to minimize 
pellet exposure to air. 
8. Examine the tungsten coil-Is it level, oxidized, or broken?  
SMALL CHAMBER: 
IF REPLACING:  
 Replacement coils can be found in the grey cabinet to the left of sink. 





 Align the coil in the center of the reactor (between the pellet-holding rods) and 
make sure that it’s not tilting to one side or the other.  
 Screw the copper side pins shut once it’s aligned. 
 Once the pins are closed and the coil does not move when lightly pressed, use the 
wire cutters to trim ends.  
9. Make sure the pellet has remained in the glove box until this point to reduce exposure. 
Once the reaction chamber is prepped remove the pellet from the glove box. 
10. Twist a thin drill bit (Size 80 or smaller) into the side of a pellet 3mm below the bottom 
of the “Top” of the pellet. Make sure you apply little to no pressure on the pellet and that 
you gently hold the pellet on a flat surface. Continue this process until a hole sufficiently 
large to hold the thermocouple wire in place has been made (2 mm at most).  
11. Using the calipers, measure 5 mm vertically below the first hole, then repeat step 11. 
(This is for the small chamber only!). 
12. Place the pellet on the coil, then move the thermocouple wires around until the first 
crossing point of the thermocouple wires is touching the first hole. Maneuver the second 
thermocouple wires around until the first crossing point of the thermocouple wires is 
touching the second hole. 
13. MAKE SURE THAT THE THERMOCOUPLE WIRES ARE NOT CROSSING OR 
TOUCHING EACH OTHER OR ANYTHING ELSE. 
14. Make sure the orange rubber o-ring is in place at the bottom of the reactor. Make sure 
that no pieces or parts extrude out past it.  
15. Place a clean glass cylinder on top of the rubber ring. Make sure that each edge of the 
cylinder rests on the ring.  
16. Pick up the Plexiglas™ box, holding onto the 4 screws and their casings and put it over 
the glass cylinder. Make sure the screw with the purple star is matched with the hole on 
the white mount labeled with a purple star. 
17. Use a wrench (Adjustable or 7/16) to tighten down the screws. Move in an X pattern so 
you don’t torque one side of the box. Be careful, you don’t want to knock over the pellet 
or move the thermocouples.  
18. Carefully attach the reaction chamber to the gold T joint tube to connect it to the argon 
tank. Make sure that you hear a click when the tube is attached (this ensures there will be 
no leaks). To release it pull the o-ring away from the chamber. Make sure the Ar tank is 





Figure B-2 Small combustion reaction chamber.  
 
19. The argon tank needs to be on = LOW P (low pressure) – this is important, because a 
high pressure rxn system has been used, because of improper labeling and has caused an 
explosion. If the argon tank is low, (the dual gauge valve will be close to 0 psi), tell Nina 
or Jake and the change it out.  
20. Attach the thermocouple cables to the correspondingly labeled plugs on the rxn chamber. 
Make sure they’re connected to the data acquisition box (DAQ, National Instruments™). 
21. Once the pellet is ready to be reacted, you will need to fill the reaction chamber with 
argon. Under the large chamber reaction (shown above), turn the lower black knob to 
small chamber and then turn the vacuum pump switch on. The top black knob should be 
turned to vacuum for 30 seconds then turn it to purge for 3 seconds. Repeat this cycle 2 
more times ending on purge. After the final purge turn the top knob to off and turn off the 
vacuum pump. 
22. Using the Computer: 
i. Turn on the computer by the work space. 
ii. COSAN = Desktop name to choose because program is already set up for this 
user. The log in will set up automatically. 
iii. Underneath computer there are 3 machines that need to be switched on: 1. The 
power supply for the small chamber. 2. Two switches (cold junction and 12 
volts) on the power supply for the data acquisition box (DAQ, National 
Instruments™). 3. The DAQ- the machine that collects reaction data- which is 
on top of its power supply box.   





v. For the small reaction chamber, there two thermocouple wires TC1 and TC2. 
Plug them into the machine on the desk. 
vi. Program info for the computer: 
 How long to read = 25- 100 seconds (total rxn collection period) 
 Voltage = 20  
 Current = 69  
 Coil on Time = 10 
vii. Always test the thermocouples to check that they’re in and working properly. 
During the test make sure that both the voltage and current = 0, otherwise the 
reaction will actually occur. 
 C1 and C2 = room temp before you do the reaction 
 Stop the coil immediately if you see the reaction go 
viii. On the computer: Folder  Exp.  Nina  Save there under a new folder 
ix. Label the folder with the name of the person/people doing the reaction and 
inside that folder, the data file should have the date, the composition (TCP/HA) 
and the pellet number. 
x. Test file under: COSAN  test  SHS-00  (For thermocouple testing) 
xi. The start button is in the upper left hand corner (just press and the reaction will 
begin and the computer will start to collect data). 
xii. Data Acquisition  Exp Nina  CaPO4  TCP etc…  
xiii. Open with Microsoft Excel (right click)  hit control A to organize the data 
into something cohesive and usable. 
xiv. Enter the total rxn time and the rxn temperature (C1 & C2); insert chart  XY 
scatter and finish. 
xv. When completing the reaction, save one to the file on the desktop and one to a 
thumb drive. 
21. Place the safety shields around the chamber. During the reaction make sure you look 
through welding glass so you do not hurt your eyes. All viewers need to use the welding 
glass too! 
22. DO NOT TURN ON THE VACUUM WHILE DOING THE REACTION!!!  the 
vacuum causes expansion of the pellet and its powders and will cause pellet to explode 
and coat entire edge of cylindrical glass chamber on inside with white powder. 
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23.  The reaction will ignite the pellet and the reaction will propagate through it, off gas will 
come from the pellet and coat the inside of the chamber with blue tungsten oxide that can 
be wiped clean after everything’s cooled. 
24. Turn on the snorkel hose by moving the lever 90° (this is in the vertical position) and 
carefully open the chamber.  
25. Carefully remove the pellet from the chamber, weigh and measure the pellet and place it 
in the properly labeled snap cap vial.  
26. Turn off the Ar cylinder, unplug the chamber from the gold hose, unplug the 




 Large replacement coils can be found in the grey cabinet to the left of sink. 
 Take one and place it into the openings on the copper side pins. 
 Align the coil in the center of the reactor (between the pellet-holding rods) and 
make sure that it’s not tilting to one side or the other.  
 Screw the copper side pins shut once it’s aligned. 
1. Make sure the pellet has remained in the glove box until this point to reduce exposure. 
Once the reaction chamber is prepped remove the pellet from the glove box. 
Twist a thin drill bit (Size 80 or smaller) into the side of a pellet 3mm below the bottom 
of the “Top” of the pellet. Make sure you apply little to no pressure on the pellet and that 
you gently hold the pellet on a flat surface. Continue this process until a hole sufficiently 
large to hold the thermocouple wire in place has been made (2 mm at most).  
2. Place the pellet on the coil, then move the thermocouple wires around until the first 
crossing point of the thermocouple wires is touching the first hole.  
3. MAKE SURE THAT THE THERMOCOUPLE WIRES ARE NOT CROSSING OR 
TOUCHING EACH OTHER OR ANYTHING ELSE. 
4. Make sure the black rubber o-ring is greased and in place at the bottom of the reactor. 
Place a clean glass cylinder on top of the rubber ring. Make sure that each edge of the 
cylinder rests on the ring. 
5. Gently place your pellet inside of the W coil. There are 2 cylindrical plugs that can be 
used to prop up your pellet so it is level with the bottom of the coil.  
6. Place the second black, greased o-ring on the top of the glass cylinder, and place the flat 
metal plate on top of the o-ring. Thread the screws through the holes in the plate, and put 
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on the washers and nuts.  Use a wrench (adjustable or 7/16) to tighten down the screws. 
Move in an X pattern so you don’t torque one side of the box. Be careful, you don’t want 
to knock over the pellet or move the thermocouple.  
7. Make sure the Ar hose is attached to the large chamber reactor. Make sure the Ar tank is 
open (and closed it when you’re done with reactions).  
8. Turn on the silver vacuum pump switch. It’s on the far right. 
9. Switch the bottom black lever to LARGE CHAMBER.  
10. Turn the top black lever to the right (vacuum) and hold it there for 30 seconds. Slowly 
and carefully turn it to the left (purge) and hold it there for 3 seconds. Repeat this cycle 
two more times. Then move the black lever to 90° (off) and keep it there during the 
reaction. 
11. Attach the thermocouple cables to the correspondingly labeled plugs on the rxn chamber. 
Make sure they’re connected to the data acquisition box (DAQ, National Instruments™).  
12. Using the Computer: 
xvi. Turn on the computer by the work space. 
xvii. COSAN = Desktop name to choose because program is already set up for this 
user. The log in will set up automatically. 
xviii. Underneath the computer there are two machines that need to be turned on. 2. 
Two switches (cold junction and 12 volts) on the power supply for the data 
acquisition box (DAQ, National Instruments™). 3. The DAQ- the machine that 
collects reaction data which- is on top of its power supply box.   
xix. On the desktop  SHS 5 (shortcut to the LabVIEW™ program) 
xx. For the large reaction chamber, there is only one pass-through so there is only 
one thermocouple wire. Plug it into the machine on the desk. 
xxi. Program info for the computer: 
 How long to read = 600-1,000 seconds (total rxn collection period) 
xxii. On the computer: Folder  Exp.  Nina  Save. 
xxiii. The argon tank needs to be on = LOW P (low pressure)- this is important, 
because a high pressure rxn system has been used, and improper labeling has 
caused an explosion). If the argon tank is low (the dual gauge valve will be close 
to 0psi) tell Nina or Jake and then change it out. 
xxiv. Data Acquisition  Exp Nina  CaPO4  TCP etc…  
xxv. After the reaction, open the folder with Microsoft Excel (right click)  hit 




xxvi. Enter the total rxn time and the rxn temperature (C1 & C2); insert chart  XY 
scatter and finish. 
xxvii. When completing the reaction, save one to the file on the desktop and one to a 
thumb drive. 
 
13. Plug in the DC power supply box (Sorensen™). 
14. Place the safety shields around the chamber. During the reaction make sure you look 
through welding glass so you do not hurt your eyes. All viewers need to use the welding 
glass too! 
15. Flip the switches on the DC power supply to heat the coil. It takes between 3 and 6 
seconds for the reaction to ignite. Immediately after turn off the coil to increase the 
number of times it can be used.  As soon as the bottom of the pellet gets bright = turn off 
coil (press stop). 
16. The reaction will ignite the pellet and the reaction will propagate through it, off gas will 
come from the pellet and coat the inside of the chamber with blue tungsten oxide that can 
be wiped clean after everything’s cooled. 
17. DO NOT TURN ON VACUUM WHILE DOING THE REACTION!!!  the vacuum 
causes expansion of the pellet and its powders and will cause pellet to explode and coat 
entire edge of cylindrical glass chamber on inside with white powder 
18. Carefully remove the pellet from the chamber, weigh and measure the pellet and place it 
in the properly labeled snap cap vial.  
19. Turn off the Ar cylinder, unplug the chamber from the gold hose, unplug the 




APPENDIX C BLUE M BOX-TYPE MUFFLE FUNACE PROTOCOL 
 
Materials List 
1. Reacted calcium phosphate pellets 
2. Orange leather heat resistant gloves 
3. Metal tongs 
4. Bent thermocouple 
5. Ceramic crucibles (glazed 1150C, unglazed 1400C) 
6. Ceramic cooling block 
 
 
Figure C-1a-b Images of a box furnace. a. Box furnace and b. heating rate gauge and dial. 
 
Set Up 
1. Take the reacted TCP or HA pellets out of the snap cap vials and place them in a ceramic 
crucible. Make sure you weigh/record the amount of powder placed in each boat. 
2. Turning on the Blue M Box type Muffle furnace. The settings should be as follows:   
a. Flip the knob to HIGH heating rate 
b. Use the black dial to set the heating rate between 75-85%. CAUTION!! Turning the dial 
too high will max out the furnace and potentially break it.  
c. Flip the on/off switch to on- after you have done this, monitor the heating rate gauge next 
to the on/off switch.  It needs to read between 70-85% during your entire run. 
3. Plug the furnace into the Athena temperature box located next to the furnace (shown below). The 
opening is on the back of the box. The temperature box will regulate the power input to the 
furnace while it’s heating. 
Heating 
Rate Gauge 
 a  b 
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4. Plug the thermocouple into the Athena temperature box. Then turn on the temperature box by 
flipping the switch to the on position.    
5. Place the bent thermocouple in the hole on the top of the furnace (as shown on the right). The tip 
of it should be just above the sample.  
a. To get accurate reaction data the thermocouple should be touching the sample/or inside 
of the construct at least 2mm.  
b. For heat treatments the thermocouple needs to be in the furnace, not touching the sample. 
6. Place the samples in the oven for the designated amount of time. Make sure you monitor the 
temperature read out. 
7. When the samples are done, use the tongs/safety gloves to remove them from the oven. Place hot 
samples on a ceramic cooling block in the fume hood.  
8. After the sample is cool to the touch, weigh it. 
9. To turn off the furnace after use, rotate the dial to zero. Give the furnace time to slow down its 




APPENDIX D IMAGE J PROTOCOL 
 
 
ImageJ Porosity Analysis:  
1. Open ImageJ 
2. Open the image you want to 
binarize 
a. Select images where the 
sample completely covered 
the image, otherwise large 
areas of black could skew 
data. 
b. Images with higher contrast 
(more black and white 
versus grey area) are easier 
to analyze. 
 
To set scale: 
3. Click straight-line tool located on 
the top banner. 
4. Hold shift and draw a line over the 
micron bar from edge to edge 
5. Go to analyze set scale fill in 
the known distance on the micron 
bar for the new scale select 
appropriate units (um for 
microns) ok. 
6. If planning to analyze multiple 
images, click global. This will 
keep the scale set for all pictures 
analyzed. Make sure the micron 






To adjust threshold: 
6. Go to image adjust 
threshold. This converts the image 
to black and white. 
7. Adjust the image by sliding the 
bars to the left or right. This will 
increase or decrease the amount of 
white area on the image. Typically 
the white area corresponds to 
calcium phosphate and black area 
corresponds to pores or void 
space. To change this, check the 
Dark Background box. 
8. Click Apply. 
 
To analyze the image: 
9.  Select the rectangle drawing tool and drag a box over the entire image leaving out the scale and 
information on the bottom. 
10. Select analyze analyze particles define size as 0 to infinity circularity 0 to 1 Show outlines  
check the following boxes:  
a. Display results  
b. Include holes 
c. Record stats  
d. Summarize 
 
11. Click okay. 




d. The original black and white image 
 
13. Save images by right clicking on the image list commands save as .jpeg label the                




14. There are some errors associated with this method of testing. 
a. Images are 3D but this characterization method is 2D. 
b. Pixel size does not necessarily encompass pores in the nano-range, which could induce 
error. 




































 Phillips Analytical™ PW3240 X’PERT data collector 
 Samples 
 Si powder (99.9% pure, Alfa Aesar™) 
 Spatula 
 Glass slide 
 Sample holder 
 Sample holder bottom plate 
 Mortar and pestle (CoorsTEK™) 
 Ethanol 
 Paper towels 
 Weigh boat 
 Scale (Ainseworth® Fisher Model 50) 





A silicon standard is used to correct the data for machine error. A 1:4 ratio is used for the samples. 
 
1. Ethanol off the work space and all utensils. 
2. Place the sample holder bottom into the holder. Make sure it’s in securely. 
3. Put the weigh boat on the scale and push tare. Measure out 0.16 grams of powder and dump it 
into the mortar.  
4. Clean the spatula with ethanol. 
5. Put the weigh boat on the scale and push tare. Measure out 0.04 grams of Silicon powder and 
dump it into the mortar.  
6. Thoroughly mix/grind the powders together with the pestle. 
7. Carefully put the mixed powder in the rectangular area in the sample holder.  
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8. Put the clean glass slide on the sample holder and firmly push it down. Carefully slide the glass 
slide off the sample holder. This sample surface is extremely important it is measured by the 
machine and it NEEDS TO BE FLAT!!   
 If the surface is not flat put more powder on the holder and smooth it out/resurface 
the powder. 
9. CAREFULLY open the glass doors on the XRD machine and gently place the sample holder- flat 
side facing in and the split side facing out- in the horizontal sample clip. This clip is brand new so 
don’t force the sample. Do not bump the sample this could deform the sample surface.  
10. GENTLY close the doors to the machine. 
11. Run the sample.  
12. Carefully remove the sample holder from the clip. The powder needs to be put into a separate 
small Nalgene™ with proper labeling. 
a. Contents e.g. SHS CaP  
b. Sample # 
c. Date 
d. Your Initials 
e. Treatment- XRD 
13. Thoroughly clean out the mortar and pestle. Any powder not used in characterization needs to be 
put in the new Nalgene™. 
14. Clean all utensils and wipe down your ENTIRE work area. Return the Si to the storage hood. 
 
 For samples that do not have .16 grams available for characterization a ratio of 1:4 Si to sample still 
needs to be mixed, but the sample holder changes. Inside of the machine on the right hand side ledge 
there is a pure silicon disc. Ethanol it off and then place a small amount of powder on the tip of the disc 
and flatten it with the glass slide. Gently place the disc in the sample holder making sure not to displace 




1. Sign in to the log book on the table. 
2. On the computer screen click the High Score Data Collector icon 
 Log-in: nvollmer 
 Password: nv-xrd 
1. The stand-by (rest) settings are:  
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 Voltage (tension) = 40 kV 
 Current = 10 mA 
 Goniometer = 12 °2 theta 
2. Check: 
  X-Ray source is copper, Cu  
 Water cooler on and water flow (Above 3.8 L/min) 
3. Load sample: 
 For a powder sample, use the flat head screw driver inside of machine to unscrew the 
screw above the sample stage. This will decrease the stage height so the MPSS (Multi-
purpose sample stage) will fit. Slide the MPSS securely into the opening (slot) above the 
stage. 
3. Click Instrument Connect Measure program Nina Vollmer 
4. Enter in the sample title and cut and paste the title in the sample description box then click the file 
box to send this measurement to Nina Vollmer’s folder. 
5. Click enter and the scan will run. To create a new program with specific scanning properties, 
follow the steps in the following Data Acquisition section. 
 
(Optional) Data Acquisition: 
1. Create/Open a file: Use “Absolute Scan” 
2. Configuration tab: 
 Check that X’Celerator detector is selected 
If scan time ~1-hour, the wrong detector is selected.  To change the detector: 
Settings  Detector  X’celerator [2]. 
 Gonio will display 2 theta in axis 
 Start Angle, Min 2 theta = 10° 
 End Angle, Max 2 theta = 150° (Abs max is 160) 
 Time per step ~ 1.9 sec for quick scan  
 Step Size ~ 0.016  
 For these setting, scan time ~2 minutes 
 Recommend a longer step time, as long as counts do not exceed 50000 
3. Warning: If scanning a single crystal, you MUST use the lowest Time per step available 
4. Close window and Save program  
5. To run a test: Measure  Program and select the file just created 
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6. Change the File Name, File Path and Comments to the desired text 
7. Run test 
8. To test more samples, just removed the current sample and place the new one in.  Repeat 





1. Click on the P’Analytical High Score data program icon. 
2. Click file Open and open the spectra you’d like to edit. 
3. Under reference patterns Retrieve pattern byRestrictions Chemistry All of the above 
Si. A reference code can be used to find data in the library: Si=00-003-0549. 
4. To correct the data: 
a. Treatment Peak search. The grey (highlighted) peaks are K1 peaks.  
b. Delete all K2 peaks. Right click on the chart on the right and hit delete all K2 
peaks. 
c. Treatment Subtract background. 
d. Treatment Corrections Correct systematic error 
e. Select standard Si Change error window so it shows all peaks and differences (This 
will show us how far off the peaks are and where they should be). 
f. Set polynomial degree 1st order. (This value needs to be checked though, because we 





polynomial)  Accept new polynomials.   
g. Now return to Treatment Corrections Click correct and then replace data. 
h. Save as an .XRDML file. 
5. To match peaks: 
a. Search peaks Insert a peak. 
b. Determine background Subtract Replace.  
c. Analysis Search match Restrictions Restrictions set Edit Typically Ca, P, O 
and H will be selected for the calcium phosphate system.     
6. Generate a report.  
a. Reports  Create Word Report 
7. Save the analysis in your data folder as a .CAF file (a Highscore specific file) 
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8. It is an option to save your data as an .XRDML file, but be careful to not overwrite the original 
data file. 
 
Shut Down Procedure 
1. Power down x-ray source (make sure to follow the order below). 
a. Change Current to 10 mA, click apply. 
b. Change Tension to 40 kV, click apply. 
c. Goniometer: Return to 2 theta = 12°. 
2. Disconnect instrument: Instrument  Disconnect. 
3. Raise the stage if it’s set up for solid specimens, 
4. Clean up your powder/samples. 
5. Do NOT turn of the computer or XRD machine. Select go off-line instead. 
 
Data Viewer:  
Click the X’pert Data Viewer icon. 
1. Open a file(s). 
2. Right click on the y-axis to change the units to cps/s. 
3. Convert the file to a different format (.csv for ASCII type). 
 File → Convert (or convert all if multiple files are open) → Check .csv and uncheck 
everything else.  




APPENDIX F IMMUNOFLUORESCENCE STAINING PROTOCOL 
 
 This protocol is for labeling surface-bound type 1 collagen for fluorescence imaging using the 
confocal or Epifluorescence microscope. This protocol should be analogous for other surface ligands such 
as laminin, fibrinogen, or type III collagen. The appropriate 1° and 2° antibodies for each ligand should 
be carefully selected. 
 
Materials and Supplies:   
1. 1° antibodies : mouse monoclonal collagen 1 antibody (Ab-Cam, ab90395) 
2. 2° antibodies:  Alexa Flour 488 goat anti-mouse IgG (H+L), highly cross-adsorbed 2 mg/mL 
(Invitrogen Catalog # A11029)   
3. BSA (Sigma, B4287-5G) 1X PBS 
4. 50mL ultrapure water 
5. Small centrifuge tubes 
6. Ice bucket and ice 
7. Labeling sharpie 
8. Pipettes- (LARGE SMALL) 
9. Pipette tip holder case (holding chamber) with water in the base- this will act as a humidity 
controlled environment for the samples and prevent evaporation. 
10. Nail polish 
11. Coverslip 
12. Flouramount (Sigma, F4680) 
13. Phosphate buffered saline (OmniPur #6507 10x conc, diluted to 1x) 
Substrate Preparation: 
1. Obtain a glass substrate or CaP cold mount section functionalized with collagen. 
2. Block the area of interest on the surface containing the collagen to be stained by pipetting 100 μL 
of 1 mg/mL BSA in 1X PBS for 1 hr. 1° antibody will bind to BSA and collagen, but not BSA on 
glass slide. (Volume is not as important as concentration during coating) 
i. 1mg BSA + 1mL PBS= 1x PBS/BSA solution 
3. Carefully remove 1 mg/mL BSA solution from surface with a pipet or dump this mixture into the 
holding chamber. Wash surface with 1X PBS 3 times, and let excess drain into the basin of the 
control chamber. Do not dry the substrate!! 
4. Manually mix the antibody vial, then dilute 1° antibody to: 
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a. 2 μg/mL in 1 mg/mL BSA in 1X PBS.  
i. (1mg BSA + 1mL PBS) base + 2µg 1° abd= 1mL or 1000µL of soln 
b. Make 100μL of 1° antibody for each area to be incubated.  
i. 1mL of soln yields 10 areas to coat 
c. Keep the 1° antibody solution on ice until use. 
5. Add 100μL of 1° antibody to the slide, and incubate at room temperature for 90 minutes. (Volume 
is not as important as concentration during coating) 
6. Carefully remove 1° antibody solution from surface with a pipet or dump this mixture into the 
holding chamber. Wash surface with 1X PBS 3 times. Make sure to wash the surface well after 
bonding the primary antibody, if there is excess 1° antibody on the surface it too will bind 2° 
antibody, and skew our fluorescence readings. 
7. Do not dry the substrate!! 
8. Manually mix the 2° antibody vial, then dilute it to: 
a. 40 μg/mL in 1 mg/mL BSA in 1X PBS. 
i. (1mg BSA + 1mL PBS) base + 40µg 2° abd= 1mL or 1000µL of soln 
b. Make 100μL of 2° antibody for each area to be incubated.  
i. 1mL of soln yields 10 areas to coat 
c. Keep the 2° antibody solution on ice until use. 
9. Add 2° antibody solution to the slide, incubate at room temperature for 60 min or overnight at 4 
°C. The 2° antibody has a fluorescent tag, which is how we image our sample. Protect it from 
light, as light will fade/photo-bleaches the stain. (Volume is not as important as concentration 
during coating)  
10. Carefully remove 2° antibody solution from surface with a pipet or dump this mixture into the 
holding chamber. THOROUGHLY wash the surface with 1X PBS 3 times and then quickly dunk 
the slide in 50mL of ultrapure H2O. Let the slide drip-dry. 
Cover slipping the Sample: 
FTIC readily photo-bleaches the samples, and so can regular light. Cover slipping a sample protects it. 
1. Pipet a small drop of Fluoromount onto the surface. Remove all air bubbles from the 
Fluoromount. 
2. Carefully place coverslip on top of droplet and wait for the Fluoromount to spread and cover the 
entire coverslip. 




1. Open software- Slidebook™ 5.0 
2. Turn on 3 stacked control boxes and 2 lamps. 
3. Press the “Focus Window” button – ‘F’ with a circle around it. This opens the Focus Control 
window 
a. Under the “Filter Set” tab select “User 1”.  
b. Select FITC button. The other buttons (Open, TRITC, CY5, DAPI) change the color of 
the light beam via changing the data collection filter. 
4. Change the objective to 40x Fluor (Do not use 40x LUCPL). 
5. The black focus knob on the right side of microscope, or the arrows on bottom right of Focus 
Control box can be used to bring and image into focus. 
6. Brightness: 
a. Increase exposure time; if there is too much red in picture, reduce exposure time. 
b. Bin size (resolution/size of pixel). Increasing the Bin size (1x1 to 2x2) decreases the 
resolution but increases the brightness of the sample. 
c. The exposure time should be maximized to get the best image. If red dots show up on the 
sample, the exposure is maxed out and the brightness needs to be decreased. 
7. If the image appears black, change the drop down box at the top center of the picture. window 
from “none” to a color scheme (greyscale, CY5, etc.) 
8. Use the joystick to navigate around the sample. 
9. Click the “Annotation” tab then “scale bar” to add a scale bar to the image. 
a. “settings” then “scale bar” to change the scale 
10. To take an image click the ‘Snap’ button in Focus Control window to take picture. 
11. Click “Open Fluor” to turn on the light beam. 
a. The light beam turns off after every picture so it must be turned on before snapping 
another image. 
12. To save an image: 
a. “My Documents” “Nina” folder 
b. This opens “Slide 2” window, which must be kept open to automatically save images to 
the folder. 
c. Save a copy of red and greyscale image. 
i. ‘Ctrl + i’ automatically saves image. 
ii. Save often because software randomly shuts down. 
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 Ramé-hart Standard Goniometer 
 Flat, sectioned samples 
 Glass coverslips 
 Kim wipes® 
 Eppendorf 10-100µm Hand Held Pipettor 
 10-100μm pipette tips 
 Diiodomethane (Sigma, 158429-100G) 
 Ethylene Glycol (Sigma, 329558-100mL) 
 Syringe to remove ethylene glycol from its sealed glass bottle 
 Deionized water 




 Save a few pellets and preserve them in cold mount media. Slice the preserved pellets to test in a 
goniometer, a device which tests the contact angle of water for the various artificial bone samples. If a 
water drop quickly passes through the sample, and has a low contact angle, than it is hydrophilic; if it has 




Contact angle measurements use a circular curve-fit to match the profile points closest to the outline of 
the drop on the surface. The profile points are subsequently used to analytically calculate the tangent, 
and contact angles. 
 
15. Safety is the first priority. Wear safety glasses, gloves, long pants, and close-toed shoes at all 
times in the lab environment. 
16. Spray ethanol on the work space to clean it. 
17. Place the pipettor in the sample holder arm (green arrow). The arm rotates freely, so tighten the 
screws to prevent it from moving during measurements.  
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18. Remove the lens cap from the camera. 
19. There are three knobs on that control the sample platform.  
a. The front knob (black arrow) is the image focus knob. It moves the sample closer or 
further from the camera. 
b. The knob on the right side of the platform (red arrow) moves the stage forward and 
backward. 




Figure G-1a-b. Contact angle images. a. Schematic of the angles created  in contact angle measurements. 
b. Machine setup. 
 
 
20. There are also three smaller knobs underneath the platform. They control the tilt angle of the 
platform. They should not  be adjusted, unless the machine is being calibrated!  
21. Place the sample on the silver platform. It needs to be on the back left (horizontally) and slightly 
toward the light source (vertically). Try to keep it within the black circle. Keep in mind sample 
location needs to be kept fairly uniform throughout all measurements.  
22. Turn on the light supply. It will be kept very low, less than 30%, for all measurements. 
23. The cables connecting to the camera are very delicate. Do not touch them or the light 
source/image on the screen will appear too dark to perform measurements. 
Computer Operation 
 





a. User: Boyes 
b. Password: Raft 
2. Click the DROPimage software. 
3. The camera will come up. As the sample platform is adjusted the camera image should adjust as 
well. If it does not, check the “Live Image” box. 
4. Click the contact angle image on the main tool bar. 
5. Set up the sample collection program. Tools: 
a. Number of collections: 5 
b. Frame averaging: 5 to10 
c. Tilt: needs to be between 0 +/-0.2 
d. Contrast: 50-60% 
6. Sample program: 
a. Select the substrate type from the drop down tab. Calcium phosphate is not listed in the 
tab so 0.00 is typically used. 
b. Select the droplet liquid from the drop down tab. Each time a different liquid is used this 
value needs to be changed. 
c. Specifically name the “Run Name” with the name of the sample, pellet number, slice 
number, and whether this is the first or second drop. Test each sample with at least two 
drops in two separate regions of the slice, or on multiple slices. 
d. If the liquid does not form a drop, and goes right through the sample, then the sample is 
determined to be completely wettable and measurements cannot be taken. 
 
  
Figure G-2ab a. Positioning of green lines to measure contact angle. b. Misreading by software. 
 
 
7. Click start. This will bring up two green lines on the camera image. The lines are controlled with  
the left/right and up/down arrows on the key board.  
a. Vertical line: Needs to be in the center of the drop.  
 a  b 
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b. Horizontal line: Needs to be placed so that it parallels the sample surface, and it lies over 
the exact points where each end of the drop meets the sample.  
c. The sample needs to lie completely flat, and the surface should parallel the green 
horizontal line. If it doesn’t use the coverslips to level the sample.  
 
8. Gently pipette 10μl of testing liquid on to the sample. Do not get bubbles in the droplet! Use the 
control knobs to move the horizontal green line, and therefore the sample, to the bottom inch of 
the DROPimage camera screen, and fine focus the image. 
a. The camera should have a good contrast between the sample surface and the droplet. If it 
is too bright the droplet will cause a reflection, if it is too dark the software won’t be able 
to determine the drop’s profile. Both will ruin the measurement.  
b. The angle of the camera should be slightly looking down onto the sample and drop. A 
slight football shaped reflection should show up on the sample surface directly 
underneath the drop.  
9. Click measure. As the program is measuring the contact angles, monitor the pink and blue 
outlines. They should match the profile of the drop exactly. If they don’t (black arrow) the 
measurements need to be restarted. 
a. After the measurements have run take an image of the drop with the measurement lines. 
Click File (Drop Image tool bar)Save image as. Specifically label it! 
b. Wait 10 seconds after the measurements have finished, and run a second set of 
measurements to analyze the effects of time on contact angle. Then take another image of 
the drop and the measurement lines. Click File (Drop Image tool bar)Save image as. 
Specifically label it again! 
10. After the measurements have finished click save the data. Click File (Contact angle tool bar) 
Generate log Folder (Nina). Then click “Stop” to end all program measurements. This will 
remove the lines from the drop. To take an image of the drop without lines click File 
(DROPimage tool bar)Save image as.  
11. Remove the sample from the platform and dry it thoroughly with a Kim wipe. Then let it air dry. 
Any residual liquid will skew drop results.  
12. Clear the data. Repeat the process for the same sample, so that there is data for two drops of the 
same liquid for each sample. Then repeat the process for all the other samples.  
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APPENDIX H CELL CULTURE PROTOCOL 
 
Objective: To successfully culture, expand, and freeze cell line HFOB 1.19. 
 
Note: Immediately upon receipt of cells make sure they are placed in liquid nitrogen or -80 °C storage so 
that they remain frozen and viable.  If cells arrive and are partially or fully thawed IMMEDIATELY place 
them into culture if you are to attempt to keep them viable. 
 
Materials 
 Hyclone 1:1 DMEM/F-12 
 Hyclone 0.25% trypsin EDTA 
 Hyclone FBS 
 MP Biomedicals G-418 
 Sigma cell-culture grade DMSO 
 VWR cryotubes (1 ml)    
 Fisherbrand non pyrogenic serological pipettes (various sizes) 
 BD Falcon centrifuge tubes (15 ml) 
 Fisherbrand microcentrifuge tubes (2.0 ml) 
 Nalgene Mr. Frosty Freezing Container 
 Nunc sterile cell-culture flasks (T-25, T-75, T-175) 
 
Starting a cell culture 
 
NOTES: The rule is freeze cells gradually, thaw cells rapidly, and always practice 
STERILE TECHNIQUE during all aspects of cell culture. 
 
1. First, make sure to turn on a bio safety cabinet (BSC) and thoroughly disinfect the entire area with 
70% ethanol. Let the BSC run for 15 minutes before beginning work in it. Once this is done place 
your cell specific cell culture medium (10% fetal Bovine serum, 3 mg/ml G418, in 1:1 DMEM/F-
12) into a 37
o
C water bath. Get the media up to temperature before beginning the thawing 
process. 
2. Once media is thoroughly heated fill a large (500 ml) beaker halfway with water from the bath and 
float a smaller beaker (250 ml) in the larger beaker. This will create a “double boiler” effect to 
rapidly thaw the cells.  
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3. Remove the cells from cryogenic storage and place the cryotube into the small beaker of the 
double boiler lying on its side. Check the cells frequently as they will thaw quickly. The cells 
should be completely thawed in about 5 minutes. 
4. While the cells thaw label a sterile T25 (25 cm2 working area) cell culture flask in the hood with 
appropriate culture information (cell type, date, passage #).  
5. When the cells have thawed take the tube and the media into the hood. Loosen the lids on the cell 
culture flask, the media, and the cryotube but do not remove them.  
6. First, remove the lid from the cryotube and carefully take up its contents into a 5 ml pipette. Next 
remove the cap from the cell culture flask and gently pipette the cells down the culture surface side 
of the flask. Replace the cap but do not screw tight. 
 
Figure H-1 Proper form for holding a small TCPS flaks at an angle. 
 
7. Change pipettes to a 10ml and remove the lid from the media flask. Pipette 10 ml out and replace 
the lid. Again remove the culture flask lid and gently dispense the media down the side of the 
flask.  
8. Now replace the lid on the cell culture flask and tighten. Lay it down on its bottom surface and 
gently rock to distribute cells. DO NOT bang the flask or allow the media to touch the lid.  
9. Place your cells in an incubator set to 34 °C and 5% CO2. Check the cells daily. 
 
Table H-1 Media and trypsin volumes for cell culture flasks 
Flask working volume Cell Media Trypsin EDTA (.25) 
T-25 10 ml 2 ml 
T-75 25 ml 5 ml 




Changing the media in a cell culture 
1. Place the cell culture media into a 370C water bath for at least 30 min to bring it to temperature. 
2. When the media is up to temperature place it in a disinfected BSC and transfer the cell culture 
flask(s) into the BSC.  
3. Loosen the lids on all flasks but leave them on the flask. Using sterile technique and a new 
pipette per flask carefully aspirate all media out of the flasks. Do not touch the sides or mouths 
of the flask(s) with the pipette(s). 
4. Add media of the appropriate volume back into the flasks and put them back into the incubator.          
5. While this should be done in accordance with the recommended media turnover time as per the 
ATCC, it will also depend on cell density within the flask.  
Figures H-2a-c. Images of proper sterile technique for cell culture. a. Proper form for opening a sterile 
plastic pipette. b. Proper form for holding a flask lid and inserting a pipette into a flask. c. Proper 
technique for grabbing a glass Pasteur pipette. 
   
 
Expanding a cell culture 
 
Note: It is time to expand a cell culture flask when the culture area appears to be 80% confluent. Cell 
density is critical because if a culture is expanded and there are not enough cells it can kill the culture.  
 
1. Place the media in the 37oC water bath and take out a bottle of 0.25% trypsin EDTA and leave it 
out until it reaches room temperature. These both must be warmed to the appropriate 
temperatures before using them on the cells. 
2. When the solutions are at temperature and it is time to expand, prepare the proper size flask(s) for 
the expansion. Again everything must be done in a BSC utilizing sterile technique.  
3. Take out the cell culture flask(s) and trypsin EDTA and place them in the BSC. As when changing 
media you should loosen the lids but do not remove them.   
4. With a Pasteur pipette aspirate the media from the cell culture flasks, making sure to not to touch 
the sides of the flasks and using a new pipette for each flask.                
 a  b  c 
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5. Once the media is aspirated off you must add trypsin EDTA to the flasks to cause the cells to 
detach from the flask.  
6. Using a 10 ml pipette slowly dispense the proper amount of trypsin EDTA down the bottom of the 
cell culture flask. It is essential to use the proper amount, as too little will result in incomplete 
detachment and too much can kill the cells.  
7. Incubate the flasks for 10-15 min or until the cells are detached. Do not incubate for over 20 
minutes.  
8. Once cells are detached add the trypsin/cell solution to a new cell culture flask and add cell culture 
media up to the working volume of the new flask(s) as well as the old (some cells will be left 
behind and the culture will expand again). 
9. Place the new and old flask(s) with new media back into the incubator. Check daily. 
 
Freezing the cells 
 
1. When cells have sufficiently expanded to a confluence of 80-90% in a large (T-175) cell culture 
flask they can be frozen down. 
2. Add trypsin to the flask as would be done during an expansion. 
3. When the cells have detached, pipette the solution into a falcon tube and centrifuge it at 100 G for 
5 minutes (each flask being frozen requires a separate falcon tube).  
4. After centrifuging a pellet should be visible at the bottom of the tube. Carefully, using sterile 
technique in a BSC, aspirate off the trypsin making sure not to dislodge the pellet.  
5. Add new media to the tube (amount depends on the size of the pellet, usually between 5 and 10 
ml) and using a small pipette gently transfer the liquid into the falcon tube to re-suspend the cells. 
Be mindful of the pipette gun during this process. Do not allow liquid to be sucked into the 
filter. 
6. Pipette 10 l of the suspension into a microcentrifuge tube and add an equal volume of trypan 
blue dye to the tube. Mix and then pipette out 9 l of this mixture onto a hemacytometer and 
gently place the cover slide on top of the drop (if air bubbles are present this must be repeated). 
Count the cells under a microscope. 
7. Use hemacytometer to count the cells and take the average:  
Number of cells per ml = 2 x average number counted x 10
4
 
Total cells in suspension = # of cells per ml x volume of original suspension 
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8. Take the remaining cell suspension (not the dyed solution) and centrifuge it at 100 G for 5 
minutes. When this is done aspirate off the media as before taking care not to aspirate the pellet as 
well. 
9. Depending on the size of the pellet, re-suspend cells in an appropriate volume of 10% Cell culture 
grade DMSO and 90% FBS in order to freeze at a density of 1-3 million cells/ml. 
10. Pipette this solution into clearly labeled cryo tubes and place these into a “Mr. Frosty” freezing 
chamber. Put this chamber into a -20 °C freezer. 
11. After the cells have been in the freezer overnight they must be transferred into a liquid nitrogen 
storage system or -80 °C for future use or they will not remain viable.                                                                                                                                                                                                                                    
 
 
 
 
 
 
 
 
 
 
 
 
 
